Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NEW PYRIDINE CARBOXAMIDES
Document Type and Number:
WIPO Patent Application WO/2019/154663
Kind Code:
A1
Abstract:
The present invention relates to the use of compounds of formula I, wherein the variables are defined as given in the description and claims. The invention further relates to the compounds I and composition for compounds of formula I.

Inventors:
SEET, Michael (Carl-Bosch-Strasse 38, Ludwigshafen, 67056, DE)
WOLF, Antje (Pfalzgrafenstraße 1, Ludwigshafen, 67061, DE)
MUELLER, Bernd (Carl-Bosch-Strasse 38, Ludwigshafen, 67056, DE)
RIEDIGER, Nadine (Speyerer Straße 2, Limburgerhof, 67117, DE)
FEHR, Marcus (Speyerer Straße 2, Limburgerhof, 67117, DE)
MENTZEL, Tobias (Industriestraße 35, Mannheim, 68169, DE)
GROTE, Thomas (Carl-Bosch-Strasse 38, Ludwigshafen, 67056, DE)
RUDOLF, Georg Christoph (Carl-Bosch-Strasse 38, Ludwigshafen, 67056, DE)
LOHMANN, Jan Klaas (Carl-Bosch-Strasse 38, Ludwigshafen, 67056, DE)
WINTER, Christian (Carl-Bosch-Strasse 38, Ludwigshafen, 67056, DE)
GRAMMENOS, Wassilios (Carl-Bosch-Strasse 38, Ludwigshafen, 67056, DE)
WIEBE, Christine (Carl-Bosch-Strasse 38, Ludwigshafen, 67056, DE)
TERTERYAN-SEISER, Violeta (Carl-Bosch-Strasse 38, Ludwigshafen, 67056, DE)
ESCRIBANO CUESTA, Ana (Carl-Bosch-Strasse 38, Ludwigshafen, 67056, DE)
Application Number:
EP2019/052031
Publication Date:
August 15, 2019
Filing Date:
January 29, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BASF SE (Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, 67056, DE)
International Classes:
C07D401/04; A01N43/86; A01N43/88; C07D213/22; C07D213/40; C07D407/04; C07D407/12; C07D409/04; C07D409/12; C07D413/12; C07D417/12
Domestic Patent References:
WO2003064572A12003-08-07
WO2001031042A22001-05-03
WO2001041558A12001-06-14
WO2002036831A22002-05-10
WO2011153186A12011-12-08
WO2013003558A12013-01-03
WO2002034946A22002-05-02
WO2002100163A22002-12-19
WO2003013224A22003-02-20
WO2004072235A22004-08-26
WO2004039986A12004-05-13
WO2005103266A12005-11-03
WO2006128573A22006-12-07
WO2007017186A12007-02-15
WO2008122406A12008-10-16
WO2008151780A12008-12-18
WO2012134808A12012-10-04
WO2013112527A12013-08-01
WO1998044140A11998-10-08
WO2004099447A22004-11-18
WO2004011601A22004-02-05
WO2005103301A22005-11-03
WO2005061720A22005-07-07
WO2005059103A22005-06-30
WO2006098952A22006-09-21
WO2006039376A22006-04-13
WO2007142840A22007-12-13
WO2007140256A12007-12-06
WO2008112019A22008-09-18
WO2009103049A22009-08-20
WO2009111263A12009-09-11
WO2010077816A12010-07-08
WO2011084621A12011-07-14
WO2011062904A12011-05-26
WO2011022469A22011-02-24
WO2013169923A22013-11-14
WO2014116854A12014-07-31
WO2015053998A12015-04-16
WO2015142571A12015-09-24
WO2014178910A12014-11-06
WO2014178913A12014-11-06
WO2014178941A12014-11-06
WO2014179276A12014-11-06
WO2016183445A12016-11-17
WO2017062831A12017-04-13
WO2017062825A12017-04-13
WO2000026345A12000-05-11
WO2004074492A12004-09-02
WO2006130436A22006-12-07
WO2006108674A22006-10-19
WO2006108675A22006-10-19
WO2008054747A22008-05-08
WO2008002872A22008-01-03
WO2009064652A12009-05-22
WO2009102873A12009-08-20
WO2010080829A12010-07-15
WO2010037016A12010-04-01
WO2011066384A12011-06-03
WO2011034704A12011-03-24
WO2012051199A22012-04-19
WO2012082548A22012-06-21
WO2013016527A12013-01-31
WO2013016516A12013-01-31
WO2014201235A22014-12-18
WO1998046608A11998-10-22
WO1999014187A11999-03-25
WO1999024413A21999-05-20
WO1999027783A11999-06-10
WO2000029404A12000-05-25
WO2000046148A12000-08-10
WO2000065913A12000-11-09
WO2001054501A22001-08-02
WO2001056358A22001-08-09
WO2002022583A22002-03-21
WO2002040431A22002-05-23
WO2003010149A12003-02-06
WO2003011853A12003-02-13
WO2003014103A12003-02-20
WO2003016286A12003-02-27
WO2003053145A12003-07-03
WO2003061388A12003-07-31
WO2003066609A12003-08-14
WO2003074491A12003-09-12
WO2004049804A22004-06-17
WO2004083193A12004-09-30
WO2005120234A22005-12-22
WO2005123689A12005-12-29
WO2005123690A12005-12-29
WO2005063721A12005-07-14
WO2005087772A12005-09-22
WO2005087773A12005-09-22
WO2006015866A12006-02-16
WO2006087325A12006-08-24
WO2006087343A12006-08-24
WO2007082098A22007-07-19
WO2007090624A22007-08-16
WO2010139271A12010-12-09
WO2011028657A12011-03-10
WO2012168188A12012-12-13
WO2007006670A12007-01-18
WO2011077514A12011-06-30
WO2013047749A12013-04-04
WO2010069882A12010-06-24
WO2013047441A12013-04-04
WO2003016303A12003-02-27
WO2009090181A22009-07-23
WO2013007767A12013-01-17
WO2013010862A12013-01-24
WO2013127704A12013-09-06
WO2013024009A12013-02-21
WO2013024010A12013-02-21
WO2013162072A12013-10-31
WO2013092224A12013-06-27
WO2011135833A12011-11-03
WO2012084812A12012-06-28
WO2009094442A22009-07-30
WO2014060177A12014-04-24
WO2013116251A22013-08-08
WO2008013622A22008-01-31
WO2015065922A12015-05-07
WO1994001546A11994-01-20
WO2007129454A12007-11-15
WO2012165511A12012-12-06
WO2011081174A12011-07-07
WO2013047441A12013-04-04
Foreign References:
EP3045455A12016-07-20
GB2001316A1979-01-31
US20070292854A12007-12-20
EP0141317A21985-05-15
EP0152031A21985-08-21
EP0226917A11987-07-01
EP0243970A11987-11-04
EP0256503A21988-02-24
EP0428941A11991-05-29
EP0532022A11993-03-17
EP1028125A12000-08-16
EP1035122A12000-09-13
EP1201648A12002-05-02
EP1122244A12001-08-08
JP2002316902A2002-10-31
DE19650197A11998-06-10
DE10021412A12001-06-21
DE102005009458A12006-09-07
US3296272A1967-01-03
US3325503A1967-06-13
CN1907024A2007-02-07
CN1456054A2003-11-19
CN103387541A2013-11-13
CN1309897A2001-08-29
EP2865265A12015-04-29
Other References:
VALÉRIE DOLLÉ ET AL: "Synthesis and Antiviral Activity of 4-Benzyl Pyridinone Derivatives as Potent and Selective Non-Nucleoside Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitors", JOURNAL OF MEDICINAL CHEMISTRY, vol. 43, no. 21, 1 October 2000 (2000-10-01), pages 3949 - 3962, XP055463191, ISSN: 0022-2623, DOI: 10.1021/jm0009437
GODARD A ET AL: "Metallation in connection with cross-coupling reactions. Coupling of hindered aryls for the synthesis of 4-phenylpyridines as part of Streptonigrin and Lavendamycin analogues", JOURNAL OF ORGANOMETALLIC CHEMISTRY, vol. 517, no. 1, 28 June 1996 (1996-06-28), ELSEVIER-SEQUOIA S.A. LAUSANNE, CH, pages 25 - 36, XP004035958, ISSN: 0022-328X, DOI: 10.1016/0022-328X(95)05979-Y
BENJAHAD A ET AL: "4-benzyl- and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones, a new family of potent anti-HIV agents: optimization and in vitro evaluation against clinically important HIV mutant strains", JOURNAL OF MEDICINAL CHEMISTRY, US, vol. 47, no. 22, 1 January 2004 (2004-01-01), pages 5501 - 5514, XP002549551, ISSN: 0021-9258, [retrieved on 20040929], DOI: 10.1021/JM0407658
ABDELLAH BENJAHAD ET AL: "4-Benzyl and 4-Benzoyl-3-dimethylaminopyridin-2(1 H )-ones: In Vitro Evaluation of New C-3-Amino-Substituted and C-5,6-Alkyl-Substituted Analogues against Clinically Important HIV Mutant Strains", JOURNAL OF MEDICINAL CHEMISTRY, vol. 48, no. 6, 1 March 2005 (2005-03-01), pages 1948 - 1964, XP055463572, ISSN: 0022-2623, DOI: 10.1021/jm0408621
DATABASE REGISTRY [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 12 June 2008 (2008-06-12), XP002779685, Database accession no. 1027457-17-5
DATABASE PubChem Compound [online] 4 August 2017 (2017-08-04), "Compound Summary for CID 129013548", XP002779686, retrieved from NCBI Database accession no. CID 129013548
DATABASE PubChem Compound [online] 4 August 2017 (2017-08-04), "Compound Summary for CID 129013550", XP002779687, retrieved from NCBI Database accession no. CID 129013550
DATABASE PubChem Compound [online] 4 August 2017 (2017-08-04), "Compound Summary for CID 129013551", XP002779688, retrieved from NCBI Database accession no. CID 129013551
CHEM. SOC. REV., 2009, pages 606 - 631
TETRAHEDRON, 2005, pages 10827 - 10852
J. MED. CHEM., vol. 38, no. 11, 1995, pages 1892 - 903
J. HETEROCYC. CHEM., vol. 18, no. 7, 1981, pages 1305 - 8
J. AM. CHEM. SOC., vol. 123, no. 25, 2001, pages 5962 - 5973
"Technical Monograph", May 2008, CROPLIFE INTERNATIONAL, article "Catalogue of pesticide formulation types and international coding system"
MOLLET; GRUBE-MANN: "Formulation technology", 2001, WILEY
KNOWLES: "New developments in crop protection product formulation", AGROW REPORTS DS243, 2005
MCCUTCHEON: "Emulsifiers & Detergents, McCutcheon's Directories", vol. 1, 2008, GLEN ROCK
KNOWLES: "Adjuvants and additives, Agrow Reports DS256", 2006, T&F INFORMA
J. PLANT SCI., vol. 48, no. 6, 1968, pages 587 - 94
Attorney, Agent or Firm:
BASF IP ASSOCIATION (BASF SE, G-FLP - C006, Ludwigshafen, 67056, DE)
Download PDF:
Claims:
Claims

1. Use of the ompounds of formula I

I

wherein

X is O, S, NH

R1 is in each case independently selected from hydrogen, halogen, OH, CN, COOH,

CONH2, N02, SH, NH2, NH(Ci-C4-alkyl), N(Ci-C4-alkyl)2, NH-S02-Rx, Ci-C6-alkyl, C2-C6- alkenyl, C2-C6-alkynyl, CrC6-alkoxy, C3-C6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein

Rx is Ci-C4-alkyl, Ci-C4-halogenalkyl, unsubstituted aryl or aryl that is substituted by 1 , 2, 3, 4 or 5 substituents Rx1 independently selected from Ci-C4-alkyl, halogen, OH, CN, Ci-C4-halogenalkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy; wherein the acyclic moieties of R1 are unsubstituted or substituted with identical or differ- ent groups R1a which independently of one another are selected from:

R1a halogen, OH, CN, COOH, CONH2, Ci-C6-alkoxy, C3-C6-cycloalkyl, C3-C6- halogencycloalkyl, Ci-C4-halogenalkoxy, Ci-C6-alkylthio, aryl and phenoxy, wherein the aryl group is unsubstituted or carries 1 , 2, 3, 4 or 5 substituents R11a selected from the group consisting of halogen, OH, Ci-C4-alkyl, Ci-C4-halogen- alkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy;

wherein the carbocyclic, heteroaryl and aryl moieties of R1 are not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R1b which independently of one another are selected from:

R1b halogen, OH, CN, COOH, CONH2, Ci-C4-alkyl, CrC4-alkoxy, Ci-C4-halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C4-halogenalkoxy and CrC6-al- kylthio;

R2 is in each case independently selected from halogen, OH, CN, COOH, CONH2, NO2, SH, NH2, NH(Ci-C4-alkyl), N(Ci-C4-alkyl)2, NH(C2-C4-alkenyl), N(C2-C4-alkenyl)2, NH(C2-C4-al- kynyl), N(C2-C4-alkynyl)2, NH(C3-C6-cycloalkyl), N(C3-C6-cycloalkyl)2, N(Ci-C4-alkyl)(C2-C4- alkenyl), N(Ci-C4-alkyl)(C2-C4-alkynyl), N(Ci-C4-alkyl)(C3-C6-cycloalkyl), N(C2-C4- alkenyl)(C2-C4-alkynyl), N(C2-C4-alkenyl)(C3-C6-cycloalkyl), N(C2-C4-alkynyl)(C3-C6-cyclo- alkyl), NH(C(=0)CrC4-alkyl), N(C(=0)CrC4-alkyl)2, NH-S02-Rx, S(0)n-Ci-C6-alkyl, S(0)n- aryl, Ci-C6-cycloalkylthio, S(0)n-C2-C6-alkenyl, S(0)n-C2-C6-alkynyl, CH(=0), C(=0)CrC6- alkyl, C(=0)C2-C6-alkenyl, C(=0)C2-C6-alkynyl, C(=0)C3-C6-cycloalkyl, C(=0)NH(CI-C6- alkyl), CH(=S), C(=S)C C6-alkyl, C(=S)C2-C6-alkenyl, C(=S)C2-C6-alkynyl, C(=S)C3-C6- cycloalkyl, C(=S)0(C2-C6-alkenyl), C(=S)0(C2-C6-alkynyl), C(=S)0(C3-C7-cycloalkyl), C(=S)NH(Ci-C6-alkyl), C(=S)NH(C2-C6-alkenyl), C(=S)NH(C2-C6-alkynyl), C(=S)NH(C3-C7- cycloalkyl),C(=S)N(Ci-C6-alkyl)2, C(=S)N(C2-C6-alkenyl)2, C(=S)N(C2-C6-alkynyl)2,

C(=S)N(C3-C7-cycloalkyl)2, Ci-C6-alkyl, Ci-C6-halogenalkyl, C2-C6-alkenyl, C2-C6-alkynyl, ORY, C3-C6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein

Rx is as defined above;

RY is Ci-C6-alkyl, CrC6-halogenalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, 02-OQ- alkynyl, C2-C6-halogenalkynyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, phenyl and phenyl-Ci-C6-alkyl; wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy and Ci-C4-halo- genalkoxy;

wherein the acyclic moieties of R2 are unsubstituted or substituted by groups R2a which independently of one another are selected from:

R2a halogen, OH, CN, COOH, CONH2, CrC6-alkoxy, C3-C6-cycloalkyl, 03-OQ- halogencycloalkyl, CrC4-halogenalkoxy, Ci-Ce-alkylthio and phenoxy, wherein the phenyl group is unsubstituted or substituted by substituents R91a selected from the group consisting of halogen, OH, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4- alkoxy and Ci-C4-halogenalkoxy;

wherein the carbocyclic, heteroaryl and aryl moieties of R2 are unsubstituted or substituted by groups R3b which independently of one another are selected from:

R2b halogen, OH, CN, COOH, CONH2, Ci-C4-alkyl, Ci-C4-alkoxy, Ci-C4-halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, CrC4-halogenalkoxy and CrC6-al- kylthio;

and wherein n is defined as above;

R3 is in each case independently selected from the substituents as defined for R2, wherein the possible substituents for R3 are R3a and R3b, respectively, which correspond to R2a and R2b, respectively;

R2, R3 together with the carbon atoms to which they are bound form a five- , six-, or seven- membered carbo-, heterocyclic or heteroaromatic ring; wherein the heterocyclic or heteroaromatic ring contains 1 , 2, 3 or 4 heteroatoms selected from N, O and S, wherein N may carry one substituent RN selected from Ci-C4-alkyl, CrC4-halogen- alkyl and S02Ph, wherein Ph is unsubstituted or substituted by substituents selected from Ci-C4-alkyl, halogen, Ci-C4-halogenalkyl, Ci-C4-alkoxy, Ci-C4-halogenalkoxy, and CN; and wherein S may be in the form of its oxide SO or S02; and wherein in each case one or two CH2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(=0) and C(=S); and wherein the carbo-, heter- ocyclic or heteroaromatic ring is substituent by (R23)m, wherein m is 0, 1 , 2, 3 or 4; R23 is in each case independently selected from halogen, OH, CN, COOH, CONH2, N02, SH, NH2, NH(Ci-C4-alkyl), N(Ci-C4-alkyl)2, NH-S02-Rx, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-al- kynyl, Ci-C6-alkoxy, C3-C6-cycloalkyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl and aryl; wherein the heterocycle and heteroaryl contains 1 , 2 or 3 heteroatoms selected from N, O and S; and wherein in each case one or two CH2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(=0) and C(=S); and wherein

Rx is as defined above;

wherein the acyclic moieties of R23 are unsubstituted or carry 1 , 2, 3 or up to the maximum pos- sible number of identical or different groups R23a which independently of one another are se- lected from:

R23a halogen, OH, CN, COOH, CONH2, Ci-C6-alkoxy, C3-C6-cycloalkyl, C3-C6- halogencycloalkyl, Ci-C4-halogenalkoxy, Ci-Ce-alkylthio and phenoxy, wherein the phenyl group is unsubstituted or unsubstituted or substituted with R91a se- lected from the group consisting of halogen, OH, Ci-C4-alkyl, Ci-C4-halogenalkyl, CrC4-alkoxy, Ci-C4-halogenalkoxy, CN, C3-C6-cycloalkyl, C3-C6-halogencycloal- kyl, Ci-C4-alkylthio;

wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R23 are unsubstituted or substituted with identical or different groups R23b which independently of one another are se- lected from:

R23b halogen, OH, CN, COOH, CONH2, Ci-C4-alkyl, Ci-C4-alkoxy, Ci-C4-halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C4-halogenalkoxy, and Ci-C6-al- kylthio;

R4 is in each case independently selected from hydrogen, halogen, OH, CN, COOH,

CON H2, N02I SH, NH2, NH(Ci-C4-alkyl), N(C C4-alkyl)2, NH-S02-Rx, Ci-C6-alkyl, C2-C6- alkenyl, C2-C6-alkynyl, Ci-C6-alkoxy, C3-C6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein

Rx is as defined above

wherein the aliphatic moieties of R4 are unsubstituted or substituted with identical or dif- ferent groups R2a which independently of one another are selected from:

R4a halogen, OH, CN, COOH, CONH2, CrC6-alkoxy, C3-C6-cycloalkyl, C3-C6- halogencycloalkyl, Ci-C4-halogenalkoxy, Ci-Ce-alkylthio, aryl and phenoxy, wherein the aryl group is unsubstituted or carries 1 , 2, 3, 4 or 5 substituents R41a selected from the group consisting of halogen, OH, Ci-C4-alkyl, Ci-C4-halogen- alkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy;

wherein the cycloalkyl, heteroaryl and aryl moieties of R4 are not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R4b which independently of one another are selected from: R4b halogen, OH, CN, COOH, CONH2, CrC4-alkyl, CrC4-alkoxy, CrC4-halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, CrC4-halogenalkoxy and CrC6-al- kylthio;

R5 is in each case independently selected from hydrogen, OH, CH(=0), C(=0)Ci-C6-alkyl, C(=0)C2-C6-alkenyl, C(=0)C2-C6-alkynyl, C(=0)C3-C6-cycloalkyl, Ci-C6-alkyl, Ci-C4-halo- genalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C4-alkoxy, Ci-C4-halogenalkoxy, ORY, C2-C6-alkenyl, C2-C6-halogenalkenyl C2-C6-alkynyl, C2-C6-halogenalkynyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three het- eroatoms selected from N, O and S; wherein the aryl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halo- gen, OH, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy;

RY is defined as above;

wherein the acyclic moieties of R5 are not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R5a which independently of one another are selected from:

R5a halogen, OH, CN, COOH, CONH2, Ci-C6-alkoxy, C3-C6-cycloalkyl, C3-C6-cycloal- kenyl, C3-C6-halogencycloalkyl, C3-C6-halogencycloalkenyl, CrC4-halogenalkoxy, Ci-C6-alkylthio, five- or six-membered heteroaryl, phenyl and phenoxy, wherein the heteroaryl, phenyl and phenoxy group is unsubstituted or carries one, two, three, four or five substituents R78a’ selected from the group consisting of halogen, OH, Ci- C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy;

wherein the alicyclic, phenyl, heterocyclic and heteroaryl moieties of R12 are not further substituted or carry one, two, three, four, five or up to the maximum number of identical or different groups R12b which independently of one another are selected from:

R5b halogen, OH, CN, COOH, CONH2, CrC4-alkyl, CrC4-alkoxy, CrC4-halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C4-halogenalkoxy and Ci-Ce-alkylthio;

R6 is independently selected from hydrogen, halogen, OH, CN, COOH, CONH2, NO2, SH, CrCe-alkylthio, NH2, NH(Ci-C4-alkyl), N(Ci-C4-alkyl)2, NH-S02-Rx, Ci-C6-alkyl, Ci-C6-hal- ogenalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, C1- C6-alkoxy, Ci-C6-halogenalkoxy, C2-C6-alkenyloxy, C2-C6-alkynyloxy, aryloxy, het- eroaryloxy, arylamino, heteroarylamino, arylthio, heteroarylthio, CH(=0), 0(=0)0I-0Q- alkyl, C(=0)0(C C6-alkyl), C(=0)NH(CrC6-alkyl), C(=0)N(CrC6-alkyl)2, CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten- membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl; wherein in each case one or two CH2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and the heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S; and wherein R’ and R” are independently selected from H, Ci-C4-alkyl, C2- C6-alkenyl, C2-C6-alkynyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl; wherein the heterocycle or heteroaryl contains one, two or three het- eroatoms selected from N, O and S, and wherein R’ and R” are independently unsubsti- tuted or substituted by R’” which is independently selected from halogen, OH, CN, NO2, SH, NH2, NH(Ci-C4-alkyl), N(Ci-C4-alkyl)2, NH-S02-Rx, Ci-C6-alkyl, Ci-C6-halogenalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, Ci-C6-alkoxy, Ci-C6-halogenalkoxy, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl and phenyl; or wherein the aliphatic moieties of and R6 are independently not further substituted or carry 1 , 2, 3 or up to the maximum possible number of identical or different groups R6a, respectively, which independently of one another are selected from:

R6a halogen, OH, CN, COOH, CONH2, N02, SH, NH2, NH(Ci-C4-alkyl), N(Ci-C4-al- kyl)2, NH-aryl, N(aryl)2, NH(C(=0)Ci-C4-aikyl), N(C(=0)Ci-C4-aikyl)2, NH-S02-Rx, Ci-C6-alkoxy, C3-C6-halogencycloalkyl, Ci-C4-halogenalkoxy, Ci-Ce-alkylthio, Ci- C6-halogenalkylthio, S(0)n-Ci-C6-alkyl, S(0)n-aryl, CH(=0), C(=0)Ci-C6-alkyl, C(=0)0(Ci-C6-aikyl), C(=0)NH(Ci-C6-aikyl), C(=0)N(Ci-C6-aikyl)2, CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, aryl, phenoxy, a five-, six- or ten-mem- bered heteroaryl; wherein in each case one or two CH2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), five- or six-membered heteroaryl and aryl; wherein the heterocycle and the heteroaryl contain independently 1 , 2, 3 or 4 heteroatoms selected from N, O and S; wherein in each case one or two CH2 groups of the carbo- and heterocy- cle may be replaced by a group independently selected from C(=0) and C(=S); wherein the carbocyclic, heterocyclic, aryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, N02, SH, NH2, NH(Ci-C4-alkyl), N(CrC4- alkyl)2, NH(C(=0)Ci-C4-aikyl), N(C(=0)Ci-C4-aikyl)2, NH-S02-Rx, Ci-C6-alkylthio, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy, Ci-C4-halogenalkoxy, and S(0)n- Ci-C6-alkyl; and wherein Rx, R’, R” and R” are as defined above

wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R6 are independently not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R6b, respectively, which independently of one another are selected from:

R6b halogen, OH, CN, COOH, CONH2, N02, SH, NH2, NH(C C4-alkyl), N(C C4-al- kyl)2, NH(C(=0)Ci-C4-aikyl), N(C(=0)CrC4-alkyl)2, NH-S02-Rx, C C4-alkyl, C C4-alkoxy, Ci-C4-halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C4- halogenalkoxy, Ci-Ce-alkylthio, Ci-C6-halogenalkylthio, S(0)n-Ci-C6-alkyl, Ci-C4- alkoxy-Ci-C4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubsti- tuted or substituted with substituents selected from the group consisting of halo- gen, OH, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy; and wherein Rx is as defined above; or

n is 0, 1 , 2 R7 is independently selected from

halogen, OH, CN, COOH, CONH2, N02, SH, Ci-C6-alkylthio, NH2, NH(C C4-alkyl), N(C C4-alkyl)2, NH-S02-Rx, Ci-C6-alkyl, Ci-C6-halogenalkyl, C2-C6-alkenyl, C2-C6-halogen- alkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, Ci-C6-alkoxy, Ci-C6-halogenalkoxy, C2-C6- alkenyloxy, C2-C6-alkynyloxy, aryloxy, heteroaryloxy, arylamino, heteroarylamino, ar- ylthio, heteroarylthio, CH(=0), C(=0)Ci-C6-alkyl, C(=0)0(Ci-C6-alkyl), C(=0)NH(Ci-C6- alkyl), C(=0)N(Ci-C6-alkyl)2, CR’=NOR”, a saturated or partially unsaturated three-, four- , five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl; wherein in each case one or two CH2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and the heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S; and wherein R’ and R” are in- dependently selected from H, Ci-C4-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, saturated or par- tially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl; wherein the heterocycle or heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein R’ and R” are independently unsubstituted or substituted by R’” which is inde- pendently selected from halogen, OH, CN, N02, SH, NH2, NH(Ci-C4-alkyl), N(CrC4-al- kyl)2, NH-S02-Rx, Ci-C6-alkyl, Ci-C6-halogenalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, Ci-C6-alkoxy, Ci-C6-halogenalkoxy, C3-C6-cycloal- kyl, C3-C6-halogencycloalkyl and phenyl; or

wherein the aliphatic moieties of and R7 are independently not further substituted or carry 1 , 2, 3 or up to the maximum possible number of identical or different groups R7a, respectively, which independently of one another are selected from:

R7a

halogen, OH, CN, COOH, CONH2, N02, SH, NH2, NH(Ci-C4-alkyl), N(C C4-alkyl)2, NH- aryl, N(aryl)2, NH(C(=0)Ci-C4-aikyl), N(C(=0)Ci-C4-aikyl)2, NH-S02-Rx, Ci-C6- alkoxy, C3-C6-halogencycloalkyl, Ci-C4-halogenalkoxy, Ci-Ce-alkylthio, Ci-C6-halo- genalkylthio, S(0)n-Ci-C6-alkyl, S(0)n-aryl, CH(=0), C(=0)Ci-C6-aikyl, C(=0)0(Ci- Ce-alkyl), C(=0)NH(Ci-C6-aikyl), C(=0)N(Ci-C6-aikyl)2, CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, aryl, phenoxy, a five-, six- or ten-membered heteroaryl; wherein in each case one or two CH2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), five- or six- membered heteroaryl and aryl; wherein the heterocycle and the heteroaryl contain independently 1 , 2, 3 or 4 heteroatoms selected from N, O and S; wherein in each case one or two CH2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S); wherein the carbocyclic, heter- ocyclic, aryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, N02, SH, NH2, NH(Ci-C4-alkyl), N(Ci-C4-alkyl)2, NH(C(=0)C C4-aikyl),

N(C(=0)Ci-C4-aikyl)2, NH-S02-Rx, Ci-Ce-alkylthio, Ci-C4-alkyl, Ci-C4-halogenalkyl, CrC4-alkoxy, CrC4-halogenalkoxy, and S(0)n-CrC6-alkyl; and wherein Rx, R’, R” and R” are as defined above

wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R7 are independently not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R7b, respectively, which independently of one another are selected from:

R7b halogen, OH, CN, COOH, CONH2, N02, SH, NH2, NH(Ci-C4-alkyl), N(Ci-C4-al- kyl)2, NH(C(=0)Ci-C4-aikyl), N(C(=0)Ci-C4-aikyl)2, NH-S02-Rx, Ci-C4-alkyl, Cr C4-alkoxy, Ci-C4-halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, C1-C4- halogenalkoxy, Ci-C6-alkylthio, Ci-C6-halogenalkylthio, S(0)n-Ci-C6-alkyl, C1-C4- alkoxy-Ci-C4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubsti- tuted or substituted with substituents selected from the group consisting of halo- gen, OH, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy; and wherein Rx is as defined above;

n is 0, 1 , 2

R8 is independently selected from CN, COOH, CONH2, Ci-C6-alkyl, Ci-C6-halogenalkyl, C2- C6-alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, CH(=0), C(=0)Ci-C6-aikyl, C(=0)0(Ci-C6-aikyl), C(=0)NH(Ci-C6-aikyl), C(=0)N(Ci-C6-aikyl)2, CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl; wherein in each case one or two CH2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the het- erocycle and the heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S, and wherein heterocycle and heteroaryl are connected via C atom; and wherein R’ and R” are independently selected from H, Ci-C4-alkyl, 02-OQ- alkenyl, C2-C6-alkynyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl; wherein the heterocycle or heteroaryl contains one, two or three heteroatoms se- lected from N, O and S, and wherein R’ and R” are independently unsubstituted or sub- stituted by R’” which is independently selected from halogen, OH, CN, N02, SH, NH2, NH(Ci-C4-alkyl), N(Ci-C4-alkyl)2, NH-S02-Rx, Ci-C6-alkyl, Ci-C6-halogenalkyl, 02-OQ- alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, Ci-C6-alkoxy, C1-C6- halogenalkoxy, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl and phenyl; or

wherein the aliphatic moieties of and R8 are independently not further substituted or carry 1 , 2, 3 or up to the maximum possible number of identical or different groups R8a, respectively, which independently of one another are selected from:

R8a halogen, OH, CN, COOH, CONH2, N02, SH, NH2, NH(Ci-C4-alkyl), N(Ci-C4-al- kyl)2, NH(C(=0)Ci-C4-aikyl), N(C(=0)Ci-C4-aikyl)2, NH-S02-Rx, Ci-C6-alkoxy, C3-C6-halogencycloalkyl, Ci-C4-halogenalkoxy, Ci-C6-alkylthio, Ci-C6-halogen- alkylthio, S(0)n-Ci-C6-alkyl, S(0)n-aryl, CH(=0), C(=0)Ci-C6-aikyl, C(=0)0(Cr Ce-alkyl), C(=0)NH(Ci-C6-aikyl), C(=0)N(Ci-C6-aikyl)2, CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-mem- bered carbocycle or heterocycle, aryl, phenoxy, a five-, six- or ten-membered het- eroaryl; wherein in each case one or two Chh groups of the carbo- and heterocy- cle may be replaced by a group independently selected from C(=0) and C(=S), five- or six-membered heteroaryl and aryl; wherein the heterocycle and the het- eroaryl contain independently 1 , 2, 3 or 4 heteroatoms selected from N, O and S; wherein in each case one or two Chh groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S); wherein the carbocyclic, heterocyclic, aryl and phenyl groups are independently unsubsti- tuted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO2, SH, NH2, NH(Ci-C4-alkyl), N(Ci-C4-alkyl)2, NH(C(=0)Ci-C4-aikyl), N(C(=0)Ci-C4-alkyl)2, NH-S02-Rx, Ci-C6-alkylthio, C1-C4- alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy, Ci-C4-halogenalkoxy, and S(0)n-Ci-C6- alkyl; and wherein Rx, R’, R” and R” are as defined above

wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R8 are independently not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R8b, respectively, which independently of one another are selected from:

R8b halogen, OH, CN, COOH, CONH2, N02, SH, NH2, NH(CrC4-alkyl), N(CrC4-al- kyl)2, NH(C(=0)Ci-C4-aikyl), N(C(=0)Ci-C4-alkyl)2, NH-S02-Rx, Ci-C4-alkyl, Cr C4-alkoxy, Ci-C4-halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, C1-C4- halogenalkoxy, Ci-Ce-alkylthio, Ci-C6-halogenalkylthio, S(0)n-Ci-C6-alkyl, C1-C4- alkoxy-Ci-C4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubsti- tuted or substituted with substituents selected from the group consisting of halo- gen, OH, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy; and wherein Rx is as defined above;

n is 0, 1 , 2

and the N-oxides and the agriculturally acceptable salts thereof as fungicides.

2. The use of claim 1 , wherein R1 is H, F, Cl, Br, CN, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, Ci-C6-alkoxy, C3-C6-cycloalkyl, wherein the acyclic moieties of R1 are unsubtitted or substi- tuted by halogen.

3. The use of claims 1 or 2, wherein R2 is selected from CN, halogen, Ci-C6-alkyl, Ci-C6-halo- genalkyl, C2-C6-alkynyl, ORY, C3-C6-cycloalkyl, wherein

RY is Ci-C6-alkyl, Ci-C6-halogenalkyl, C2-C6-alkenyl or C2-C6-alkynyl.

4. The use of any one of claims 1 to 3, wherein R3 is selected from CN, halogen, Ci-C6-alkyl, CrC6-halogenalkyl, C2-C6-alkynyl, ORY, C3-C6-cycloalkyl, wherein

RY is Ci-C6-alkyl, Ci-C6-halogenalkyl, C2-C6-alkenyl or C2-C6-alkynyl.

5. The use of any one of claims 1 to 4, wherein R4 is H, F, Cl, Br, CN, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, Ci-C6-alkoxy, C3-C6-cycloalkyl, wherein the acyclic moieties of R1 are unsubtit- ted or substituted by halogen.

6. The use of any one of claims 1 to 5, wherein R5 is H.

7. The use of any one of claims 1 to 5, wherein R6 is selected from CN, Ci-C6-alkyl, CrC6-halo- genalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C3-C6-cycloalkenyl, C2-C6-alkynyl, C2-C6-halo- genalkynyl, Ci-C6-alkoxy, C3-C6-cycloalkynyl, C(=0)Ci-C6-alkyl, C(=0)0(Ci-C6-alkyl),

CR’=NOR”, a saturated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six-membered heteroaryl, benzyl or aryl.

8. The use of any one of claims 1 to 7, wherein R7 and R8 are independently selected from CN, CrC6-alkyl, CrC6-halogenalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C3-C6-cycloalkenyl, C2- C6-alkynyl, C2-C6-halogenalkynyl, CrC6-alkoxy, C3-C6-cycloalkynyl, C(=0)CrC6-alkyl, C(=0)0(Ci-C6-alkyl), CR -NOR”, a saturated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six-membered heteroaryl, benzyl or aryl.

9. Compounds of the fomula I as defined in claims 1 to 8,

wherein R6, R7 and R8 are as defined above and

X is O,

R1 is H,

R2 is Ci-C6-alkyl and Ci-C6-halogenalkyl,

R3 is CrC6-alkyl and CrC6-halogenalkyl,

R4 is H,

R5 is H.

10. Compounds of the fomula I as defined in claims 1 to 9,

wherein R6, R7 and R8 are as defined above and

X is O,

R1 is in each case independently selected from CN, COOH, CONH2, Ci-C6-alkyl, C2-C6- alkenyl, C2-C6-alkynyl, CrC6-alkoxy, C3-C6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein

Rx is Ci-C4-alkyl, Ci-C4-halogenalkyl, unsubstituted aryl or aryl that is substituted by 1 , 2, 3, 4 or 5 substituents Rx1 independently selected from Ci-C4-alkyl, halogen, OH, CN, Ci-C4-halogenalkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy; wherein the acyclic moieties of R1 are unsubstituted or substituted with identical or differ- ent groups R1a which independently of one another are selected from: R1a halogen, OH, CN, COOH, CONH2, Ci-C6-alkoxy, C3-C6-cycloalkyl, C3-C6- halogencycloalkyl, Ci-C4-halogenalkoxy, CrC6-alkylthio, aryl and phenoxy, wherein the aryl group is unsubstituted or carries 1 , 2, 3, 4 or 5 substituents R11a selected from the group consisting of halogen, OH, Ci-C4-alkyl, Ci-C4-halogen- alkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy;

wherein the carbocyclic, heteroaryl and aryl moieties of R1 are not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R1b which independently of one another are selected from:

R1b halogen, OH, CN, COOH, CONH2, Ci-C4-alkyl, CrC4-alkoxy, Ci-C4-halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, CrC4-halogenalkoxy and CrC6-al- kylthio;

R2 is Ci-C6-alkyl and Ci-C6-halogenalkyl,

R3 is Ci-C6-alkyl and Ci-C6-halogenalkyl,

R4 is is in each case independently selected from CN, COOH, CONH2, Ci-C6-alkyl, 02-0Q- alkenyl, C2-C6-alkynyl, Ci-C6-alkoxy, C3-C6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein

Rx is Ci-C4-alkyl, CrC4-halogenalkyl, unsubstituted aryl or aryl that is substituted by 1 , 2, 3, 4 or 5 substituents Rx4 independently selected from Ci-C4-alkyl, halogen, OH, CN, Ci-C4-halogenalkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy; wherein the acyclic moieties of R4 are unsubstituted or substituted with identical or differ- ent groups R4a which independently of one another are selected from:

R4a halogen, OH, CN, COOH, CONH2, Ci-C6-alkoxy, C3-C6-cycloalkyl, C3-C6- halogencycloalkyl, Ci-C4-halogenalkoxy, Ci-C6-alkylthio, aryl and phenoxy, wherein the aryl group is unsubstituted or carries 1 , 2, 3, 4 or 5 substituents R41a selected from the group consisting of halogen, OH, CrC4-alkyl, Ci-C4-halogen- alkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy;

wherein the carbocyclic, heteroaryl and aryl moieties of R4 are not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R4b which independently of one another are selected from:

R4b halogen, OH, CN, COOH, CONH2, Ci-C4-alkyl, Ci-C4-alkoxy, Ci-C4-halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C4-halogenalkoxy and Ci-C6-al- kylthio;

R5 is H.

11. A composition, comprising one compound of formula I, as defined in any of the claims 1 to 10, an N-oxide or an agriculturally acceptable salt thereof.

12. A use of a compound of the formula I, as defined in any of the claims 1 to 10, and of an agriculturally acceptable salt thereof and of the compositions, as defined in any of the claim 11 , for combating phytopathogenic fungi. 13. A method for combating phytopathogenic fungi, comprising treating the fungi or the mate- rials, plants, the soil or seeds to be protected against fungal attack with an effective amount of at least one compound of formula I, as defined in any of the claims 1 to 10 or with a composi- tion, as defined in any of the claim 11.

14. Seed, coated with at least one compound of the formula I, as defined in any of the claims 1 to 10 or an agriculturally acceptable salt thereof or with a composition, as defined in any of the claim 11 , in an amount of from 0.1 to 10 kg per 100 kg of seed.

Description:
New pyridine carboxamides

The present invention relates to pyridine compounds and the N-oxides and the salts thereof for combating phytopathogenic fungi, and to the use and methods for combating phytopathogenic fungi and to seeds coated with at least one such compound. The invention also relates to pro- cesses for preparing these compounds, intermediates, processes for preparing such intermedi- ates, and to compositions comprising at least one compound I.

In many cases, in particular at low application rates, the fungicidal activity of the known fungi- cidal compounds is unsatisfactory. Based on this, it was an object of the present invention to provide compounds having improved activity and/or a broader activity spectrum against phyto- pathogenic harmful fungi.

Surprisingly, this object is achieved by the use of the inventive pyridine compounds of formula I having favorable fungicidal activity against phytopathogenic fungi.

Accordingly, the present invention relates to use of the compounds of formula I

wherein

X is O, S, NH

R 1 is in each case independently selected from hydrogen, halogen, OH, CN, COOH,

CONH 2 , N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, C 2 -C 6 - alkenyl, C2-C6-alkynyl, Ci-C 6 -alkoxy, C3-C6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein

R x is Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, unsubstituted aryl or aryl that is substituted by 1 , 2, 3, 4 or 5 substituents R x1 independently selected from Ci-C 4 -alkyl, halogen, OH, CN, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy;

wherein the acyclic moieties of R 1 are unsubstituted or substituted with identical or differ- ent groups R 1a which independently of one another are selected from:

R 1a halogen, OH, CN, COOH, CONH2, Ci-C 6 -alkoxy, C3-C6-cycloalkyl, C3-C6- halogencycloalkyl, Ci-C 4 -halogenalkoxy, Ci-C 6 -alkylthio, aryl and phenoxy, wherein the aryl group is unsubstituted or carries 1 , 2, 3, 4 or 5 substituents R 11a selected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogen- alkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy;

wherein the carbocyclic, heteroaryl and aryl moieties of R 1 are not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R 1b which independently of one another are selected from: R 1b halogen, OH, CN, COOH, CONH 2 , Ci-C 4 -alkyl, CrC 4 -alkoxy, Ci-C 4 -halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-C 6 -al- kylthio;

R 2 is in each case independently selected from halogen, OH, CN, COOH, CONH2, NO2, SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C 2 -C 4 -alkenyl), N(C 2 -C 4 -alkenyl) 2 , NH(C 2 -C 4 -al- kynyl), N(C2-C 4 -alkynyl)2, NH(C3-C6-cycloalkyl), N(C3-C6-cycloalkyl)2, N(Ci-C 4 -alkyl)(C2-C 4 - alkenyl), N(Ci-C 4 -alkyl)(C2-C 4 -alkynyl), N(Ci-C 4 -alkyl)(C3-C6-cycloalkyl), N(C2-C 4 - alkenyl)(C2-C 4 -alkynyl), N(C2-C 4 -alkenyl)(C3-C6-cycloalkyl), N(C2-C 4 -alkynyl)(C3-C6-cyclo- alkyl), NH(C(=0)C r C 4 -alkyl), N(C(=0)CrC 4 -alkyl) 2, NH-S0 2 -R x , S(0) n -Ci-C 6 -alkyl, S(0) n - aryl, Ci-C 6 -cycloalkylthio, S(0) n -C 2 -C 6 -alkenyl, S(0) n -C 2 -C 6 -alkynyl, CH(=0), C(=0)Ci-C 6 - alkyl, C(=0)C 2 -C 6 -alkenyl, C(=0)C 2 -C 6 -alkynyl, C(=0)C 3 -C 6 -cycloalkyl, C(=0)NH(C I -C 6 - alkyl), CH(=S), C(=S)Ci-C 6 -alkyl, C(=S)C 2 -C 6 -alkenyl, C(=S)C 2 -C 6 -alkynyl, C(=S)C 3 -C 6 - cycloalkyl, C(=S)0(C 2 -C 6 -alkenyl) , C(=S)0(C 2 -C 6 -alkynyl) , C(=S)0(C 3 -C 7 -cycloalkyl) , C(=S)NH(Ci-C 6 -alkyl), C(=S)NH(C 2 -C 6 -alkenyl) , C(=S)NH(C 2 -C 6 -alkynyl) , C(=S)NH(C 3 -C 7 - cycloalkyl),C(=S)N(Ci-C 6 -alkyl) 2 , C(=S)N(C 2 -C 6 -alkenyl) 2, C(=S)N(C 2 -C 6 -alkynyl) 2,

C(=S)N(C 3 -C 7 -cycloalkyl) 2, CrC 6 -alkyl, Ci-C 6 -halogenalkyl, C2-C6-alkenyl, C2-C6-alkynyl, OR Y , C3-C6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein

R x is as defined above;

R Y is Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6- alkynyl, C2-C6-halogenalkynyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, phenyl and phenyl-Ci-C 6 -alkyl; wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and CrC 4 -halo- genalkoxy;

wherein the acyclic moieties of R 2 are unsubstituted or substituted by groups R 2a which independently of one another are selected from:

R 2a halogen, OH, CN, COOH, CONH2, Ci-C 6 -alkoxy, C3-C6-cycloalkyl, C3-C6- halogencycloalkyl, Ci-C 4 -halogenalkoxy, Ci-Ce-alkylthio and phenoxy, wherein the phenyl group is unsubstituted or substituted by substituents R 91a selected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 - alkoxy and Ci-C 4 -halogenalkoxy;

wherein the carbocyclic, heteroaryl and aryl moieties of R 2 are unsubstituted or substituted by groups R 3b which independently of one another are selected from:

R 2b halogen, OH, CN, COOH, CONH2, Ci-C 4 -alkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-C 6 -al- kylthio;

and wherein n is defined as above;

R 3 is in each case independently selected from the substituents as defined for R 2 , wherein the possible substituents for R 3 are R 3a and R 3b , respectively, which correspond to R 2a and R 2b , respectively; R 2 , R 3 together with the carbon atoms to which they are bound form a five- , six-, or seven- membered carbo-, heterocyclic or heteroaromatic ring; wherein the heterocyclic or heteroaromatic ring contains 1 , 2, 3 or 4 heteroatoms selected from N, O and S, wherein N may carry one substituent R N selected from Ci-C4-alkyl, Ci-C 4 -halogen- alkyl and SC>2Ph, wherein Ph is unsubstituted or substituted by substituents selected from Ci-C4-alkyl, halogen, Ci-C4-halogenalkyl, Ci-C4-alkoxy, Ci-C4-halogenalkoxy, and CN; and wherein S may be in the form of its oxide SO or S0 2 ; and wherein in each case one or two CH 2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(=0) and C(=S); and wherein the carbo-, heter- ocyclic or heteroaromatic ring is substituent by (R 23 ) m , wherein m is 0, 1 , 2, 3 or 4;

R 23 is in each case independently selected from halogen, OH, CN, COOH, CONH 2 , N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -al- kynyl, Ci-C 6 -alkoxy, C3-C6-cycloalkyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl and aryl; wherein the heterocycle and heteroaryl contains 1 , 2 or 3 heteroatoms selected from N, O and S; and wherein in each case one or two CH 2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(=0) and C(=S); and wherein

R x is as defined above;

wherein the acyclic moieties of R 23 are unsubstituted or carry 1 , 2, 3 or up to the maximum pos- sible number of identical or different groups R 23a which independently of one another are se- lected from:

R 23a halogen, OH, CN, COOH, CONH 2 , Ci-C 6 -alkoxy, C3-C6-cycloalkyl, C3-C6- halogencycloalkyl, CrC4-halogenalkoxy, Ci-Ce-alkylthio and phenoxy, wherein the phenyl group is unsubstituted or unsubstituted or substituted with R 91a se- lected from the group consisting of halogen, OH, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy, Ci-C4-halogenalkoxy, CN, C3-C6-cycloalkyl, C3-C6-halogencycloal- kyl, Ci-C4-alkylthio;

wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R 23 are unsubstituted or substituted with identical or different groups R 23b which independently of one another are se- lected from:

R 23b halogen, OH, CN, COOH, CONH 2 , Ci-C4-alkyl, CrC4-alkoxy, Ci-C4-halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, CrC4-halogenalkoxy, and CrC 6 -al- kylthio;

R 4 is in each case independently selected from hydrogen, halogen, OH, CN, COOH,

CON H 2 , N0 2I SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, C 2 -C 6 - alkenyl, C 2 -C 6 -alkynyl, Ci-C 6 -alkoxy, C3-C6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein

R x is as defined above wherein the aliphatic moieties of R 4 are unsubstituted or substituted with identical or dif- ferent groups R 2a which independently of one another are selected from:

R 4a halogen, OH, CN, COOH, CONH 2 , Ci-C 6 -alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 - halogencycloalkyl, Ci-C 4 -halogenalkoxy, Ci-Ce-alkylthio, aryl and phenoxy, wherein the aryl group is unsubstituted or carries 1 , 2, 3, 4 or 5 substituents R 41a selected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogen- alkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy;

wherein the cycloalkyl, heteroaryl and aryl moieties of R 4 are not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R 4b which independently of one another are selected from:

R 4b halogen, OH, CN, COOH, CONH 2 , Ci-C 4 -alkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-C6-al- kylthio;

R 5 is in each case independently selected from hydrogen, OH, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)C 2 -C 6 -alkenyl, C(=0)C 2 -C 6 -alkynyl, C(=0)C 3 -C 6 -cycloalkyl, Ci-C 6 -alkyl, Ci-C 4 -halo- genalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -alkoxy, CrC 4 -halogenalkoxy, OR Y , C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three het- eroatoms selected from N, O and S; wherein the aryl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halo- gen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy;

R Y is defined as above;

wherein the acyclic moieties of R 5 are not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R 5a which independently of one another are selected from:

R 5a halogen, OH, CN, COOH, CONH 2 , Ci-C 6 -alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloal- kenyl, C 3 -C 6 -halogencycloalkyl, C 3 -C 6 -halogencycloalkenyl, Ci-C 4 -halogenalkoxy, Ci-C 6 -alkylthio, five- or six-membered heteroaryl, phenyl and phenoxy, wherein the heteroaryl, phenyl and phenoxy group is unsubstituted or carries one, two, three, four or five substituents R 78a’ selected from the group consisting of halogen, OH, Ci- C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy;

wherein the alicyclic, phenyl, heterocyclic and heteroaryl moieties of R 12 are not further substituted or carry one, two, three, four, five or up to the maximum number of identical or different groups R 12b which independently of one another are selected from:

R 5b halogen, OH, CN, COOH, CONH 2 , Ci-C 4 -alkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-Ce-alkylthio; R 6 is independently selected from hydrogen, halogen, OH, CN, COOH, CONH 2 , N0 2 , SH, CrCe-alkylthio, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, Ci-C 6 -hal- ogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, Ci- C 6 -alkoxy, Ci-C 6 -halogenalkoxy, C 2 -C 6 -alkenyloxy, C 2 -C 6 -alkynyloxy, aryloxy, het- eroaryloxy, arylamino, heteroarylamino, arylthio, heteroarylthio, CH(=0), C(=0)Ci-C6- alkyl, C(=0)0(Ci-C 6 -alkyl), C(=0)NH(Ci-C 6 -alkyl), C(=0)N(Ci-C 6 -alkyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten- membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and the heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S; and wherein R’ and R” are independently selected from H, Ci-C 4 -alkyl, C 2 - C 6 -alkenyl, C 2 -C 6 -alkynyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl; wherein the heterocycle or heteroaryl contains one, two or three het- eroatoms selected from N, O and S, and wherein R’ and R” are independently unsubsti- tuted or substituted by R’” which is independently selected from halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl and phenyl; or wherein the aliphatic moieties of and R 6 are independently not further substituted or carry 1 , 2, 3 or up to the maximum possible number of identical or different groups R 6a , respectively, which independently of one another are selected from:

R 6a halogen, OH, CN, COOH, CONH 2 , N0 2 , SH, NH 2 , NH(C C 4 -alkyl), N(Ci-C 4 -al- kyl) 2 , NH-aryl, N(aryl) 2 , NH(C(=0)C r C 4 -alkyl), N(C(=0)C C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkoxy, C3-C6-halogencycloalkyl, Ci-C 4 -halogenalkoxy, Ci-Ce-alkylthio, Ci- C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(Ci-C 6 -aikyl), C(=0)N(Ci-C 6 -aikyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, aryl, phenoxy, a five-, six- or ten-mem- bered heteroaryl; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), five- or six-membered heteroaryl and aryl; wherein the heterocycle and the heteroaryl contain independently 1 , 2, 3 or 4 heteroatoms selected from N, O and S; wherein in each case one or two CH 2 groups of the carbo- and heterocy- cle may be replaced by a group independently selected from C(=0) and C(=S); wherein the carbocyclic, heterocyclic, aryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(C I -C 4 - alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , C r C 6 -alkylthio, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, and S(0) n - Ci-C 6 -alkyl; and wherein R x , R’, R” and R” are as defined above

wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R 6 are independently not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R 6b , respectively, which independently of one another are selected from:

R 6b halogen, OH, CN, COOH, CONH 2 , N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -al- kyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-C 4 -alkyl, Cr C 4 -alkoxy, Ci-C 4 -halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, C1-C4- halogenalkoxy, Ci-C 6 -alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, C1-C4- alkoxy-Ci-C4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubsti- tuted or substituted with substituents selected from the group consisting of halo- gen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, CrC4-alkoxy and CrC4-halogenalkoxy; and wherein R x is as defined above; or

n is 0, 1 , 2

R 7 is independently selected from

halogen, OH, CN, COOH, CONH 2 , N0 2 , SH, Ci-C 6 -alkylthio, NH 2, NH(Ci-C 4 -alkyl), N(Ci- C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogen- alkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy, 0 2 -O Q - alkenyloxy, C 2 -C 6 -alkynyloxy, aryloxy, heteroaryloxy, arylamino, heteroarylamino, ar- ylthio, heteroarylthio, CH(=0), C(=0)Ci-C 6 -aikyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(Ci-C 6 - alkyl), C(=0)N(Ci-C 6 -alkyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four- , five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and the heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S; and wherein R’ and R” are in- dependently selected from H, Ci-C 4 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, saturated or par- tially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl; wherein the heterocycle or heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein R’ and R” are independently unsubstituted or substituted by R’” which is inde- pendently selected from halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -al- kyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy, C3-C6-cycloal- kyl, C3-C6-halogencycloalkyl and phenyl; or

wherein the aliphatic moieties of and R 7 are independently not further substituted or carry 1 , 2, 3 or up to the maximum possible number of identical or different groups R 7a , respectively, which independently of one another are selected from:

R 7a

halogen, OH, CN, COOH, CONH 2 , N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH- aryl, N(aryl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-C 6 - alkoxy, C3-C6-halogencycloalkyl, Ci-C4-halogenalkoxy, Ci-C 6 -alkylthio, Ci-C 6 -halo- genalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)C C 6 -alkyl, C(=0)0(C r Ce-alkyl), C(=0)NH(Ci-C 6 -aikyl), C(=0)N(Ci-C 6 -aikyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, aryl, phenoxy, a five-, six- or ten-membered heteroaryl; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), five- or six- membered heteroaryl and aryl; wherein the heterocycle and the heteroaryl contain independently 1 , 2, 3 or 4 heteroatoms selected from N, O and S; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S); wherein the carbocyclic, heter- ocyclic, aryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, N0 2 , SH, NH 2I NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl),

N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-Ce-alkylthio, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, and S(0) n -Ci-C 6 -alkyl; and wherein R x , R’, R” and R” are as defined above

wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R 7 are independently not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R 7b , respectively, which independently of one another are selected from:

R 7b halogen, OH, CN, COOH, CONH 2 , N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -al- kyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-C 4 -alkyl, Cr C 4 -alkoxy, Ci-C 4 -halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C 4 - halogenalkoxy, Ci-C 6 -alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, Ci-C 4 - alkoxy-Ci-C 4 -alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubsti- tuted or substituted with substituents selected from the group consisting of halo- gen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, CrC 4 -alkoxy and Ci-C 4 -halogenalkoxy; and wherein R x is as defined above;

n is 0, 1 , 2

R 8 is independently selected from CN, COOH, CONH 2 , Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 - C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), C(=0)NH(Ci-C 6 -aikyl), C(=0)N(Ci-C 6 -aikyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the het- erocycle and the heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S, and wherein heterocycle and heteroaryl are connected via C atom; and wherein R’ and R” are independently selected from H, Ci-C 4 -alkyl, 0 2 -O Q - alkenyl, C 2 -C 6 -alkynyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl; wherein the heterocycle or heteroaryl contains one, two or three heteroatoms se- lected from N, O and S, and wherein R’ and R” are independently unsubstituted or sub- stituted by R’” which is independently selected from halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 - alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, CrC 6 -alkoxy, O I -O Q - halogenalkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl and phenyl; or

wherein the aliphatic moieties of and R 8 are independently not further substituted or carry 1 , 2, 3 or up to the maximum possible number of identical or different groups R 8a , respectively, which independently of one another are selected from:

R 8a halogen, OH, CN, COOH, CONH 2 , N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -al- kyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkoxy, C3-C6-halogencycloalkyl, Ci-C4-halogenalkoxy, Ci-C 6 -alkylthio, CrC 6 -halogen- alkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(C r Ce-alkyl), C(=0)NH(Ci-C 6 -alkyl), C(=0)N(Ci-C 6 -alkyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-mem- bered carbocycle or heterocycle, aryl, phenoxy, a five-, six- or ten-membered het- eroaryl; wherein in each case one or two CH2 groups of the carbo- and heterocy- cle may be replaced by a group independently selected from C(=0) and C(=S), five- or six-membered heteroaryl and aryl; wherein the heterocycle and the het- eroaryl contain independently 1 , 2, 3 or 4 heteroatoms selected from N, O and S; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S); wherein the carbocyclic, heterocyclic, aryl and phenyl groups are independently unsubsti- tuted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO2, SH, NH2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl)2, NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkylthio, Ci-C 4 - alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, and S(0) n -Ci-C 6 - alkyl; and wherein R x , R’, R” and R” are as defined above

wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R 8 are independently not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R 8b , respectively, which independently of one another are selected from:

R 8b halogen, OH, CN, COOH, CONH 2 , N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -al- kyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-C 4 -alkyl, Cr C 4 -alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 - halogenalkoxy, Ci-C 6 -alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, Ci-C 4 - alkoxy-Ci-C 4 -alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubsti- tuted or substituted with substituents selected from the group consisting of halo- gen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy; and wherein R x is as defined above;

n is 0, 1 , 2

and the N-oxides and the agriculturally acceptable salts thereof as fungicides.

The numbering of the ring members and substituents in the compounds of the present invention is as given in formula I above. A skilled person will realize that compounds of formula I can be accessed via an amide coupling reaction of 3-aminopyridines of type II with carboxylic acids of type III. Among various reported methods for such amide coupling reactions, a robust method involves the treatment of carboxylic acids of type III with thionyl chloride or oxalyl chloride or dicyclohexylcarbodiimide in solvents like tetrahydrofurane, dimethylformamide or dichloromethane at room temperature. Subsequent ad- dition of amines of type II in the presence of a base like triethylamine at room temperature gives the target compounds of type I (see: Chem. Soc. Rev. 2009, 606-631 , or Tetrahedron 2005, 10827-10852).

The compounds oft he formula II and III are commercial available.

The N-oxides may be prepared from the inventive compounds according to conventional oxida- tion methods, e. g. by treating compounds I with an organic peracid such as metachloroper- benzoic acid (cf. WO 03/64572 or J. Med. Chem. 38(1 1 ), 1892-903, 1995); or with inorganic oxi- dizing agents such as hydrogen peroxide (cf. J. Heterocyc. Chem. 18(7), 1305-8, 1981 ) or ox- one (cf. J. Am. Chem. Soc. 123(25), 5962-5973, 2001 ). The oxidation may lead to pure mono- N-oxides or to a mixture of different N-oxides, which can be separated by conventional methods such as chromatography.

In the following, the intermediate compounds are further described. A skilled person will readily understand that the preferences for the substituents, also in particular the ones given in the ta- bles below for the respective substituents, given herein in connection with compounds I apply for the intermediates accordingly. Thereby, the substituents in each case have independently of each other or more preferably in combination the meanings as defined herein.

If the synthesis yields mixtures of isomers, a separation is generally not necessarily required since in some cases the individual isomers can be interconverted during work-up for use or dur- ing application (e. g. under the action of light, acids or bases). Such conversions may also take place after use, e. g. in the treatment of plants in the treated plant, or in the harmful fungus to be controlled.

In the definitions of the variables given above, collective terms are used which are generally representative for the substituents in question. The term "C n -C m " indicates the number of carbon atoms possible in each case in the substituent or substituent moiety in question.

The term "halogen" refers to fluorine, chlorine, bromine and iodine.

The term "Ci-C 6 -alkyl" refers to a straight-chained or branched saturated hydrocarbon group having 1 to 6 carbon atoms, e.g. methyl, ethyl, propyl, 1-methylethyl, butyl, 1 -methylpropyl, 2- methylpropyl, 1 , 1 -dimethylethyl, pentyl, 1 -methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dime- thylpropyl, 1-ethylpropyl, 1 ,1-dimethylpropyl, 1 ,2-dimethylpropyl, hexyl, 1-methylpentyl, 2- methylpentyl, 3-methylpentyl, 4-methylpentyl, 1 ,1 -dimethylbutyl, 1 ,2-dimethylbutyl, 1 ,3-dimethyl- butyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1 ,1 ,2-tri- methyl propyl , 1 ,2,2-trimethylpropyl, 1 -ethyl-1 -methylpropyl and 1 -ethyl-2-methylpropyl. Likewise, the term "C2-C4-alkyl" refers to a straight-chained or branched alkyl group having 2 to 4 carbon atoms, such as ethyl, propyl (n-propyl), 1-methylethyl (iso-propoyl), butyl, 1 -methylpropyl (sec.- butyl), 2-methylpropyl (iso-butyl), 1 , 1 -dimethylethyl (tert.-butyl).

The term "CrC 6 -halogenalkyl" refers to an alkyl group having 1 or 6 carbon atoms as defined above, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as mentioned above. Examples are "CrC2-halogenalkyl" groups such as chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlor- ofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1 -chloroethyl, 1 -bromoethyl, 1 -fluoro- ethyl, 2-fluoroethyl, 2 ,2-d ifluoroethyl , 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-

2.2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl or pentafluoroethyl.

The term "CrC 6 -hydroxyalkyl" refers to an alkyl group having 1 or 6 carbon atoms as defined above, wherein some or all of the hydrogen atoms in these groups may be replaced by OH groups.

The term "Ci-C4-alkoxy-Ci-C4-alkyl" refers to alkyl having 1 to 4 carbon atoms (as defined above), whereAccording to one hydrogen atom of the alkyl radical is replaced by a Ci-C4-alkoxy group (as defined above). Likewise, the term "Ci-C6-alkoxy-Ci-C4-alkyl" refers to alkyl having 1 to 4 carbon atoms (as defined above), whereAccording to one hydrogen atom of the alkyl radi cal is replaced by a Ci-C 6 -alkoxy group (as defined above).

The term "C2-C6-alkenyl" refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 6 carbon atoms and a double bond in any position. Examples are "C2-C4-alkenyl" groups, such as ethenyl, 1 -propenyl, 2-propenyl (allyl), 1 -methylethenyl, 1 -butenyl, 2-butenyl, 3-butenyl, 1 -methyl-1 -propenyl, 2-methyl-1 -propenyl, 1 -methyl-2-propenyl, 2-methyl-2-propenyl.

The term "C2-C6-alkynyl" refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 6 carbon atoms and containing at least one triple bond. Examples are "C2-C4-al- kynyl" groups, such as ethynyl, prop-1 -ynyl, prop-2 -ynyl (propargyl), but-1-ynyl, but-2-ynyl, but- 3-ynyl, 1 -methyl-prop-2-ynyl.

The term "CrC 6 -alkoxy" refers to a straight-chain or branched alkyl group having 1 to 6 carbon atoms which is bonded via an oxygen, at any position in the alkyl group. Examples are "C1-C4- alkoxy" groups, such as methoxy, ethoxy, n-propoxy, 1-methylethoxy, butoxy, 1 -methyhprop- oxy, 2-methylpropoxy or 1 ,1-dimethylethoxy.

The term "Ci-C 6 -halogenalkoxy" refers to a Ci-C 6 -alkoxy radical as defined above, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as men- tioned above. Examples are "Ci-C4-halogenalkoxy" groups, such as OCH2F, OCHF2, OCF 3 , OCH2CI, OCHCI2, OCCI3, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chlorothoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoro- ethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2- trichloroethoxy, OC2F5, 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy,

2.3-difluoro ~, propoxy, 2 chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromopropoxy, 3 bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH2-C2F5, OCF2-C2F5, 1 -fluo- romethyl-2-fluoroethoxy, 1 -chloromethyl-2-chloroethoxy, 1 -bromomethyl-2-bromoethoxy, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy.

The term "C2-C6-alkenyloxy" refers to a straight-chain or branched alkenyl group having 2 to 6 carbon atoms which is bonded via an oxygen, at any position in the alkenyl group. Examples are "C2-C4-alkenyloxy" groups.

The term "C2-C6-alkynyloxy" refers to a straight-chain or branched alkynyl group having 2 to 6 carbon atoms which is bonded via an oxygen, at any position in the alkynyl group. Examples are "C2-C4-alkynyloxy" groups.

The term "C3-C6-cycloalkyl" refers to monocyclic saturated hydrocarbon radicals having 3 to 6 carbon ring members, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl. Accordingly, a saturated three-, four-, five-, six-, seven-, eight-, nine or ten-membered carbocyclyl or carbo- cycle is a "C3-Cio-cycloalkyl".

The term "C3-C6-cycloalkenyl" refers to a monocyclic partially unsaturated 3-, 4- 5- or 6-mem- bered carbocycle having 3 to 6 carbon ring members and at least one double bond, such as cy- clopentenyl, cyclopentadienyl, cyclohexadienyl. Accordingly, a partially unsaturated three-, four- , five-, six-, seven-, eight-, nine or ten-membered carbocyclyl or carbocycle is a "C3-Cio-cycloal- kenyl".

The term "C3-C8-cycloalkyl-Ci-C4-alkyl" refers to alkyl having 1 to 4 carbon atoms (as defined above), whereAccording to one hydrogen atom of the alkyl radical is replaced by a cycloalkyl radical having 3 to 8 carbon atoms (as defined above).

The term "Ci-C 6 -alkylthio" as used herein refers to straight-chain or branched alkyl groups hav- ing 1 to 6 carbon atoms (as defined above) bonded via a sulfur atom. Accordingly, the term "C1- C 6 -halogenalkylthio" as used herein refers to straight-chain or branched halogenalkyl group hav- ing 1 to 6 carbon atoms (as defined above) bonded through a sulfur atom, at any position in the halogenalkyl group.

The term "C(=0)-Ci-C 6 -alkyl” refers to a radical which is attached through the carbon atom of the group C(=0) as indicated by the number valence of the carbon atom. The number of va- lence of carbon is 4, that of nitrogen is 3. Likewise the following terms are to be construed: NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C 3 -C 6 -cycloalkyl), N(C 3 -C 6 -cycloalkyl) 2 , C(=0)-NH(Ci-C 6 - alkyl), C(=0)-N(Ci-C 6 -alkyl) 2 .

The term“saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine or ten- membered heterocyclyl or heterocycle, wherein the heterocyclyl or heterocycle contains 1 , 2, 3 or 4 heteroatoms selected from N, O and S” is to be understood as meaning both saturated and partially unsaturated heterocycles, wherein the ring member atoms of the heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms independently selected from the group of O, N and S. For example:

a 3- or 4-membered saturated heterocycle which contains 1 or 2 heteroatoms from the group consisting of O, N and S as ring members such as oxirane, aziridine, thiirane, oxetane, azet- idine, thiethane, [1 ,2]dioxetane, [1 ,2]dithietane, [1 ,2]diazetidine; and a 5- or 6-membered saturated or partially unsaturated heterocycle which contains 1 , 2 or 3 het- eroatoms from the group consisting of O, N and S as ring members such as 2-tetrahydrofuranyl, 3-tetrahydrofuranyl, 2-tetrahydrothienyl, 3-tetrahydrothienyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 3-isox- azolidinyl, 4-isoxazolidinyl, 5-isoxazolidinyl, 3-isothiazolidinyl, 4-isothiazolidinyl, 5-isothiazoli- dinyl, 3-pyrazolidinyl, 4-pyrazolidinyl, 5-pyrazolidinyl, 2-oxazolidinyl, 4-oxazolidinyl, 5-oxazoli- dinyl, 2-thiazolidinyl, 4-thiazolidinyl, 5-thiazolidinyl, 2-imidazolidinyl, 4-imidazolidinyl,

1 ,2,4-oxadiazolidin-3-yl, 1 ,2,4-oxadiazolidin-5-yl, 1 ,2,4-thiadiazolidin-3-yl, 1 ,2,4-thiadiazolidin-5- yl, 1 ,2,4-triazolidin-3-yl, 1 ,3,4-oxadiazolidin-2-yl, 1 ,3,4-thiadiazolidin-2-yl, 1 ,3,4-triazolidin-2-yl, 2,3-dihydrofur-2-yl, 2,3-dihydrofur-3-yl, 2,4-dihydrofur-2-yl, 2,4-dihydrofur-3-yl, 2,3-dihydrothien-

2-yl, 2,3-dihydrothien-3-yl, 2,4-dihydrothien-2-yl, 2,4-dihydrothien-3-yl, 2-pyrrolin-2-yl, 2-pyrrolin-

3-yl, 3-pyrrolin-2-yl, 3-pyrrolin-3-yl, 2-isoxazolin-3-yl, 3-isoxazolin-3-yl, 4-isoxazolin-3-yl, 2-isoxa- zolin-4-yl, 3-isoxazolin-4-yl, 4-isoxazolin-4-yl, 2-isoxazolin-5-yl, 3-isoxazolin-5-yl, 4-isoxazolin-5- yl, 2-isothiazolin-3-yl, 3-isothiazolin-3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin-4- yl, 4-isothiazolin-4-yl, 2-isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3-dihydropyra- zol-1-yl, 2,3-dihydropyrazol-2-yl, 2,3-dihydropyrazol-3-yl, 2,3-dihydropyrazol-4-yl, 2,3-dihydropy- razol-5-yl, 3,4-dihydropyrazol-1-yl, 3,4-dihydropyrazol-3-yl, 3,4-dihydropyrazol-4-yl, 3,4-dihydro- pyrazol-5-yl, 4,5-dihydropyrazol-1-yl, 4,5-dihydropyrazol-3-yl, 4,5-dihydropyrazol-4-yl, 4,5-dihy- dropyrazol-5-yl, 2,3-dihydrooxazol-2-yl, 2,3-dihydrooxazol-3-yl, 2,3-dihydrooxazol-4-yl, 2,3-dihy- drooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 3,4-dihy- drooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 2-piperidi- nyl, 3-piperidinyl, 4-piperidinyl, 1 ,3-dioxan-5-yl, 2-tetrahydropyranyl, 4-tetrahydropyranyl, 2-tet- rahydrothienyl, 3-hexahydropyridazinyl, 4-hexahydropyridazinyl, 2-hexahydropyrimidinyl, 4-hex- ahydropyrimidinyl, 5-hexahydropyrimidinyl, 2-piperazinyl, 1 ,3,5-hexahydrotriazin-2-yl and 1 ,2,4- hexahydrotriazin-3-yl and also the corresponding -ylidene radicals; and

a 7-membered saturated or partially unsaturated heterocycle such as tetra- and hexahydroaze- pinyl, such as 2,3,4,5-tetrahydro[1 H]azepin-1-,-2-,-3-,-4-,-5-,-6- or-7-yl, 3,4,5,6-tetrahy- dro[2H]azepin-2-,-3-,-4-,-5-,-6- or-7-yl, 2,3,4,7-tetrahydro[1 H]azepin-1-,-2-,-3-,-4-,-5-,-6- or-7-yl,

2.3.6.7-tetrahydro[1 H]azepin-1-,-2-,-3-,-4-,-5-,-6- or-7-yl, hexahydroazepin-1-,-2-,-3- or-4-yl, tetra- and hexahydrooxepinyl such as 2,3,4,5-tetrahydro[1 H]oxepin-2-,-3-,-4-,-5-,-6- or-7-yl,

2.3.4.7-tetrahydro[1 H]oxepin-2-,-3-,-4-,-5-,-6- or-7-yl, 2,3,6,7-tetrahydro[1 H]oxepin-2-, -3-, -4-, -5- ,-6- or-7-yl, hexahydroazepin-1-,-2-,-3- or-4-yl, tetra- and hexahydro-1 ,3-diazepinyl, tetra- and hexahydro-1 ,4-diazepinyl, tetra- and hexahydro-1 ,3-oxazepinyl, tetra- and hexahydro-1 ,4-oxa- zepinyl, tetra- and hexahydro-1 ,3-dioxepinyl, tetra- and hexahydro-1 ,4-dioxepinyl and the corre- sponding -ylidene radicals.

The term“substituted” refers to substitued with 1 , 2, 3 or up to the maximum possible number of substituents.

The term“5-or 6-membered heteroaryl” or“5-or 6-membered heteroaromatic” refers to aromatic ring systems incuding besides carbon atoms, 1 , 2, 3 or 4 heteroatoms independently selected from the group consisting of N, O and S, for example,

a 5-membered heteroaryl such as pyrrol-1 -yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan- 2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isoth iazol-3-yl , isothiazol-4-yl, isothiazol-5-yl, 1.2.4-triazolyl-1 -yl, 1 ,2,4-triazol-3-yl 1 ,2,4-triazol-5-yl, 1 ,2,4-oxadiazol-3-yl, 1 ,2,4-oxadiazol-5-yl and 1 ,2,4-thiadiazol-3-yl, 1 ,2,4-thiadiazol-5-yl; or

a 6-membered heteroaryl, such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyri- dazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl and

1.2.4-triazin-3-yl.

Agriculturally acceptable salts of the inventive compounds encompass especially the salts of those cations or the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the fungicidal action of said compounds. Suitable cations are thus in particular the ions of the alkali metals, preferably sodium and potassium, of the alkaline earth metals, preferably calcium, magnesium and barium, of the transition metals, preferably manga- nese, copper, zinc and iron, and also the ammonium ion which, if desired, may carry one to four Ci-C 4 -alkyl substituents and/or one phenyl or benzyl substituent, preferably diisopropylammo- nium, tetramethylammonium, tetrabutylammonium, trimethylbenzylammonium, furthermore phosphonium ions, sulfonium ions, preferably tri(Ci-C4-alkyl)sulfonium, and sulfoxonium ions, preferably tri(Ci-C4-alkyl)sulfoxonium. Anions of useful acid addition salts are primarily chloride, bromide, fluoride, hydrogensulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, phos- phate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate, and the anions of Ci-C4-alkanoic acids, preferably formate, acetate, propionate and butyrate. They can be formed by reacting such inventive compound with an acid of the corresponding anion, preferably of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid.

The inventive compounds can be present in atropisomers arising from restricted rotation about a single bond of asymmetric groups. They also form part of the subject matter of the present in- vention.

Depending on the substitution pattern, the compounds of formula I and their N-oxides may have one or more centers of chirality, in which case they are present as pure enantiomers or pure di- astereomers or as enantiomer or diastereomer mixtures. Both, the pure enantiomers or dia- stereomers and their mixtures are subject matter of the present invention.

In the following, particular embodiments of the inventive compounds are described. Therein, specific meanings of the respective substituents are further detained, wherein the meanings are in each case on their own but also in any combination with one another, particular embodiments of the present invention.

Furthermore, in respect of the variables, generally, the embodiments of the compounds I also apply to the intermediates.

R 1 according to the invention is in each case independently selected from hydrogen, halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-C 6 -alkoxy, C3-C6-cycloalkyl, five- or six-membered heteroaryl and aryl;

wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein

R x is Ci-C4-alkyl, CrC4-halogenalkyl, unsubstituted aryl or aryl that is substituted with one, two, three, four or five substituents R x1 independently selected from CrC4-alkyl, halogen, OH, CN, Ci-C4-halogenalkyl, CrC4-alkoxy and CrC4-halogenalkoxy; wherein the acyclic moieties of R 1 are unsubstituted or substituted with identical or different groups R 1a which independently of one another are selected from:

R 1a halogen, OH, CN, Ci-C6-alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalky, Ci-C 4 -halogen- alkoxy, Ci-Ce-alkylthio, aryl and phenoxy, wherein the aryl and phenoxy group is unsubstituted or unsubstituted or substituted with R 11a selected from the group consisting of halogen, OH, Ci- C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy;

wherein the carbocyclic, heteroaryl and aryl moieties of R 1 are unsubstituted or substituted with identical or different groups R 1b which independently of one another are selected from:

R 1b halogen, OH, CN, Ci-C 4 -alkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 - halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-Ce-alkylthio.

For every R 1 that is present in the inventive compounds, the following embodiments and preferences apply independently of the meaning of any other R 1 that may be present in the ring.

According to one embodiment of formula I, R 1 is H, halogen or Ci-C6-alkyl, in particular H, CH 3 , Et, F, Cl, more specifically H, CH 3 , F or Cl most preferred H, F or Cl.

According to another embodiment of formula I, R 1 is hydrogen.

According to still another embodiment of formula I, R 1 is halogen, in particular Br, F or Cl, more specifically F or Cl.

According to another embodiment of formula I, R 1 is F

According to another embodiment of formula I, R 1 is Cl

According to another embodiment of formula I, R 1 is Br.

According to still another embodiment of formula I, R 1 is OH.

According to still another embodiment of formula I, R 1 is COOH.

According to still another embodiment of formula I, R 1 is CONH 2 .

According to still another embodiment of formula I, R 1 is CN.

According to still another embodiment of formula I, R 1 is NO 2 .

According to still another embodiment of formula I, R 1 is SH.

According to still another embodiment of formula I R 1 is NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 or NH-SC> 2 -R x , wherein R x is Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, unsubstituted aryl or aryl that is sub- stituted with one, two, three, four or five substituents R x1 independently selected from Ci-C 4 -al- kyl, halogen, OH, CN, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, or Ci-C 4 -halogenalkoxy. In particular Ci-C 4 -alkyl, such as NHCH 3 and N(CH 3 ) 2 . In particular R x is Ci-C 4 -alkyl, and phenyl that is sub- stituted with one CH 3 , more specifically S02-R x is CH 3 and tosyl group (“Ts”).

According to still another embodiment of formula I, R 1 is Ci-C6-alkyl, in particular Ci-C 4 -alkyl, such as CH3 or CH2CH3.

According to still another embodiment of formula I, R 1 is Ci-C6-halogenalkyl, in particular Ci-C 4 - halogenalkyl, such as CF 3 , CHF 2 , CH 2 F, CCI 3 , CHCI 2 , CH 2 CI, CF3CH2, CCI3CH2 or CF 2 CHF 2 .

According to still another embodiment of formula I, R 1 is C 2 -C 6 -alkenyl or C 2 -C 6 -halogenalkenyl, in particular C 2 -C 4 -alkenyl or C 2 -C 4 -halogenalkenyl, such as CH=CH 2 , C(CH 3 )=CH 2, CH=CCl 2 ,

According to still another embodiment of formula I, R 1 is C 2 -C 6 -alkynyl or C 2 -C 6 -halogenalkynyl, in particular C 2 -C 4 -alkynyl or C 2 -C 4 -halogenalkynyl, such as CECH, CECCI, CECF. CH 2 CECH, CH 2 CºCCI, or CH 2 CºCF.

According to still another embodiment of formula I, R 1 is CrC 6 -alkoxy, in particular CrC 4 -alkoxy, more specifically Ci-C 2 -alkoxy such as OCH 3 or OCH 2 CH 3 .

According to still another embodiment of formula I, R 1 is Ci-C 6 -halogenalkoxy, in particular Ci- C 4 -halogenalkoxy, more specifically Ci-C 2 -halogenalkoxy such as OCF 3 , OCHF 2 , OCH 2 F,

OCCI 3 , OCHC or OCH2CI, in particular OCF 3 , OCHF 2 , OCCI 3 or OCHCI 2 .

According to still another embodiment of formula I R 1 is C 3 -C 6 -cycloalkyl, in particular cyclopro- pyi-

According to still another embodiment of formula I, R 1 is C 3 -C 6 -cycloalkyl, for example cyclopro- pyl, substituted with one, two, three or up to the maximum possible number of identical or differ- ent groups R 1b as defined and preferably herein.

According to still another embodiment of formula I, R 1 is C 3 -C 6 -halogencycloalkyl. In a special embodiment R 1 is fully or partially halogenated cyclopropyl.

According to still another embodiment of formula I, R 1 is unsubstituted aryl or aryl that is substituted with one, two, three or four R 1b , as defined herein. In particular, R 1 is unsubstituted phenyl or phenyl that is substituted with one, two, three or four R 1b , as defined herein.

According to still another embodiment of formula I, R 1 is unsubstituted 5- or 6-membered heteroaryl. According to still a further embodiment, R 1 is 5- or 6-membered heteroaryl that is substituted with one, two or three R 1b , as defined herein.

According to still another embodiment of formula l,R 1 is in each case independently selected from hydrogen, halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-C 6 -alkoxy and C 3 -C 6 -cycloalkyl; wherein the acyclic moieties of R 1 are not further substituted or carry one, two, three, four or five identical or differ- ent groups R 1a as defined below and wherein the carbocyclic, heteroaryl and aryl moieties of R 1 are not further substituted or carry one, two, three, four or five identical or different groups R 1b as defined below.

According to still another embodiment of formula I, R 1 is independently selected from hydrogen, halogen, CN, OH, Ci-C 6 -alkyl,Ci-C 6 -alkoxy, C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 6 -cycloalkyl, wherein the acyclic and cyclic moieties of R 1 are unsubtitted or substituted by halogen.

According to still another embodiment of formula I, R 1 is independently selected from hydrogen, halogen, CN, OH, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, Ci-C 6 -alkoxy and Ci-C 6 -halogenalkoxy, in particular independently selected from H, F, Cl, Br, CN, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, C 1 - C 4 -alkoxy and Ci-C 4 -halogenalkoxy.

According to still another embodiment of formula I, R 1 is independently selected from H, CN, halogen or Ci-C 6 -alkyl, in particular H, CN, CH 3 , Et, F, Cl, more specifically H, CN, CH 3 , F or Cl most preferred H, CH 3, F or Cl.

R 1a are the possible substituents for the acyclic moieties of R 1 .

R 1a according to the invention is independently selected from halogen, OH, CN, Ci-C 6 -alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy, Ci-C 6 -alkylthio, aryl and phe- noxy, wherein the aryl group is unsubstituted or unsubstituted or substituted with R 11a selected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci- C 4 -halogenalkoxy, in particular selected from halogen, Ci-C 2 -alkyl, Ci-C 2 -halogenalkyl, C 1 -C 2 - alkoxy and Ci-C 2 -halogenalkoxy, more specifically selected from halogen, such as F, Cl and Br.

In to one embodiment R 1a is independently selected from halogen, OH, CN, Ci-C 2 -alkoxy, C 3 - C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl and Ci-C 2 -halogenalkoxy. Specifically, R 1a is

independently selected from F, Cl, OH, CN, Ci-C 2 -alkoxy, cyclopropyl, 1-F-cyclopropyl, 1 -CI- cyclopropyl, 1 ,1 -F 2 -cyclopropyl, 1 ,1-Cl 2 -cyclopropyl and Ci-C 2 -halogenalkoxy.

According to one embodiment R 1a is independently selected from halogen, such as F, Cl, Br and I, more specifically F, Cl and Br.

According to still another embodiment of formula I, R 1a is independently selected from OH, C 3 - C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl and Ci-C 2 -halogenalkoxy. Specifically, R 1a is

independently selected from OH, cyclopropyl and Ci-C 2 -halogenalkoxy.

According to still another embodiment of formula I, R 1a is independently selected from aryl and phenoxy, wherein the aryl group is unsubstituted or substituted with R 11a selected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halo- genalkoxy, in particular selected from halogen, Ci-C 2 -alkyl, Ci-C 2 -halogenalkyl, Ci-C 2 -alkoxy and Ci-C 2 -halogenalkoxy, more specifically selected from halogen, such as F, Cl and Br.

R 1b are the possible substituents for the carbocyclic, heteroaryl and aryl moieties of R 1 .

R 1b according to the invention is independently selected from halogen, OH, CN, Ci-C 4 -alkyl, C 1 - C 4 -alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-C6-alkylthio;

According to one embodiment thereof R 1b is independently selected from halogen, CN, C 1 -C 2 - alkyl, Ci-C 2 -alkoxy, Ci-C 2 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl and C 1 -C 2 - halogenalkoxy. Specifically, R 1b is independently selected from F, Cl, Br, OH, CN, CH 3 , OCH 3, CHF 2 , OCHF 2 , cyclopropyl, 1-F-cyclopropyl, 1-CI-cyclopropyl, 1 ,1-F 2 -cyclopropyl, 1 , 1 -CI 2 - cyclopropyl, OCF3, and OCHF2.

According to still another embodiment thereof R 1b is independently selected from halogen, C-i- C 2 -alkyl, CrC 2 -alkoxy, Ci-C 2 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl and C 1 -C 2 - halogenalkoxy. Specifically, R 1b is independently selected from halogen, CN, OH, CH 3 , CHF 2 , OCHF 2 , OCF 3 , OCH 3 , cyclopropyl, 1-F-cyclopropyl, 1 -CI-cyclopropyl, 1 ,1-F 2 -cyclopropyl, 1 , 1 -CI 2 - cyclopropyl and halogenmethoxy, more specifically independently selected from F, Cl, OH, CH 3 , OCH 3, CHF 2 , OCH 3 , cyclopropyl, 1 -F-cyclopropyl, 1 -CI-cyclopropyl, 1 ,1-F 2 -cyclopropyl, 1 , 1 -CI 2 - cyclopropyl, OCHF 2 and OCF 3 .

R x in the substituent NH-S0 2 -R X is in each case independently selected from Ci-C 4 -alkyl, Ci-C 4 - halogenalkyl, unsubstituted aryl and aryl that is substituted with one, two, three, four or five substituents R x1 independently selected from Ci-C 4 -alkyl, halogen, OH, CN, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and CrC4-halogenalkoxy. In particular, R x is in each case independently selected from Ci-C4-alkyl, halogen, OH, CN and phenyl that is substituted with one, two or three R x1 independently selected from Ci-C2-alkyl, more specifically R x is in each case independently selected from Ci-C4-alkyl and phenyl that is substituted with one CH 3 , more specifically S0 2 -R x is the tosyl group (“Ts”).

Particularly preferred embodiments of R 1 according to the invention are in Table P1 below, wherein each line of lines P1-1 to P1-16 corresponds to one particular embodiment of the inven- tion. Thereby, for every R 1 that is present in the inventive compounds, these specific

embodiments and preferences apply independently of the meaning of any other R 1 that may be present in the ring:

Table P1 :

Ts” in the table stands for the tosylgroup SC>2-(p-CH3)phenyl.

R 2 is in each case independently selected from H, halogen, COOH, CONH 2 , OH, CN, NO 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C 2 -C 4 -alkenyl), N(C 2 -C 4 -alkenyl) 2 , NH(C 2 -C 4 - alkynyl), N(C2-C 4 -alkynyl)2, NH(C3-C6-cycloalkyl), N(C3-C6-cycloalkyl)2, N(C2-C 4 -alkyl)(C2-C 4 - alkenyl), N(C 2 -C 4 -alkyl)(C 2 -C 4 -alkynyl), N(C 2 -C 4 -alkyl)(C 3 -C 6 -cycloalkyl), N(C 2 -C 4 -alkenyl)(C 2 -C 4 - alkynyl), N(C 2 -C 4 -alkenyl)(C 3 -C 6 -cycloalkyl), N(C 2 -C 4 -alkynyl)(C 3 -C 6 -cycloalkyl), NH(C(=0)Ci-C 4 - alkyl), N(C(=0)Ci-C 4 -alkyl) 2, NH-S0 2 -R X , S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, Ci-C 6 -cycloalkylthio, S(0) n -C 2 -C 6 -alkenyl, S(0) n -C 2 -C 6 -alkynyl, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)C 2 -C 6 -alkenyl, C(=0)C 2 -C 6 -alkynyl, C(=0)C 3 -C 6 -cycloalkyl, C(=0)NH(C r C 6 -alkyl), CH(=S), C(=S)Ci-C 6 -alkyl, C(=S)C 2 -C 6 -alkenyl, C(=S)C 2 -C 6 -alkynyl, C(=S)C 3 -C 6 -cycloalkyl, (=S)0(C 2 -C 6 -alkenyl) ,

C(=S)0(C 2 -C 6 -alkynyl) , C(=S)0(C 3 -C 7 -cycloalkyl) , C(=S)NH(Ci-C 6 -alkyl), C(=S)NH(C 2 -C 6 - alkenyl), C(=S)NH(C 2 -C 6 -alkynyl), C(=S)NH(C3-C7-cycloalkyl),C(=S)N(Ci-C 6 -alkyl)2, C(=S)N(C 2 - C6-alkenyl)2, C(=S)N(C2-C6-alkynyl)2, C(=S)N(C3-C7-cycloalkyl)2, Ci-C6-alkyl, C2-C6-alkenyl, C2- C 6 -alkynyl, OR Y , C 3 -C 6 -cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein

R x is as defined above;

R Y is Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 - alkynyl, C 2 -C 6 -halogenalkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl; phenyl and phenyl-Ci-C 6 -alkyl; wherein the phenyl group is unsubstituted or substituted with substituents selected from the group consisting of halogen, CN, OH, O-I-OQ- alkyl, Ci-C 6 -halogenalkyl, Ci-C 6 -alkoxy and Ci-C 6 -halogenalkoxy; wherein the acyclic moieties of R 2 are unsubstituted or substituted with groups R 2a which independently of one another are selected from:

R 2a halogen, OH, CN, CrC 6 -alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, CrC 4 - halogenalkoxy, Ci-Ce-alkylthio, aryl and phenoxy, wherein the aryl and phenoxy group is unsubstituted or substituted with substituents R 21a selected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy;

wherein the carbocycle, heteroaryl and aryl moieties of R 2 are unsubstituted or substituted with groups R 2b which independently of one another are selected from:

R 2b halogen, OH, CN, Ci-C 4 -alkyl, CrC 4 -alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-Ce-alkylthio.

According to one embodiment of formula I, R 2 is selected from the group consisting of halogen, CN, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 - halogenalkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, and OR Y .

According to still another embodiment of formula I, R 2 is halogen, in particular F, Cl, Br or I, more specifically F, Cl or Br, in particular F or Cl.

According to still another embodiment of formula I, R 2 is F.

According to still another embodiment of formula I, R 2 is Cl.

According to still another embodiment of formula I, R 2 is Br. According to still another embodiment of formula I, R 2 is COOH.

According to still another embodiment of formula I, R 2 is CONH 2 .

According to still another embodiment of formula I, R 2 is OH.

According to still another embodiment of formula I, R 2 is CN.

According to still another embodiment of formula I, R 2 is NO 2 .

According to still another embodiment of formula I, R 2 is SH.

According to still another embodiment of formula I, R 2 is NH 2 .

According to still another embodiment of formula I, R 2 is , NH(Ci-C 4 -alkyl), in particular NH(CH3),

NH(C 2 H 5 ).

According to still another embodiment of formula I, R 2 is , N(Ci-C4-alkyl)2, in particular NH(CH 3 ) 2 , NH(C 2 H 5 ) 2 .

According to still another embodiment of formula I, R 2 is , NH(C 2 -C 4 -alkenyl), in particular NH(CH=CH 2 ), NH(CH 2 CH=CH 2 ).

According to still another embodiment of formula I, R 2 is , N(C 2 -C 4 --alkenyl) 2 , in particular N(CH=CH 2 ) 2 , N(CH 2 CH=CH 2 ) 2 .

According to still another embodiment of formula I, R 2 is , NH(C 2 -C 4 -alkynyl), in particular NH(C= CH), NH(CH 2 CºCH).

According to still another embodiment of formula I, R 2 is , N(C 2 -C4-alkynyl)2, in particular N(C= CH) 2 , N(CH 2 CºCH) 2 .

According to still another embodiment of formula I, R 2 is , NH(C 3 -C 6 -cycloalkyl), in particular NH(C 3 H 7 ), NH(C 4 H 2 ).

According to still another embodiment of formula I, R 2 is , N(C 3 -C 6 -cycloalkyl) 2 , in particular N(C 3 H 7 ) 2 , N(C 4 H 2 ) 2 .

According to still another embodiment of formula I, R 2 is N(Ci-C 4 -alkyl)(C 2 -C 4 -alkenyl), in particular N(CH 3 )(CH=CH 2 ), N(CH3)(CH 2 CH=CH 2 ), N(C 2 H5)(CH=CH 2 ), N(C 2 H5)(CH 2 CH=CH2).

According to still another embodiment of formula I, R 2 is N(Ci-C 4 -alkyl)(C 2 -C 4 -alkynyl), in particular N(CH 3 )(CºCH), N(CH 3 )(CH 2 CºCH), N(C 2 H 5 )(CºCH), N(C 2 H 5 )(CH 2 CºCH).

According to still another embodiment of formula I, R 2 is N(Ci-C 4 -alkyl)(C 3 -C 6 -cycloalkyl), in particular N(CH 3 )(C 3 H 7 ), N(CH3)(C 4 H 2 ), N(C 2 H 5 )(C 3 H 7 ), N(CH 3 )(C 4 H 2 ).

According to still another embodiment of formula I, R 2 is N(C 2 -C 4 -alkenyl)(C 2 -C 4 -alkynyl), in particular N(CH=CH 2 )(CºCH), N(CH 2 CH=CH 2 )(CH 2 CºCH), N(CH=CH 2 )(CºCH),

N(CH 2 CH=CH 2 )(CH 2 CºCH).

According to still another embodiment of formula I, R 2 is N(C 2 -C 4 -alkenyl)(C 3 -C 6 -cycloalkyl), in particular N(CH=CH 2 )(C 3 H 7 ), N(CH 2 CH=CH 2 )(C 4 H 2 ), N(CH=CH 2 )(C 3 H 7 ), N(CH 2 CH=CH 2 )(C 4 H 2 ).

According to still another embodiment of formula I, R 2 is N(C 2 -C 4 -alkynyl)(C 3 -C 6 -cycloalkyl), in particular N(CºCH)(C 3 H 7 ), N(CH 2 CºCH)(C 4 H 2 ), N(CºCH)(C 3 H 7 ), N(CH 2 CºCH)(C 4 H 2 ). According to still another embodiment of formula I, R 2 is , NH(C(=0)(Ci-C 4 -alkyl), in particular NH(C(=0)(CH 3 ), NH(C(=0)(C 2 H 5 ).

According to still another embodiment of formula I, R 2 is N(C(=0)(Ci-C 4 -alkyl) 2 , in particular N(C(=0)(CH 3 ) 2 , N(C(=0)(C 2 H 5 ) 2 .

According to a further specific embodiment of formula I, R 2 is NH-S0 2 -R X such as NH-SO 2 -CH 3 , NH-SO2-CH2-CH3, NH-S0 2 -CF 3I NH-S0 2 -TS.

According to still another embodiment of formula I, R 2 is S(0)n-Ci-C 6 -alkyl such as SCH 3 , S(=0) CH 3 , S(0) 2 CH 3 .

According to still another embodiment of formula I, R 2 is S(0)n-aryl such as S-phenyl, S(=0) phenyl, S(0) 2 phenyl.

According to still another embodiment of formula I, R 2 is S(0)n-C 2 -C 6 -alkenyl such as

According to still another embodiment of formula I, R 2 is S(0)n-C 2 -C 6 -alkynyl such as SC CH, S(=0)CºCH, S(0) 2 CºCH, SCH 2 CºCH, S(=0)CH 2 CºCH, S(0) 2 CH 2 CºCH.

According to a further specific embodiment of formula I, R 2 is CH(=0).

According to a further specific embodiment of formula I, R 2 is C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 - alkyl) or C(=0)NH(Ci-C 6 -alkyl), wherein alkyl is CH3, C 2 H 5 , n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to a further specific embodiment of formula I, R 2 is C(=0)C 2 -C 6 -alkenyl, C(=0)0(C 2 - C 6 -alkenyl) or (=0)NH(C 2 -C 6 -alkenyl) wherein alkenyl is CH=CH2 , CH2CH=CH2.

According to a further specific embodiment of formula I, R 2 is C(=0)C 2 -C 6 -alkynyl, C(=0)0(C 2 - C 6 -alkynyl) orC(=0)NH(C 2 -C 6 -alkynyl)„ wherein alkynyl is C CH , CI-hC CH.

According to a further specific embodiment of formula I, R 2 is C(=0)C 3 -C 6 -cycloalkyl,

C(=0)0(C 3 -C 6 -cycloalkyl) or C(=0)NH(C 3 -C 6 -cycloalkyl), wherein cycloalkyl is cyclopropyl (C3H7) or cyclobutyl (C4H2).

According to a further specific embodiment of formula I, R 2 is CH(=S).

According to a further specific embodiment of formula I, R 2 is C(=S)Ci-C 6 -alkyl, C(=S)OCi-C 6 - alkyl, C(=S)NH(Ci-C 6 -alkyl) or C(=S)NH(Ci-C 6 -alkyl), wherein alkyl is CH3, C 2 H 5 , n-propyl, i-pro- pyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to a further specific embodiment of formula I, R 2 is C(=S)C2-C6-alkenyl, C(=S)OC2-C6- alkenyl, C(=S)NH(C2-C6-alkenyl) or C(=S)N(C2-C6-alkenyl) 2 , wherein alkenyl is CH=CH 2, CH 2 CH=CH 2 .

According to a further specific embodiment of formula I, R 2 is C(=S)C2-C6-alkynyl, , C(=S)0(C 2 - C 6 -alkynyl), C(=S)NH(C2-C6-alkynyl) or C(=S)N(C2-C6-alkynyl)2 , wherein alkynyl is C CH , CI-hC CH. According to a further specific embodiment of formula I, R 2 is C(=S)C 3 -C 6 -cycloalkyl, ,

C(=S)0(C 3 -C 7 -cycloalkyl), C(=S)NH(C 3 -C 7 -cycloalkyl) or , C(=S)N(C 3 -C 7 -cycloalkyl) 2 , wherein cycloalkyl is cyclopropyl (C 3 H 7 ) or cyclobutyl (C 4 H 2 ).

According to still another embodiment of formula I, R 2 is Ci-C 6 -alkyl, in particular Ci-C4-alkyl, such as CH 3 . or C 2 H 5 , in particular CH 3 or CH 2 CH 3 .

According to still another embodiment of formula I, R 2 is Ci-C 6 -halogenalkyl, in particular C 1 -C 4 - halogenalkyl, such as CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF3CH2, CCI3CH2 or CF 2 CHF 2 . According to still a further embodiment of formula I, R 2 is C 2 -C 6 -alkenyl, in particular C 2 -C 4 -alk- enyl, such as CH=CH 2 , C(CH 3 )=CH 2 , CH 2 CH=CH 2 .

According to a further specific embodiment of formula I, R 2 is C 2 -C 6 -halogenalkenyl, in particular C 2 -C 4 -halogenalkenyl, more specifically C 2 -C 3 -halogenalkenyl such as CH=CHF, CH=CHCI,

According to still a further embodiment of formula I, R 2 is C 2 -C 6 -alkynyl or C 2 -C 6 -halogenalkynyl, in particular C 2 -C 4 -alkynyl or C 2 -C 4 -halogenalkynyl, such as C CH, CFhC CH, C CCI,

CH 2 CºCCI, or CCI 2 CºCCI.

According to a further specific embodiment of formula I, R 2 is OR Y wherein R Y is Ci-C6-alkyl, Cr C6-halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, C 3 - C6-cycloalkyl, C 3 -C 6 -halogencycloalkyl.

According to a further specific embodiment of formula I, R 2 is OR Y wherein R Y is Ci-C6-alkyl, in particular Ci-C 4 -alkyl, more specifically Ci-C 2 -alkoxy. R 2 is such as OCH 3 or OCH 2 CH 3 .

According to a further specific embodiment of formula I, R 2 is OR Y wherein R Y is Ci-C6-halogen- alkyl, in particular Ci-C 4 -halogenalkyl, more specifically Ci-C 2 -halogenalkyl. R 2 is such as OCF 3 , OCHF 2I OCH 2 F, OCCI 3 , OCHC or OCH 2 CI, in particular OCF 3 , OCHF 2 , OCCI 3 or OCHCI 2 .

According to a further specific embodiment of formula I, R 2 is OR Y wherein R Y C 2 -C 6 -alkenyl, in particular C 2 -C 4 -alkenyl, more specifically Ci-C 2 -alkenyl. R 2 is such as OCH=CH 2 ,

OCH 2 CH=CH 2 .

According to a further specific embodiment of formula I, R 2 is OR Y wherein R Y C 2 -C 6 -halogen- alkenyl, in particular C 2 -C 4 -halogenalkenyl, more specifically Ci-C 2 -halogenalkenyl.

According to a further specific embodiment of formula I, R 2 is OR Y wherein R Y C 2 -C 6 -alkynyl, in particular C 2 -C 6 -alkynyl, in particular C 2 -C 4 -alkynyl, more specifically Ci-C 2 -alkynyl. R 2 is such as OC CH,

According to a further specific embodiment of formula I, R 2 is OR Y wherein R Y C 2 -C 6 -halogen- alkynyl, in particular C 2 -C 6 -halogenalkynyl, in particular C 2 -C 4 -halogenalkynyl, more specifically Ci-C 2 -halogenalkynyl. R 2 is such as OC CCI, OCFhC CCI, or OCChC CCI.

According to still another embodiment of formula I, R 2 is is OR Y wherein R Y C 3 -C 6 -cycloalkenyl, in particular cyclopropenyl.

According to still another embodiment of formula I, R 2 is C 3 -C 6 -cycloalkyl, in particular cyclopro- pyi- According to still another embodiment of formula I, R 2 is C3-C6-halogencycloalkyl. In a special embodiment R 2b is fully or partially halogenated cyclopropyl, such as 1 -F-cyclopropyl, 1 -CI- cyclopropyl, 1 ,1 -F 2 -cyclopropyl, 1 ,1-Cl 2 -cyclopropyl .

According to still another embodiment of formula I, R 2 is phenyl-Ci-C 6 -alkyl, such as phenyl- CH2, wherein the phenyl moiety in each case is unsubstituted or substituted by one, two or three identical or different groups R 2b which independently of one another are selected from halogen, Ci-C2-alkyl, Ci-C2-alkoxy, Ci-C2-halogenalkyl and Ci-C2-halogenalkoxy, in particular F, Cl, Br, CHs, OCH 3 , CF 3 and OCF 3 .

According to still another embodiment of formula I, R 2 is aryl, in particular phenyl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R 2b which independently of one another are selected from CN, halogen, Ci-C2-alkyl, C1- C2-alkoxy, Ci-C2-halogenalkyl and Ci-C2-halogenalkoxy, in particular CN, F, Cl, Br, CH3, OCH3, CHF2, OCHF2 , CF3 and OCF3. According to one embodiment, R 2 is unsubstituted phenyl. Ac- cording to another embodiment, R 2 is phenyl, that is substituted with one, two or three, in partic- ular one, halogen, in particular selected from F, Cl and Br, more specifically selected from F and Cl.

According to still another embodiment of formula I, R 2 is a 5-membered heteroaryl such as pyr- rol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol- 3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2- yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isoth iazol-4-yl , isothiazol-5-yl, 1 ,2,4-triazolyl-1 -yl, 1 ,2,4-triazol-3-yl 1 ,2,4-triazol-5-yl, 1 ,2,4-oxadiazol-3-yl, 1 ,2,4-oxadiazol-5-yl and 1 ,2,4-thiadiazol-3-yl, 1 ,2,4-thia- diazol-5-yl.

According to still another embodiment of formula I, R 2 is a 6-membered heteroaryl such as pyri- din-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, py- rimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl and 1 ,2,4-triazin-3-yl.

According to still another embodiment of formula I, R 2 is in each case independently selected from halogen, CN, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C2-C6-alkenyl, C2-C6-alkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy, C3-C6-alkenyloxy, C3-C6-alkynyloxy, C3-C6-cycloalkyl and C3-C6-halogen- cycloalkyl, wherein the acyclic moieties of R 2 are unsubstituted or substituted with identical or different groups R 2a as defined and preferably defined herein, and wherein the carbocyclic, phe- nyl and heteroaryl moieties of R 2 are unsubstituted or substituted with identical or different groups R 2b as defined and preferably defined herein.

According to still another embodiment of formula I, R 2 is in each case independently selected from halogen, CN, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C2-C6-alkenyl, C2-C6-alkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy; wherein the acyclic moieties of R 2 are unsubstituted or substituted with identical or different groups R 2a as defined and preferably defined herein.

According to still another embodiment of formula I, R 2 is in each case independently selected from CN, halogen, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C2-C6-alkynyl, OR Y , C3-C6-cycloalkyl;

wherein R Y is Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C2-C6-alkenyl or C2-C6-alkynyl.

R 2a are the possible substituents for the acyclic moieties of R 2 . According to one embodiment R 2a is independently selected from halogen, OH, CN, C 1 -C 6 - alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy, Ci-C 6 -alkylthio, aryl and phenoxy, wherein the aryl and phenyl group is unsubstituted or substituted with substitu- ents R 21a selected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy.

According to one embodiment R 2a is independently selected from halogen, CrC 6 -alkoxy, C 3 -C 6 - cycloalkyl, C 3 -C 6 -halogencycloalkyl and Ci-C 4 -halogenalkoxy. Specifically, R 2a is independently selected from F, Cl, Br, I, Ci-C 2 -alkoxy, cyclopropyl, 1-F-cyclopropyl, 1-CI-cyclopropyl, 1 ,1-F 2 - cyclopropyl, 1 ,1-Cl 2 -cyclopropyl and Ci-C 2 -halogenalkoxy.

According to still another embodiment of formula I, R 2a is independently halogen, in particular selected from F, Cl, Br and I, more specifically F, Cl and Br.

R 2b are the possible substituents for the carbocyclic, heteroaryl and phenyl moieties of R 2 . R 2b according to the invention is independently selected from halogen, OH, CN, Ci-C 4 -alkyl, C 1 -C 4 - alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-C 6 -alkylthio.

According to one embodiment thereof R 2b is independently selected from halogen, CN, C 1 -C 4 - alkyl, CrC 4 -alkoxy, CrC 4 -halogenalkyl and Ci-C 4 -halogenalkoxy, in particular halogen, C 1 -C 4 - alkyl and Ci-C 4 -alkoxy. Specifically, R 2b is independently selected from F, Cl, CN, CH 3 , OCH 3 and halogenmethoxy.

Particularly preferred embodiments of R 2 according to the invention are in Table P2 below, wherein each line of lines P2-1 to P2-41 corresponds to one particular embodiment of the inven- tion, wherein P2-1 to P2-41 are also in any combination with one another a preferred embodi- ment of the present invention. The connection point to the carbon atom, to which R 2 is bound is marked with“#” in the drawings.

Table P2:

R 3 is in each case independently selected fromhalogen, OH, COOH, CONH 2 , CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(CrC 4 -alkyl) 2 , NH(C 2 -C 4 -alkenyl), N(C 2 -C 4 -alkenyl) 2 , NH(C 2 -C 4 -alkynyl), N(C 2 -C 4 -alkynyl) 2 , NH(C3-C6-cycloalkyl), N(C3-C6-cycloalkyl) 2 , N(C 2 -C 4 -alkyl)(C 2 -C 4 -alkenyl), N(C 2 -C 4 -alkyl)(C 2 -C 4 -alkynyl), N(C 2 -C 4 -alkyl)(C3-C6-cycloalkyl), N(C 2 -C 4 -alkenyl)(C 2 -C 4 -alkynyl), N(C 2 -C 4 -alkenyl)(C3-C6-cycloalkyl), N(C 2 -C 4 -alkynyl)(C3-C6-cycloalkyl), NH(C(=0)Ci-C 4 -alkyl), N(C(=0)Ci-C 4 -alkyl) 2, NH-S0 2 -R x , S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, Ci-C 6 -cycloalkylthio, S(0) n -C 2 - C 6 -alkenyl, S(0) n -C 2 -C 6 -alkynyl, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)C 2 -C 6 -alkenyl, C(=0)C 2 -C 6 - alkynyl, C(=0)C 3 -C 6 -cyclpalkyl, C(=0)NH(C C 6 -alkyl), CH(=S), C(=S)Ci-C 6 -alkyl, C(=S)C 2 -C 6 - alkenyl, C(=S)C 2 -C 6 -alkynyl, C(=S)C 3 -C 6 -cyclpalkyl, C(=S)0(C 2 -C 6 -alkenyl) , C(=S)0(C 2 -C 6 - alkynyl) , C(=S)0(C 3 -C 7 -cycloalkyl) , C(=S)NH(Ci-C 6 -alkyl), C(=S)NH(C 2 -C 6 -alkenyl) , C(=S)NH(C 2 - Ce-alkynyl), C(=S)NH(C 3 -C 7 -cycloalkyl),C(=S)N(Ci-C 6 -alkyl) 2 , C(=S)N(C 2 -C 6 -alkenyl) 2,

C(=S)N(C2-C6-alkynyl)2, C(=S)N(C 3 -C 7 -cycloalkyl)2, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl,

OR Y , C 3 -C 6 -cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein

R x is as defined above;

R Y is as defined above;

wherein the acyclic moieties of R 3 are unsubstituted or substituted with groups R 3a which independently of one another are selected from:

R 3a halogen, OH, CN, Ci-C 6 -alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 - halogenalkoxy, Ci-Ce-alkylthio, aryl and phenoxy, wherein the aryl and phenyl group is unsubstituted or substituted with substituents R 31a selected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and CrC 4 -halogenalkoxy;

wherein the carbocyclic, heteroaryl and aryl moieties of R 3 are unsubstituted or

substituted with groups R 3b which independently of one another are selected from:

R 3b halogen, OH, CN, Ci-C 4 -alkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-Ce-alkylthio.

According to one embodiment of formula I, R 3 is selected from the group consisting of halogen, CN, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 - halogenalkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy and OR Y .

R 3 is secected from the group consisting of halogen, CN, Ci-C6-alkyl, Ci-C6-halogenalkyl, C 2 -C 6 - alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, CrC6-alkoxy, Ci-C6-halo- genalkoxy and OR Y .

According to still another embodiment of formula I R 3 is halogen, in particular F, Cl, Br or I, more specifically F, Cl or Br, in particular F or Cl.

According to stil another embodiment of formula R 3 s F.

According to stil another embodiment of formula R 3 s Cl.

According to stil another embodiment of formula R 3 s Br.

According to stil another embodiment of formula R 3 s OH.

According to stil another embodiment of formula R 2 s COOH.

According to stil another embodiment of formula R 2 s CONH2.

According to stil another embodiment of formula R 3 s CN.

According to stil another embodiment of formula R 3 s N0 2 .

According to stil another embodiment of formula R 3 s SH. According to still another embodiment of formula I, R 3 is Nhh.

According to still another embodiment of formula I, R 3 is , NH(Ci-C 4 -alkyl), in particular NH(CH3), NH(C 2 H 5 ).

According to still another embodiment of formula I, R 3 is , N(Ci-C4-alkyl)2, in particular NH(CH 3 ) 2 , NH(C 2 H 5 ) 2 .

According to still another embodiment of formula I, R 3 is , NH(C 2 -C 4 -alkenyl), in particular NH(CH=CH 2 ), NH(CH 2 CH=CH 2 ).

According to still another embodiment of formula I, R 3 is , N(C2-C4--alkenyl)2, in particular N(CH=CH 2 ) 2 , N(CH 2 CH=CH 2 ) 2 .

According to still another embodiment of formula I, R 3 is , NH(C 2 -C 4 -alkynyl), in particular NH(C= CH), NH(CH 2 CºCH).

According to still another embodiment of formula I, R 3 is , N(C2-C4-alkynyl)2, in particular N(C= CH) 2 , N(CH 2 CºCH) 2 .

According to still another embodiment of formula I, R 3 is , NH(C 3 -C 6 -cycloalkyl), in particular NH(C 3 H 7 ), NH(C 4 H 9 ).

According to still another embodiment of formula I, R 3 is , N(C3-C6-cycloalkyl)2, in particular N(C 3 H 7 )2, N(C 4 H 9 ) 2 .

According to still another embodiment of formula I, R 3 is N(Ci-C 4 -alkyl)(C 2 -C 4 -alkenyl), in particular N(CH 3 )(CH=CH 2 ), N(CH3)(CH 2 CH=CH 2 ), N(C 2 H5)(CH=CH 2 ), N(C 2 H5)(CH 2 CH=CH2).

According to still another embodiment of formula I, R 3 is N(Ci-C 4 -alkyl)(C 2 -C 4 -alkynyl), in particular N(CH 3 )(CºCH), N(CH 3 )(CH 2 CºCH), N(C 2 H 5 )(CºCH), N(C 2 H 5 )(CH 2 CºCH).

According to still another embodiment of formula I, R 3 is N(CrC 4 -alkyl)(C 3 -C 6 -cycloalkyl), in particular N(CH 3 )(C 3 H 7 ), N(CH 3 )(C 4 H 9 ), N(C 2 H 5 )(C 3 H 7 ), N(CH 3 )(C 4 H 9 ).

According to still another embodiment of formula I, R 3 is N(C 2 -C 4 -alkenyl)(C 2 -C 4 -alkynyl), in particular N(CH=CH 2 )(CºCH), N(CH 2 CH=CH 2 )(CH 2 CºCH), N(CH=CH 2 )(CºCH),

N(CH 2 CH=CH 2 )(CH 2 CºCH).

According to still another embodiment of formula I, R 3 is N(C 2 -C 4 -alkenyl)(C 3 -C 6 -cycloalkyl), in particular N(CH=CH 2 )(C 3 H 7 ), N(CH 2 CH=CH 2 )(C 4 H 9 ), N(CH=CH 2 )(C 3 H 7 ), N(CH 2 CH=CH 2 )(C 4 H 9 ).

According to still another embodiment of formula I, R 3 is N(C 2 -C 4 -alkynyl)(C 3 -C 6 -cycloalkyl), in particular N(CºCH)(C 3 H 7 ), N(CH 2 CºCH)(C 4 H 9 ), N(CºCH)(C 3 H 7 ), N(CH 2 CºCH)(C 4 H 9 ).

According to still another embodiment of formula I, R 3 is , NH(C(=0)(CrC4-alkyl), in particular NH(C(=0)(CH 3 ), NH(C(=0)(C 2 H 5 ).

According to still another embodiment of formula I, R 3 is N(C(=0)(Ci-C4-alkyl)2, in particular N(C(=0)(CH 3 ) 2 , N(C(=0)(C 2 H 5 ) 2 .

According to a further specific embodiment of formula I, R 3 is NH-SC>2-R X such as NH-SO2-CH3, NH-SO2-CH2-CH3, NH-S0 2 -CF 3I NH-S0 2 -TS.

According to still another embodiment of formula I, R 3 is S(0)n-Ci-C 6 -alkyl such as SCH3, S(=0) CH 3I S(0) 2 CH 3 . According to still another embodiment of formula I, R 3 is S(0)n-aryl such as S-phenyl, S(=0) phenyl, S(0) 2 phenyl.

According to still another embodiment of formula I, R 3 is S(0)n-C 2 -C 6 -alkenyl such as

According to still another embodiment of formula I, R 3 is S(0)n-C 2 -C 6 -alkynyl such as SC CH, S(=0)CºCH, S(0) 2 CºCH, SCH 2 CºCH, S(=0)CH 2 CºCH, S(0) 2 CH 2 CºCH.

According to a further specific embodiment of formula I, R 3 is CH(=0).

According to a further specific embodiment of formula I, R 3 is C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 - alkyl) or C(=0)NH(Ci-C 6 -alkyl), wherein alkyl is CH3, C 2 H 5 , n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to a further specific embodiment of formula I, R 3 is C(=0)C 2 -C 6 -alkenyl, C(=0)0(C 2 - Ce-alkenyl) or C(=0)NH(C 2 -C 6 -alkenyl), wherein alkenyl is CH=CH 2, C(CH 3 )=CH 2 , CH 2 CH=CH 2 .

According to a further specific embodiment of formula I, R 3 is C(=0)C 2 -C 6 -alkynyl, C(=0)0(C 2 - C 6 -alkynyl) or C(=0)NH(C 2 -C 6 -alkynyl), wherein alkynyl is C CH CFhC CH,

According to a further specific embodiment of formula I, R 3 is C(=0)C 3 -C 6 -cycloalkyl,

C(=0)0(C 3 -C 6 -cycloalkyl) or C(=0)NH(C 3 -C 6 -cycloalkyl), wherein cycloalkyl is cyclopropyl (C3H7) or cyclobutyl (C4H9).

According to a further specific embodiment of formula I, R 3 is CH(=S).

According to a further specific embodiment of formula I, R 3 is C(=S)Ci-C 6 -alkyl, C(=S)OCi-C 6 - alkyl, C(=S)NH(Ci-C 6 -alkyl) or C(=S)NH(Ci-C 6 -alkyl), wherein alkyl is CH3, C 2 H 5 , n-propyl, i-pro- pyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to a further specific embodiment of formula I, R 3 is C(=S)C2-C6-alkenyl, C(=S)OC2-C6- alkenyl, C(=S)NH(C2-C6-alkenyl) or C(=S)N(C2-C6-alkenyl) 2 , wherein alkenyl is CH=CH 2, CH 2 CH=CH 2 .

According to a further specific embodiment of formula I, R 3 is C(=S)C2-C6-alkynyl, C(=S)0(C 2 - C 6 -alkynyl), C(=S)NH(C2-C6-alkynyl) or C(=S)N(C2-C6-alkynyl), wherein alkynyl is C CH CFhC CH.

According to a further specific embodiment of formula I, R 3 is C(=S)C3-C6-cycloalkyl,

C(=S)0(C 3 -C 7 -cycloalkyl), C(=S)NH(C3-C7-cycloalkyl) or , C(=S)N(C 3 -C 7 -cycloalkyl) 2, wherein cy- cloalkyl is cyclopropyl (C3H7) or cyclobutyl (C 4 H 9 ).

According to still another embodiment of formula I, R 3 is Ci-C 6 -alkyl, in particular Ci-C4-alkyl, such as CH 3 . or C 2 H 5 , in particular CH 3 or CH 2 CH 3 .

According to still another embodiment of formula I, R 3 is Ci-C 6 -halogenalkyl, in particular C1-C4- halogenalkyl, such as CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF3CH2, CCI3CH2 or CF 2 CHF 2 . According to still a further embodiment of formula I, R 3 is C2-C6-alkenyl, in particular C2-C4-alk- enyl, such as CH=CH2.

According to a further specific embodiment of formula I, R 3 is C2-C6-halogenalkenyl, in particular C2-C4-halogenalkenyl, more specifically C2-C3-halogenalkenyl such as CH=CHF, CH=CHCI,

According to still a further embodiment of formula I, R 3 is C 2 -C 6 -alkynyl or C 2 -C 6 -halogen- alkynyl, in particular C 2 -C 4 -alkynyl or C 2 -C4-halogenalkynyl, such as C CH, CH 2 C CH, C CCI, CH 2 CºCCI, or CCI 2 CºCCI.

According to a further specific embodiment of formula I, R 3 is OR Y wherein R Y is Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl.

According to a further specific embodiment of formula I, R 3 is OR Y wherein R Y is Ci-C 6 -alkyl, in particular Ci-C4-alkyl, more specifically Ci-C 2 -alkoxy. R 3 is such as OCH 3 or OCFhCFh.

According to a further specific embodiment of formula I, R 3 is OR Y wherein R Y is Ci-C 6 -halogen- alkyl, in particular Ci-C4-halogenalkyl, more specifically Ci-C 2 -halogenalkyl. R 3 is such as OCF 3 , OCHF 2 , OCH 2 F, OCCI 3 , OCHC or OCH 2 CI, in particular OCF 3 , OCHF 2 , OCCI 3 or OCHCI 2 .

According to a further specific embodiment of formula I, R 3 is OR Y wherein R Y C 2 -C 6 -alkenyl, in particular C 2 -C4-alkenyl, more specifically Ci-C 2 -alkenyl. R 3 is such as OCH=CH 2 ,

OCH 2 CH=CH 2 .

According to a further specific embodiment of formula I, R 3 is OR Y wherein R Y C 2 -C 6 -alkynyl, in particular C 2 -C 6 -alkynyl, in particular C 2 -C4-alkynyl, more specifically Ci-C 2 -alkynyl. R 3 is such as OCºCH, OCºCCI, OCH 2 CºCCI, or OCCI 2 CºCCI

According to still another embodiment of formula I R 3 is OR Y wherein R Y is C3-C6-cycloalkyl, in particular cyclopropyl.

According to still another embodiment of formula I, R 3 is OR Y wherein R Y is C3-C6-halogencyclo- alkyl. In a special embodiment R 1 is fully or partially halogenated cyclopropyl.

According to still another embodiment of formula I, R 3 is is OR Y wherein R Y C3-C6-cycloalkenyl, in particular cyclopropenyl.

According to still another embodiment of formula I, R 3 is C3-C6-cycloalkyl, in particular cyclopro- pyl.

According to still another embodiment of formula I, R 3 is C3-C6-halogencycloalkyl. In a special embodiment R 3b is fully or partially halogenated cyclopropyl, such as 1 -F-cyclopropyl, 1 -CI- cyclopropyl, 1 ,1 -F 2 -cyclopropyl, 1 ,1-CI 2 -cyclopropyl

According to still another embodiment of formula I, R 3 is phenyl-Ci-C 6 -alkyl, such as phenyl- CH 2 , wherein the phenyl moiety in each case is unsubstituted or substituted by one, two or three identical or different groups R 3b which independently of one another are selected from halogen, Ci-C 2 -alkyl, Ci-C 2 -alkoxy, Ci-C 2 -halogenalkyl and Ci-C 2 -halogenalkoxy, in particular F, Cl, Br, CHs, OCH3, CFs and OCF 3 .

According to still another embodiment of formula I, R 3 is aryl, in particular phenyl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R 3b which independently of one another are selected from CN, halogen, Ci-C 2 -alkyl, C1- C 2 -alkoxy, CrC 2 -halogenalkyl and CrC 2 -halogenalkoxy, in particular CN, F, Cl, Br, CH 3 , OCH 3 , CHF 2 , OCHF 2, CF 3 and OCF 3 . According to one embodiment, R 3 is unsubstituted phenyl. Ac- cording to another embodiment, R 3 is phenyl, that is substituted with one, two or three, in partic- ular one, halogen, in particular selected from F, Cl and Br, more specifically selected from F and Cl.

According to still another embodiment of formula I, R 3 is a 5-membered heteroaryl such as pyr- rol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol- 3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2- yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isoth iazol-3-yl , isothiazol-4-yl, isoth iazol-5-y 1 , 1 ,2,4-triazolyl-1 -yl, 1 ,2,4-triazol-3-yl 1 ,2,4-triazol-5-yl, 1 ,2,4-oxadiazol-3-yl, 1 ,2,4-oxadiazol-5-yl and 1 ,2,4-thiadiazol-3-yl, 1 ,2,4-thia- diazol-5-yl.

According to still another embodiment of formula I, R 3 is a 6-membered heteroaryl such as pyri- din-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, py- rimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl and 1 ,2,4-triazin-3-yl.

According to still another embodiment of formula I, R 3 is in each case independently selected fromhalogen, CN, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, CrC 6 -alkoxy, Ci-C 6 -halogenalkoxy,C 3 -C 6 -alkenyloxy, C 3 -C 6 -alkynyloxy, C 3 -C 6 -cycloalkyl and C 3 -C 6 -halogen- cycloalkyl, wherein the acyclic moieties of R 3 are unsubstituted or substituted with identical or different groups R 3a as defined and preferably defined herein, and wherein the carbocyclic, phe- nyl and heteroaryl moieties of R 3 are unsubstituted or substituted with identical or different groups R 3b as defined and preferably defined herein.

According to still another embodiment of formula I, R 3 is in each case independently selected from halogen, CN, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy; wherein the acyclic moieties of R 3 are unsubstituted or substituted with identical or different groups R 3a as defined and preferably defined herein.

According to still another embodiment of formula I, R 3 is in each case independently selected from CN, halogen, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkynyl, OR Y , C 3 -C 6 -cycloalkyl;

wherein R Y is Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl or C 2 -C 6 -alkynyl.

R 3a are the possible substituents for the acyclic moieties of R 3 .

According to one embodiment R 3a is independently selected from halogen, OH, CN, C1-C6- alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy, Ci-C 6 -alkylthio, aryl and phenoxy, wherein the aryl and phenyl group is unsubstituted or substituted with substitu- ents R 31a selected from the group consisting of halogen, OH, CrC4-alkyl, CrC4-halogenalkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy.

According to one embodiment R 3a is independently selected from halogen, Ci-C 6 -alkoxy, C 3 -C 6 - cycloalkyl, C 3 -C 6 -halogencycloalkyl and Ci-C4-halogenalkoxy. Specifically, R 3a is independently selected from F, Cl, Br, I, Ci-C 2 -alkoxy, cyclopropyl, 1 -F-cyclopropyl, 1-CI-cyclopropyl, 1 ,1 -F 2 - cyclopropyl, 1 ,1 -CI 2 -cyclopropyl and Ci-C 2 -halogenalkoxy.

According to still another embodiment of formula I, R 3a is independently halogen, in particular selected from F, Cl, Br and I, more specifically F, Cl and Br.

R 3b are the possible substituents for the carbocyclic, heteroaryl and phenyl moieties of R 3 . R 3b according to the invention is independently selected from halogen, OH, CN, Ci-C4-alkyl, C1-C4- alkoxy, Ci-C4-halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C4-halogenalkoxy and Ci-C 6 -alkylthio.

According to one embodiment thereof R 3b is independently selected from halogen, CN, C1-C4- alkyl, Ci-C4-alkoxy, Ci-C4-halogenalkyl and Ci-C4-halogenalkoxy, in particular halogen, C1-C4- alkyl and Ci-C4-alkoxy. Specifically, R 3b is independently selected from F, Cl, CN, CH 3 , OCH 3 and halogenmethoxy.

Particularly preferred embodiments of R 3 according to the invention are in Table P3 below, wherein each line of lines P3-1 to P3-41 corresponds to one particular embodiment of the inven- tion, wherein P3-1 to P3-41 are also in any combination with one another a preferred embodi- ment of the present invention. The connection point to the carbon atom, to which R 3 is bound is marked with“#” in the drawings.

Table P3:

According to still another embodiment of formula I, R 2 , R 3 together with the carbon atoms to which they are bound form a five- , six-, or seven- membered carbo-, heterocyclic or heteroaro- matic ring; wherein the heterocyclic or heteroaromatic ring contains 1 , 2, 3 or 4 heteroatoms se- lected from N, O and S, wherein N may carry one substituent R N selected from Ci-C4-alkyl, Ci- C 4 -halogenalkyl and S0 2 Ph, wherein Ph is unsubstituted or substituted by substituents selected from Ci-C 4 -alkyl, halogen, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, and CN; and wherein S may be in the form of its oxide SO or SO 2 ; and wherein in each case one or two CH 2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(=0) and C(=S); and wherein the carbo-, heterocyclic or heteroaromatic ring is substituent by (R 23 ) m , wherein m is 0, 1 , 2, 3 or 4;

R 23 is in each case independently selected from halogen, OH, CN, COOH,

CONH 2 , N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(CrC 4 -alkyl) 2 , NH-S0 2 -R x , C r C 6 -alkyl, C 2 - C 6 -alkenyl, C 2 -C 6 -alkynyl, CrC 6 -alkoxy, C 3 -C 6 -cycloalkyl, saturated or partially un- saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl and aryl; wherein the heterocycle and heteroaryl contains 1 , 2 or 3 heteroatoms selected from N, O and S; and wherein in each case one or two CH 2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(=0) and C(=S); and wherein

R x is as defined above;

wherein the acyclic moieties of R 23 are unsubstituted or carry 1 , 2, 3 or up to the maximum pos- sible number of identical or different groups R 23a which independently of one another are se- lected from:

R 23a halogen, OH, CN, COOH, CONH 2 , Ci-C 6 -alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 - halogencycloalkyl, Ci-C 4 -halogenalkoxy, Ci-Ce-alkylthio and phenoxy, wherein the phenyl group is unsubstituted or unsubstituted or substituted with R 91a se- lected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, CN, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloal- kyl, CrC 4 -alkylthio;

wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R 23 are unsubstituted or substituted with identical or different groups R 23b which independently of one another are se- lected from:

R 23b halogen, OH, CN, COOH, CONH 2 , Ci-C 4 -alkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy, and Ci-C 6 -al- kylthio.

According to still another embodiment of formula I, R 2 , R 3 together with the carbon atoms to which they are bound form a five- , six-, or seven- membered carbo-, heterocyclic or heteroaro- matic ring; wherein the heterocyclic or heteroaromatic ring contains 1 , 2, 3 or 4 heteroatoms se- lected from N, O and S, wherein N may carry one substituent R N selected from Ci-C 4 -alkyl, Ci- C 4 -halogenalkyl and S0 2 Ph, wherein Ph is unsubstituted or substituted with substituents se- lected from Ci-C 4 -alkyl, halogen, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy, and CN; and wherein S may be in the form of its oxide SO or SO 2 ; and wherein in each case one or two CH 2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(=0) and C(=S); and wherein the carbo-, heterocyclic or heteroaromatic ring is substituent by (R 23 ) m wherein m is 0, 1 , 2, 3 or 4;

R N is the substituent of the heteroatom N that is contained in the heterocycle formed by R 2 and R 3 in some of the inventive compounds. R N is selected from Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl and SC>2Ph, wherein Ph is unsubstituted phenyl or phenyl that is substituted with one, two or three substituents selected from Ci-C 4 -alkyl. In one preferred embodiment, R N is in each case inde- pendently selected from Ci-C2-alkyl, Ci-C2-halogenalkyl and SC>2Ph, wherein Ph is unsubsti- tuted phenyl or phenyl that is substituted with one methyl substituents. In one particular embodi- ment, R N is in each case independently selected from Ci-C2-alkyl, more particularly methyl. In one particular embodiment, R N is in each case independently selected from SC>2Ph, wherein Ph is unsubstituted phenyl or phenyl that is substituted with one methyl.

According to still another embodiment of formula I, R 2 and R 3 together with the carbon atoms to which they are bound form a saturated or partially unsaturated five-, six-or seven -membered carbo- and heterocycle that is unsubstituted or substituted.

According to one embodiment, R 2 and R 3 form a 3-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 23 . According to still another embodiment of formula I, it is substituted with R 23 .

According to one embodiment, R 2 and R 3 form a 4-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 23 . According to still another embodiment of formula I, it is substituted with R 23 .

According to one embodiment, R 2 and R 3 form a 5-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 23 . According to still another embodiment of formula I, it is substituted with R 23 .

According to one embodiment, R 2 and R 3 form a 6-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 23 . According to still another embodiment of formula I, it is substituted with R 23 .

According to one embodiment, R 2 and R 3 form a 7-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 23 . According to still another embodiment of formula I, it is substituted with R 23 .

According to one embodiment, R 2 and R 3 form a 3-membered saturated heterocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 23 . According to still another embodiment of formula I, it is substituted with R 23 .

According to one embodiment, R 2 and R 3 form a 4-membered saturated heterocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 23 . According to still another embodiment of formula I, it is substituted with R 23 .

According to one embodiment, R 2 and R 3 form a 5-membered saturated heterocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 23 . According to still another embodiment of formula I, it is substituted with R 23 .

According to one embodiment, R 2 and R 3 form a 6-membered saturated heterocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 23 . According to still another embodiment of formula I, it is substituted with R 23 .

According to one embodiment, R 2 and R 3 form a 7-membered saturated heterocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 23 . According to still another embodiment of formula I, it is substituted with R 23 . According to one embodiment, R 2 and R 3 form a 5-membered saturated heteroaryl. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 23 . According to still another embodiment of formula I, it is substituted with R 23 .

According to one embodiment, R 2 and R 3 form a 6-membered heteroaryl. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 23 . According to still another embodiment of formula I, it is substituted with R 23 .

According to one embodiment, R 2 and R 3 do not form a cyclic substituent.

R 23 according to the invention is in each case independently selected from halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R*, C C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 - alkynyl, Ci-C 6 -alkoxy, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl and aryl; wherein the heterocycle and heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein in each case one or two CH 2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(=0) and C(=S); and wherein

R x is as defined above;

wherein the acyclic moieties of R 23 are unsubstituted or substituted with identical or different groups R 23a which independently of one another are selected from:

R 23a halogen, OH, CN, Ci-C 6 -alkoxy, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C 4 -halo- genalkoxy, Ci-Ce-alkylthio, aryl and phenoxy, wherein the aryl group is unsubstituted or unsub- stituted or substituted with R 231a selected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, CN, C3-C6-cycloalkyl, C3-C6-halogency- cloalkyl, Ci-C 4 -alkylthio;

wherein the carbocyclic, heterocyclic, heteroaryl and aryl of R 23 are unsubstituted or substituted with identical or different groups R 23b which independently of one another are selected from:

R 23b halogen, OH, CN, Ci-C 4 -alkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkyl, C3-C6-cycloalkyl, C3-C6- halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-Ce-alkylthio.

For every R 23 that is present in the inventive compounds, the following embodiments and preferences apply independently of the meaning of any other R 23 that may be present in the ring.

According to one embodiment of formula I, wherein m is 0, 1 , 2, 3 or 4.

According to still another embodiment of formula l,m is 0.

According to still another embodiment of formula I, m is 1 .

According to still another embodiment of formula I, m is 2 or 3. According to one specific embodiment thereof, m is 2. According to still another embodiment of formula I, m is 3.

According to one embodiment of formula I, R 23 is halogen, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, Ci- C 6 -alkoxy or , Ci-C 6 -halogenalkoxy, in particular CH 3 , Et, CHF 2 , OCH 3 , OCHF 2 , OCF 3 , F, Cl, more specifically H, CH 3 , F or Cl most preferred F or Cl.

According to still another embodiment of formula I, R 23 is halogen, in particular Br, F or Cl, more specifically F or Cl. According to still another embodiment of formula I, R 23 is OH.

According to still another embodiment of formula I, R 23 is CN.

According to still another embodiment of formula I R 23 is NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 or NH-S0 2 -R x , wherein R x is Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, unsubstituted aryl or aryl that is sub- stituted with one, two, three, four or five substituents R x23 independently selected from C 1 -C 4 - alkyl.

According to still another embodiment of formula I, R 23 is Ci-C 6 -alkyl, in particular Ci-C 4 -alkyl, such as CH 3 .

According to still another embodiment of formula I, R 23 is Ci-C 6 -halogenalkyl, in particular C 1 -C 4 - halogenalkyl, such as CF 3 , CHF 2 , CH 2 F, CCI 3 , CHCI 2 or CH 2 CI.

According to still another embodiment of formula I, R 23 is C 2 -C 6 -alkenyl or C 2 -C 6 -halogenalkenyl, in particular C 2 -C 4 -alkenyl or C 2 -C 4 -halogenalkenyl, such as CH=CH 2 , C(CH3)=CH2,

According to still another embodiment of formula I, R 23 is C 2 -C 6 -alkynyl or C 2 -C 6 -halogenalkynyl, in particular C 2 -C 4 -alkynyl or C 2 -C 4 -halogenalkynyl, such as C CH, CH 2 C=CH, C C-CI, C C- CH 3 , CH 2 CºCH, CH 2 CºCCI or CH 2 CºC-CH 3 .

According to still another embodiment of formula I, R 23 is Ci-C6-alkoxy, in particular C 1 -C 4 - alkoxy, more specifically Ci-C 2 -alkoxy such as OCH 3 or OCH 2 CH 3 .

According to still another embodiment of formula I, R 23 is Ci-C 6 -halogenalkoxy, in particular C 1 - C 4 -halogenalkoxy, more specifically Ci-C 2 -halogenalkoxy such as OCF 3 , OCHF 2 , OCH 2 F,

OCCI3, OCHCh or OCH2CI, in particular OCF 3 , OCHF 2 , OCCI 3 or OCHCI 2 .

According to still another embodiment of formula I R 23 is C 3 -C 6 -cycloalkyl, in particular cyclopro- pyi-

According to still another embodiment of formula I, R 23 is C 3 -C 6 -cycloalkyl, for example cyclopro- pyl, substituted with one, two, three or up to the maximum possible number of identical or differ- ent groups R 23b as defined and preferably herein.

According to still another embodiment of formula I, R 23 is C 3 -C 6 -halogencycloalkyl. In a special embodiment R 23 is fully or partially halogenated cyclopropyl.

According to still another embodiment of formula I, R 23 is unsubstituted aryl or aryl that is substituted with one, two, three or four R 23b , as defined herein. In particular, R 23 is unsubstituted phenyl or phenyl that is substituted with one, two, three or four R 23b , as defined herein.

According to still another embodiment of formula I, R 23 is unsubstituted 5- or 6-membered heteroaryl. According to still a further embodiment, R 23 is 5- or 6-membered heteroaryl that is substituted with one, two or three R 23b , as defined herein.

According to still another embodiment of formula I, R 23 is in each case independently selected from halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-C 6 -alkoxy and C 3 -C 6 -cycloalkyl; wherein the acyclic moieties of R 23 are not further substituted or carry one, two, three, four or five identical or different groups R 23a as defined below and wherein the carbocyclic, heterocyclic and heteroaryl moieties of R 23 are not further substituted or carry one, two, three, four or five identical or different groups R 23b as defined below.

According to still another embodiment of formula I, R 23 is independently selected from halogen, OH, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, Ci-C 6 -alkoxy and Ci-C 6 -halogenalkoxy, in particular inde- pendently selected from F, Cl, Br, CN, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy.

R 23a are the possible substituents for the acyclic moieties of R 23 .

R 23a according to the invention is independently selected from halogen, OH, CN, Ci-C 6 -alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy, Ci-C 6 -alkylthio, aryl and phe- noxy, wherein the aryl and phenyl group is unsubstituted or unsubstituted or substituted with R 231a selected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 - alkoxy, Ci-C 4 -halogenalkoxy, CN, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -alkylthio.

R 23a according to the invention is independently selected from halogen, OH, CN, Ci-C 6 -alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy, CrC 6 -alkylthio, aryl and phe- noxy, wherein the aryl and phenyl group is unsubstituted or unsubstituted or substituted with R 231a selected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 - alkoxy and Ci-C 4 -halogenalkoxy, in particular selected from halogen, Ci-C 2 -alkyl, Ci-C 2 -halo- genalkyl, Ci-C 2 -alkoxy, Ci-C 2 -halogenalkoxy, more specifically selected from halogen, such as F, Cl and Br.

In to one embodiment R 23a is independently selected from halogen, OH, CN, CrC 2 -alkoxy, C 3 - C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl and Ci-C 2 -halogenalkoxy. Specifically, R 23a is

independently selected from F, Cl, OH, CN, Ci-C 2 -alkoxy, cyclopropyl, 1-F-cyclopropyl, 1 -CI- cyclopropyl, 1 ,1 -F 2 -cyclopropyl, 1 ,1-Cl 2 -cyclopropyl and Ci-C 2 -halogenalkoxy.

According to one embodiment R 23a is independently selected from halogen, such as F, Cl, Br and I, more specifically F, Cl and Br.

According to still another embodiment of formula I, R 23a is independently selected from OH, C 3 - C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl and Ci-C 2 -halogenalkoxy. Specifically, R 23a is

independently selected from OH, cyclopropyl and Ci-C 2 -halogenalkoxy.

R 23b are the possible substituents for the carbocyclic, heterocyclic and heteroaryl moieties of R 23 .

R 23b according to the invention is independently selected from halogen, OH, CN, Ci-C 4 -alkyl, C 1 - C 4 -alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl and Ci-C 4 -halogen- alkoxy.

According to one embodiment thereof R 23b is independently selected from halogen, CN, C 1 -C 2 - alkyl, Ci-C 2 -alkoxy, Ci-C 2 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalky and Ci-C 2 -hal- ogenalkoxy. Specifically, R 23b is independently selected from F, Cl, OH, CN, CH 3 , OCH 3, cyclopropyl, 1-F-cyclopropyl, 1-CI-cyclopropyl, 1 ,1-F 2 -cyclopropyl, 1 ,1-Cl 2 -cyclopropyl and halogenmethoxy. According to still another embodiment thereof R 23b is independently selected from Ci-C2-alkyl, Ci-C2-alkoxy, Ci-C2-halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl and Ci-C2-halogen- alkoxy. Specifically, R 23b is independently selected from OH, CH3, OCH3, cyclopropyl, 1-F- cyclopropyl, 1-CI-cyclopropyl, 1 ,1-F 2 -cyclopropyl, 1 ,1-Cl 2 -cyclopropyl and halogenmethoxy, more specifically independently selected from OH, CH3, OCH3 , cyclopropyl, 1-F-cyclopropyl, 1- Cl-cyclopropyl, 1 ,1-F 2 -cyclopropyl, 1 ,1-Cl 2 -cyclopropyl cyclopropyl and OCHF2.

Particularly preferred embodiments of combinations of R 2 and R 3 according to the invention are in Table P35 below, wherein each line of lines P35-1 to P35-305 corresponds to one particular embodiment of the invention, wherein P35-1 to P35-305 are also in any combination with one another a preferred embodiment of the present invention. The carbon atom, to which R 2 bound is marked with * in the drawings and the carbon atom, to which R 3 is bound is marked with # in the drawings. cPr stands for cyclopropyl.

Table P23:

R 4 according to the invention is in each case independently selected from hydrogen, halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-C 6 -alkoxy, C3-C6-cycloalkyl, five- or six-membered heteroaryl and aryl;

wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein

R x is Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, unsubstituted aryl or aryl that is substituted with one, two, three, four or five substituents R x4 independently selected from CrC 4 -alkyl, halogen, OH, CN, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy;

wherein the acyclic moieties of R 4 are unsubstituted or substituted with identical or different groups R 4a which independently of one another are selected from:

R 4a halogen, OH, CN, Ci-C 6 -alkoxy, C3-C6-cycloalkyl, C3-C6-halogencycloalky, Ci-C 4 -halogen- alkoxy, Ci-Ce-alkylthio, aryl and phenoxy, wherein the aryl and phenoxy group is unsubstituted or unsubstituted or substituted with R 44a selected from the group consisting of halogen, OH, Ci- C 4 -alkyl, Ci-C 4 -halogenalkyl, CrC 4 -alkoxy and Ci-C 4 -halogenalkoxy;

wherein the carbocyclic, heteroaryl and aryl moieties of R 4 are unsubstituted or substituted with identical or different groups R 4b which independently of one another are selected from:

R 4b halogen, OH, CN, Ci-C 4 -alkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 - halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-Ce-alkylthio.

For every R 4 that is present in the inventive compounds, the following embodiments and preferences apply independently of the meaning of any other R 4 that may be present in the ring.

According to one embodiment of formula I, R 4 is H, halogen or Ci-C6-alkyl, in particular H, CH 3 , Et, F, Cl, more specifically H, CH 3 , F or Cl most preferred H, F or Cl.

According to another embodiment of formula I, R 4 is hydrogen.

According to still another embodiment of formula I, R 4 is halogen, in particular Br, F or Cl, more specifically F or Cl.

According to another embodiment of formula I, R 4 is F

According to another embodiment of formula I, R 4 is Cl

According to another embodiment of formula I, R 4 is Br.

According to still another embodiment of formula I, R 4 is OH.

According to still another embodiment of formula I, R 4 is COOH.

According to still another embodiment of formula I, R 4 is CONH 2 .

According to still another embodiment of formula I, R 4 is CN.

According to still another embodiment of formula I, R 4 is NO 2 .

According to still another embodiment of formula I, R 4 is SH.

According to still another embodiment of formula I R 4 is NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 or NH-SC> 2 -R x , wherein R x is Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, unsubstituted aryl or aryl that is sub- stituted with one, two, three, four or five substituents R x4 independently selected from Ci-C 4 -al- kyl, halogen, OH, CN, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, or Ci-C 4 -halogenalkoxy. In particular Ci-C 4 -alkyl, such as NHCH 3 and N(CH 3 ) 2 . In particular R x is Ci-C 4 -alkyl, and phenyl that is sub- stituted with one CH 3 , more specifically S02-R x is CH 3 and tosyl group (“Ts”).

According to still another embodiment of formula I, R 4 is Ci-C6-alkyl, in particular Ci-C 4 -alkyl, such as CH3 or CH2CH3.

According to still another embodiment of formula I, R 4 is Ci-C6-halogenalkyl, in particular CrC 4 - halogenalkyl, such as CF 3 , CHF 2 , CH 2 F, CCI 3 , CHCI 2 , CH 2 CI, CF3CH2, CCI3CH2 or CF 2 CHF 2 .

According to still another embodiment of formula I, R 4 is C 2 -C 6 -alkenyl or C 2 -C 6 -halogenalkenyl, in particular C 2 -C 4 -alkenyl or C 2 -C 4 -halogenalkenyl, such as CH=CH 2 , C(CH 3 )=CH 2, CH=CCl 2 ,

CH=CF 2 , CCI=CCI 2 , CF=CF 2 , CH=CH 2 , CH 2 CH=CCI 2 , CH 2 CH=CF 2 , CH 2 CCI=CCI 2 , CH 2 CF=CF 2 ,

CCI 2 CH=CCI 2 , CF 2 CH=CF 2 , CCI 2 CCI=CCI 2 , or CF 2 CF=CF 2 .

According to still another embodiment of formula I, R 4 is C 2 -C 6 -alkynyl or C 2 -C 6 -halogenalkynyl, in particular C 2 -C 4 -alkynyl or C 2 -C 4 -halogenalkynyl, such as CECH, CECCI, CECF. CH 2 CECH, CH 2 CºCCI, or CH 2 CºCF.

According to still another embodiment of formula I, R 4 is Ci-C6-alkoxy, in particular Ci-C 4 -alkoxy, more specifically Ci-C 2 -alkoxy such as OCH 3 or OCH 2 CH 3 .

According to still another embodiment of formula I, R 4 is Ci-C 6 -halogenalkoxy, in particular C1- C4-halogenalkoxy, more specifically Ci-C2-halogenalkoxy such as OCF3, OCHF2, OCH2F,

OCCI3, OCHCh or OCH2CI, in particular OCF 3 , OCHF 2 , OCCI 3 or OCHCI 2 .

According to still another embodiment of formula I R 4 is C 3 -C 6 -cycloalkyl, in particular cyclopro- pyi-

According to still another embodiment of formula I, R 4 is C3-C6-cycloalkyl, for example cyclopro- pyl, substituted with one, two, three or up to the maximum possible number of identical or differ- ent groups R 4b as defined and preferably herein.

According to still another embodiment of formula I, R 4 is C3-C6-halogencycloalkyl. In a special embodiment R 4 is fully or partially halogenated cyclopropyl.

According to still another embodiment of formula I, R 4 is unsubstituted aryl or aryl that is substituted with one, two, three or four R 4b , as defined herein. In particular, R 4 is unsubstituted phenyl or phenyl that is substituted with one, two, three or four R 4b , as defined herein.

According to still another embodiment of formula I, R 4 is unsubstituted 5- or 6-membered heteroaryl. According to still a further embodiment, R 4 is 5- or 6-membered heteroaryl that is substituted with one, two or three R 4b , as defined herein.

According to still another embodiment of formula l,R 4 is in each case independently selected from hydrogen, halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, C2-C6-alkenyl, C2-C6-alkynyl, Ci-C 6 -alkoxy and C3-C6-cycloalkyl; wherein the acyclic moieties of R 4 are not further substituted or carry one, two, three, four or five identical or differ- ent groups R 4a as defined below and wherein the carbocyclic, heteroaryl and aryl moieties of R 4 are not further substituted or carry one, two, three, four or five identical or different groups R 4b as defined below.

According to still another embodiment of formula I, R 4 is independently selected from hydrogen, halogen, CN, OH, Ci-C 6 -alkyl,Ci-C 6 -alkoxy, C 6 -alkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl, wherein the acyclic and cyclic moieties of R 4 are unsubtitted or substituted by halogen.

According to still another embodiment of formula I, R 4 is independently selected from hydrogen, halogen, CN, OH, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, Ci-C 6 -alkoxy and Ci-C 6 -halogenalkoxy, in particular independently selected from H, F, Cl, Br, CN, OH, Ci-C4-alkyl, Ci-C4-halogenalkyl, Cr C4-alkoxy and Ci-C4-halogenalkoxy.

According to still another embodiment of formula I, R 4 is independently selected from H, CN, halogen or Ci-C 6 -alkyl, in particular H, CN, CH3, Et, F, Cl, more specifically H, CN, CH3, F or Cl most preferred H, CH3, F or Cl.

R 4a are the possible substituents for the acyclic moieties of R 4 .

R 4a according to the invention is independently selected from halogen, OH, CN, CrC 6 -alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy, CrC 6 -alkylthio, aryl and phe- noxy, wherein the aryl group is unsubstituted or unsubstituted or substituted with R 44a selected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci- C 4 -halogenalkoxy, in particular selected from halogen, Ci-C 2 -alkyl, Ci-C 2 -halogenalkyl, C 1 -C 2 - alkoxy and Ci-C 2 -halogenalkoxy, more specifically selected from halogen, such as F, Cl and Br.

In to one embodiment R 4a is independently selected from halogen, OH, CN, CrC 2 -alkoxy, C 3 - C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl and Ci-C 2 -halogenalkoxy. Specifically, R 4a is

independently selected from F, Cl, OH, CN, Ci-C 2 -alkoxy, cyclopropyl, 1-F-cyclopropyl, 1 -CI- cyclopropyl, 1 ,1 -F 2 -cyclopropyl, 1 ,1-Cl 2 -cyclopropyl and CrC 2 -halogenalkoxy.

According to one embodiment R 4a is independently selected from halogen, such as F, Cl, Br and I, more specifically F, Cl and Br.

According to still another embodiment of formula I, R 4a is independently selected from OH, C 3 - C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl and Ci-C 2 -halogenalkoxy. Specifically, R 4a is

independently selected from OH, cyclopropyl and Ci-C 2 -halogenalkoxy.

According to still another embodiment of formula I, R 4a is independently selected from aryl and phenoxy, wherein the aryl group is unsubstituted or substituted with R 44a selected from the group consisting of halogen, OH, CrC 4 -alkyl, CrC 4 -halogenalkyl, CrC 4 -alkoxy and CrC 4 -halo- genalkoxy, in particular selected from halogen, Ci-C 2 -alkyl, Ci-C 2 -halogenalkyl, Ci-C 2 -alkoxy and Ci-C 2 -halogenalkoxy, more specifically selected from halogen, such as F, Cl and Br.

R 4b are the possible substituents for the carbocyclic, heteroaryl and aryl moieties of R 4 .

R 4b according to the invention is independently selected from halogen, OH, CN, Ci-C 4 -alkyl, C 1 - C 4 -alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-C6-alkylthio;

According to one embodiment thereof R 4b is independently selected from halogen, CN, C 1 -C 2 - alkyl, CrC 2 -alkoxy, CrC 2 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl and C 1 -C 2 - halogenalkoxy. Specifically, R 4b is independently selected from F, Cl, Br, OH, CN, CH 3 , OCH 3, CHF 2 , OCHF 2 , cyclopropyl, 1 -F-cyclopropyl, 1 -CI-cyclopropyl, 1 ,1-F 2 -cyclopropyl, 1 , 1 -CI 2 - cyclopropyl, OCF3, and OCHF2.

According to still another embodiment thereof R 4b is independently selected from halogen, C-i- C 2 -alkyl, Ci-C 2 -alkoxy, Ci-C 2 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl and C 1 -C 2 - halogenalkoxy. Specifically, R 4b is independently selected from halogen, CN, OH, CH 3 , CHF 2 , OCHF 2 , OCF 3 , OCH 3 , cyclopropyl, 1-F-cyclopropyl, 1 -CI-cyclopropyl, 1 ,1-F 2 -cyclopropyl, 1 , 1 -CI 2 - cyclopropyl and halogenmethoxy, more specifically independently selected from F, Cl, OH, CH 3 , OCH 3, CHF 2 , OCH 3 , cyclopropyl, 1 -F-cyclopropyl, 1 -CI-cyclopropyl, 1 ,1-F 2 -cyclopropyl, 1 , 1 -CI 2 - cyclopropyl, OCHF 2 and OCF 3 .

R x in the substituent NH-S0 2 -R X is in each case independently selected from Ci-C 4 -alkyl, Ci-C 4 - halogenalkyl, unsubstituted aryl and aryl that is substituted with one, two, three, four or five substituents R x4 independently selected from Ci-C 4 -alkyl, halogen, OH, CN, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy. In particular, R x is in each case independently selected from CrC 4 -alkyl, halogen, OH, CN and phenyl that is substituted with one, two or three R x4 independently selected from Ci-C 2 -alkyl, more specifically R x is in each case independently selected from Ci-C 4 -alkyl and phenyl that is substituted with one CH 3 , more specifically SC>2-R X is the tosyl group (“Ts”).

Particularly preferred embodiments of R 4 according to the invention are in Table P4 below, wherein each line of lines P4-1 to P4-16 corresponds to one particular embodiment of the inven- tion. Thereby, for every R 4 that is present in the inventive compounds, these specific

embodiments and preferences apply independently of the meaning of any other R 4 that may be present in the ring:

Table P4:

“Ts” in the table stands for the tosylgroup SC>2-(p-CH3)phenyl.

10

R 5 is in each case independently selected from hydrogen, OH, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)C 2 -C 6 -alkenyl, C(=0)C 3 -C 6 -cycloalkyl, Ci-C 6 -alkyl, Ci-C 4 -halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, OR Y , C2-C6-alkenyl, C2-C6- halogenalkenyl C2-C6-alkynyl, C2-C6-halogenalkynyl, S(0)n-Ci-C 6 -alkyl, S(0)n-CrC 6 - halogenalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein the aryl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halo- gen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy; wherein n and R Y are as defined above.

R 5a is the subtituent of the acyclic moieties of R 5 . The acyclic moieties of R 5 are not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R 5a which independently of one another are selected from halogen, OH, CN, CrC 6 -alkoxy, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, C3-C6-halogencycloalkyl, C3-C6- halogencycloalkenyl, Ci-C 4 -halogenalkoxy, Ci-Ce-alkylthio, five- or six-membered heteroaryl, aryl and phenoxy, wherein the heteroaryl, aryl and phenoxy group is unsubstituted or carries one, two, three, four or five substituents R 78a’ selected from the group consisting of halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy;

R 5b is the subtituyend of carbocyclic, phenyl, heterocyclic and heteroaryl moieties of R 5 . The carbocyclic, phenyl, heterocyclic and heteroaryl moieties of R 5 are not further substituted or carry one, two, three, four, five or up to the maximum number of identical or different groups R 5b which independently of one another are selected from halogen, OH, CN, Ci-C 4 -alkyl, Ci-C 4 - alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-C6-alkylthio.

According to one embodiment of formula I, R 5 is H.

According to still another embodiment of formula I, R 5 is OH.

According to a further specific embodiment of formula I, R 5 is CH(=0).

According to a further specific embodiment of formula I, R 5 is C(=0)Ci-C6-alkyl, wherein alkyl is CH 3 , C 2 H 5 , n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to a further specific embodiment of formula I, R 5 is C(=0)C2-C6-alkenyl, wherein alkenyl is CH=CH 2, CH 2 CH=CH 2 .

According to a further specific embodiment of formula I, R 5 is C(=0)C2-C6-alkynylwherein al- kynyl is CºCH , CH 2 CºCH.

According to a further specific embodiment of formula I, R 5 is C(=0)C3-C6-cycloalkyl, wherein cycloalkyl is cyclopropyl (C 3 H 7 ) or cyclobutyl (C 4 Hg).

According to still another embodiment of formula I, R 5 is Ci-C6-alkyl, such as CH 3 , C 2 H 5 , n-pro- pyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to still another embodiment of formula I, R 5 is Ci-C6-alkyl, in particular Ci-C 4 -alkyl, such as CH 3 , C 2 H 5 , n-propyl, i-propyl.

According to still another embodiment of formula I, R 5 is Ci-C6-halogenalkyl, in particular Ci-C 4 - halogenalkyl, such as CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF3CH2, CCI3CH2 or CF 2 CHF 2 .

According to still another embodiment of formula I R 5 is C 3 -C 6 -cycloalkyl, in particular cyclopro- pyl.

According to still another embodiment of formula I, R 5 is C 3 -C 6 -halogencycloalkyl. In a special embodiment R 5b is fully or partially halogenated cyclopropyl, such as 1-F-cyclopropyl, 1-CI- cyclopropyl, 1 ,1-F2-cyclopropyl, 1 ,1-Cl2-cyclopropyl .

According to still another embodiment of formula I, R 5 is Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy, in particular Ci-C 3 -alkoxy, Ci-C 3 -halogenalkoxy, such as CH 2 OCH 3 , CH 2 OCF 3 or CH 2 OCHF 2 .

According to a further specific embodiment of formula I, R 5 is OR Y wherein R Y is Ci-C6-alkyl, C 1 - C6-halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, C 3 - C6-cycloalkyl, C 3 -C 6 -halogencycloalkyl, phenyl and phenyl-Ci-C6-alkyl; wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, CrC 4 -alkoxy and CrC 4 - halogenalkoxy;

According to a further specific embodiment of formula I, R 5 is OR Y wherein R Y is Ci-C6-alkyl, in particular Ci-C 4 -alkyl, more specifically Ci-C 2 -alkyl. R 5 is such as OCH 3 or OCH 2 CH 3 .

According to a further specific embodiment of formula I, R 5 is OR Y wherein R Y is Ci-C6-halogen- alkyl, in particular Ci-C 4 -halogenalkyl, more specifically Ci-C 2 -halogenalkyl. R 5 is such as OCF 3 , OCHF 2I OCH 2 F, OCCI S , OCHCI 2 or OCH 2 CI, in particular OCF 3 , OCHF 2 , OCCI 3 or OCHCI 2 .

According to a further specific embodiment of formula I, R 5 is OR Y wherein R Y C 2 -C 6 -alkenyl, in particular C 2 -C4-alkenyl, more specifically Ci-C 2 -alkenyl. R 5 is such as OCH=CH 2 ,

OCH 2 CH=CH 2 .

According to a further specific embodiment of formula I, R 5 is OR Y wherein R Y C 2 -C 6 -alkynyl, in particular C 2 -C 6 -alkynyl, in particular C 2 -C 4 -alkynyl, more specifically Ci-C 2 -alkynyl. R 5 is such as OCºCH

According to still another embodiment of formula I, R 5 is OR Y wherein R Y is C 3 -C 6 -halogencyclo- alkyl. In a special embodiment R 1 is fully or partially halogenated cyclopropyl.

According to still another embodiment of formula I, R 5 is is OR Y wherein R Y and phenyl; wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy and Ci-C 4 -halogenalkoxy.

According to still another embodiment of formula I, R 5 is is OR Y wherein R Y phenyl-Ci-C 6 -alkyl, such as phenyl-CH 2 , herein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, Ci-C 4 -alkyl, CrC 4 -hal- ogenalkyl, CrC 4 -alkoxy and Ci-C 4 -halogenalkoxy. R 5 is such as OCH 2 Ph.

According to still a further embodiment of formula I, R 5 is C 2 -C 6 -alkenyl, in particular C 2 -C 4 -alk- enyl, such as CH=CH 2 , C(CH 3 )=CH 2 , CH 2 CH=CH 2 .

According to a further specific embodiment of formula I, R 5 is C 2 -C 6 -halogenalkenyl, in particular C 2 -C 4 -halogenalkenyl, more specifically C 2 -C 3 -halogenalkenyl such as CH=CHF, CH=CHCI, CH=CF 2 , CH=CCI 2 , CH 2 CH=CHF, CH 2 CH=CHCI, CH 2 CH=CF 2I CH 2 CH=CCI 2 , CF 2 CH=CF 2I CCI 2 CH=CCI 2 , CF 2 CF=CF 2 , CCI 2 CCI=CCI 2 .

According to still a further embodiment of formula I, R 5 is C 2 -C 6 -alkynyl or C 2 -C 6 -halogenalkynyl, in particular C 2 -C 4 -alkynyl or C 2 -C 4 -halogenalkynyl, such as OXOH, OH 2 OXOH.

According to still another embodiment of formula I, R 5 is phenyl-Ci-C 6 -alkyl, such as phenyl- CH 2 , wherein the phenyl moiety in each case is unsubstituted or substituted by one, two or three identical or different groups R 5b which independently of one another are selected from halogen, Ci-C 2 -alkyl, Ci-C 2 -alkoxy, Ci-C 2 -halogenalkyl and Ci-C 2 -halogenalkoxy, in particular F, Cl, Br, CH 3 , OCH S , CF 3 and OCF 3 .

According to still another embodiment of formula I, R 5 is aryl, in particular phenyl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted by identical or different groups R 5b which independently of one another are selected from halogen, Ci-C 2 -alkyl, CrC 2 -alkoxy, Ci-C 2 -halogenalkyl and Ci-C 2 -halogenalkoxy, in particular F, Cl, Br, CH 3 , OCH 3 , CF 3 and OCF 3 . According to one embodiment, R 5 is unsubstituted phenyl. According to another embodiment,

R 5 is phenyl, that is substituted by one, two or three, in particular one, halogen, in particular se- lected from F, Cl and Br, more specifically selected from F and Cl.

According to still another embodiment of formula I, R 5 is a 5-membered heteroaryl such as pyr- rol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol- 3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2- yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isoth iazol-3-yl , isothiazol-4-yl, isoth iazol-5-y 1 , 1 ,2,4-triazolyl-1-yl, 1 ,2,4-triazol-3-yl 1 ,2,4-triazol-5-yl, 1 ,2,4-oxadiazol-3-yl, 1 ,2,4-oxadiazol-5-yl and 1 ,2,4-thiadiazol-3-yl, 1 ,2,4-thia- diazol-5-yl.

According to still another embodiment of formula I, R 5 is a 6-membered heteroaryl such as pyri- din-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, py- rimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl and 1 ,2,4-triazin-3-yl.

According to still another embodiment of formula I, R 5 is in each case independently selected from H, halogen, OH, CN, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C2-C6-alkenyl, C2-C6-alkynyl, O I -O Q - alkoxy, Ci-C 6 -halogenalkoxy, C3-C6-alkenyloxy, C3-C6-alkynyloxy and C3-C6-cycloalkyl wherein the acyclic moieties of R 5 are unsubstituted or substituted with identical or different groups R 5a as defined and preferably defined herein, and wherein the carbocyclic, phenyl and heteroaryl moieties of R 5 are unsubstituted or substituted with identical or different groups R 5b as defined and preferably defined herein.

According to still another embodiment of formula I, R 5 is in each case independently selected from H, halogen, OH, CN, Ci-C 6 -alkyl, C2-C6-alkenyl, C2-C6-alkynyl, Ci-C 6 -alkoxy, C3-C6- alkenyloxy, C3-C6-alkynyloxy and C3-C6-cycloalkyl, wherein the acyclic moieties of R 5 are unsub- stituted or substituted with identical or different groups R 5a as defined and preferably defined herein, and wherein the cycloalkyl moieties of R 5 are unsubstituted or substituted with identical or different groups R 5b as defined and preferably defined herein.

According to still another embodiment of formula I, R 5 is in each case independently selected from H and OR Y , wherein R Y is most preferably Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, phenyl and phenyl-Ci-C 6 -alkyl; wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, Ci-C4-alkyl, Ci-C4-halogenalkyl, C1-C4- alkoxy and Ci-C4-halogenalkoxy.

According to still another embodiment of formula I, R 5 is in each case independently selected from H and OR Y , wherein R Y is most preferably C2-C6-alkenyl, C2-C6-alkynyl, phenyl and phenyl- Ci-C 6 -alkyl; wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy.

According to still another embodiment of formula I, R 5 is in each case independently selected from H, CH(=0), C(=0)Ci-C 6 -alkyl, , wherein the acyclic moieties of R 5 are unsubstituted or substituted with identical or different groups R 5a as defined and preferably defined herein, and wherein the cycloalkyl moieties of R 5 are unsubstituted or substituted with identical or different groups R 5b as defined and preferably defined herein.

According to one embodiment R 5a is independently selected from halogen, Ci-C 6 -alkoxy, C3-C6- cycloalkyl, C3-C6-halogencycloalkyl and Ci-C4-halogenalkoxy. Specifically, R 5a is independently selected from F, Cl, Br, I, Ci-C2-alkoxy, cyclopropyl, 1-F-cyclopropyl, 1-CI-cyclopropyl, 1 ,1 -F2- cyclopropyl, 1 ,1-Cl 2 -cyclopropyl and Ci-C2-halogenalkoxy.

According to still another embodiment of formula I, R 5a is independently halogen, in particular selected from F, Cl, Br and I, more specifically F, Cl and Br. R 5b are the possible substituents for the cycloalkyl, heteroaryl and phenyl moieties of R 5 . R 5b according to the invention is independently selected from halogen, OH, CN, Ci-C 4 -alkyl, C1-C4- alkoxy, Ci-C 4 -halogenalkyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C 4 -halogenalkoxy and Ci-C 6 -alkylthio.

According to one embodiment thereof R 5b is independently selected from halogen, CN, Ci-C 4 - alkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkyl and Ci-C 4 -halogenalkoxy, in particular halogen, Ci-C 4 - alkyl and Ci-C 4 -alkoxy. Specifically, R 5b is independently selected from F, Cl, CN, CH3, CHF2, CF 3 OCH 3 and halogenmethoxy.

Particularly preferred embodiments of R 5 according to the invention are in Table P5 below, wherein each line of lines P5-1 to P5-32 corresponds to one particular embodiment of the inven- tion, wherein P5-1 to P5-32 are also in any combination with one another a preferred embodi- ment of the present invention. The connection point to the carbon atom, to which R 5 is bound is marked with“#” in the drawings.

Table P5:

15 R 6 is independently selected from H, halogen, OH, CN, N0 2 , SH, CrC 6 -alkylthio, NH 2, NH(Cr C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -hal- ogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy, 0 2 -O Q - alkenyloxy, C 2 -C 6 -alkynyloxy, aryloxy, heteroaryloxy, arylamino, heteroarylamino, arylthio, het- eroarylthio, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), C(=0)NH(Ci-C 6 -alkyl), C(=0)N(Cr C 6 -alkyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight- , nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and het- eroaryl contain independently one, two, three or four heteroatoms selected from N, O and S; and wherein R’ and R” are independently selected from H, Ci-C 4 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -al- kynyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten- membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl; wherein the hetero- cycle or heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein R’ and R” are independently unsubstituted or substituted with R’” which is inde- pendently selected from halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH- S0 2 -R x , CrC 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 - C 6 -halogenalkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy, C3-C6-cycloalkyl, C3-C6-halogencycloal- kyl and phenyl;

wherein R x is as defined above;

wherein the acyclic moieties of R 6 are independently not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R 6a , which inde- pendently of one another are selected from:

R 6a halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , CrC 6 -alkoxy, Ci-C4-halogenalkoxy, C3-C6-cycloalkyl, C3-C6- halogencycloalkyl, Ci-C 6 -alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl,

CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(Ci-C 6 -aikyl), C(=0)N(Ci-C 6 -aikyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- or heterocycle, a five-, six- or ten-membered heteroaryl, aryl or phenoxy, wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and het- eroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbo-, heterocyclic, heteroaryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 - alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkylthio, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halo- genalkoxy, and S(0)n-Ci-C 6 -alkyl; and wherein R x , R’ and R” are as defined above; n is 0, 1 , 2; and

wherein the carbo-, heterocyclic, heteroaryl and aryl moieties of R 6 are independently unsubsti- tuted or substituted with identical or different groups R 6b , which independently of one another are selected from:

R 6b halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -alkyl), N(C(=0)Ci-C 4 -alkyl) 2 , NH-SC>2-R X , CrC4-alkyl, Ci-C 4 -alkoxy, Ci-C4-halogenalkyl, C 3 -C 6 -cycloal- kyl, C3-C6- alogencycloalkyl, Ci-C4-halogenalkoxy, Ci-C 6 -alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, Ci-C4-alkoxy-Ci-C4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consist- ing of halogen, OH, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy; and wherein R x and n are as defined above.

According to one embodiment of formula I, R 6 is independently selected from H, halogen, OH, CN, N0 2 , SH, CrCe-alkylthio, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , substituted C C 6 -alkyl, CrC 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halo- genalkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy, C 2 -C 6 -alkenyloxy, C 2 -C 6 -alkynyloxy, CH(=0), C(=0)Ci-C 6 -aikyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(Ci-C 6 -aikyl), C(=0)N(Ci-C 6 -aikyl) 2 ,

CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group in- dependently selected from C(=0) and C(=S), and wherein the heterocycle and the heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S; and wherein R’ and R” are independently selected from H, Ci-C4-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl; wherein the heterocycle or het- eroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein R’ and R” are independently unsubstituted or substituted by R’” which is independently selected from halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, Ci- C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, Ci- C 6 -alkoxy, Ci-C 6 -halogenalkoxy, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl and phenyl; or wherein the aliphatic moieties of R 6 are independently not further substituted or carry 1 , 2, 3 or up to the maximum possible number of identical or different groups R 6a , respectively, which in- dependently of one another are selected from:

R 6a halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-aryl, N(aryl) 2 ,

NH(C(=0)Ci-C 4 -alkyl), N(C(=0)Ci-C 4 -alkyl) 2 , Ci-C 6 -alkoxy, C3-C6-halogencycloalkyl, Ci- C4-halogenalkoxy, Ci-Ce-alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)Ci-C 6 -aikyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(Ci-C 6 -aikyl), C(=0)N(Ci-C 6 - alkyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, aryl, phenoxy, a five-, six- or ten-membered heteroaryl; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), five- or six-membered heteroaryl and aryl; wherein the heterocycle and the heteroaryl con- tain independently 1 , 2, 3 or 4 heteroatoms selected from N, O and S; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S); wherein the carbocyclic, heterocyclic, aryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkylthio, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy, Ci-C4-halogenalkoxy, and S(0) n -Ci-C 6 -alkyl; and wherein R x , R’, R” and R” are as defined above wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R 6 are independently not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R 6b , respectively, which independently of one another are selected from:

R 6b halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-C 4 -alkyl, Ci-C4-alkoxy, Ci-C 4 -halogenalkyl, C3-C6- cycloalkyl, C3-C6-halogencycloalkyl, Ci-C4-halogenalkoxy, Ci-C 6 -alkylthio, Ci-C 6 -halogen- alkylthio, S(0) n -Ci-C 6 -alkyl, Ci-C4-alkoxy-Ci-C4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or substituted with substituents selected from the group consisting of halogen, OH, Ci-C4-alkyl, CrC4-halogenalkyl, CrC4-alkoxy and Ci-C4-halo- genalkoxy.

According to one embodiment of formula I, R 6 is selected from substituted H, Ci-C 6 -alkyl, O-I-OQ- halogenalkyl, C 2 -C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C3-C6-cycloalkenyl, C 2 - C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, C3-C6-cycloalkynyl, Ci-C 6 -alkoxy, aryloxy, heteroaryloxy, ar- ylamino, heteroarylamino, arylthio, heteroarylthio, CN, CH(=0), C(=0)C 2 -C 6 -alkyl, C(=0)0(C 2 - C 6 -alkyl), CR’=NOR”, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C 6 -alkyl-five- and six-mem- bered heteroaryl ,a five- or six-membered heteroaryl, benzyl, aryl; wherein R’ and R” are de- fined below; and wherein the acyclic moieties of R 6 are unsubstituted or substituted with identi cal or different groups R 6a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R 6b as de- fined below.

According to one embodiment of formula I, R 6 is selected from H, Ci-C 6 -alkyl substituted with halogen, CN, Ci-C 6 -alkoxy, aryloxy, arylamino, arylthio, Ci-C4-halogenalkoxy, Ci-C 6 -alkylthio, S(0) n -Ci-C 6 -aikyl, NH-S0 2 -R x , N(Ci-C 6 -alkyl) 2 , NH-S0 2 -R x , NH(Ci-C 6 -alkyl), N(Ci-C 6 -alkyl) 2 , CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), a saturated three-, four-, five-, six-, membered carbo- or heterocycle, aryl, a five- or six-membered heteroaryl; wherein R x is defined below; and wherein the acyclic moieties of R 6 are unsubstituted or substituted with identical or different groups R 6a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R 6b as defined below.

According to another embodiment of formula I, R 6 is H.

According to another embodiment of formula I, R 6 is F.

According to another embodiment of formula I, R 6 is Cl.

According to another embodiment of formula I, R 6 is Br.

According to still another embodiment of formula I, R 6 is OH.

According to still another embodiment of formula I, R 6 is CN.

According to still another embodiment of formula I, R 6 is N0 2 .

According to still another embodiment of formula I, R 6 is SH.

According to still another embodiment of formula I, R 6 is Ci-C 6 -alkylthio, such as SCH3, SC 2 Hs, S-n-propyl, S-i-propyl, S-n-butyl, S-i-butyl, S-tert-butyl, S-n-pentyl, S-i-pentyl, CH 2 SCH 3 or CH 2 SCH 2 CH 3 . According to still another embodiment of formula I, R 6 is Ci-C6-halogenalkylthio, such as SCF 3 , SCCI3, CH2SCF3 or CH2SCF3.

According to still another embodiment of formula I, R 6 is selected from CN, substituted C 1 -C 6 - alkyl, Ci-C6-halogenalkyl or Ci-C6-alkyl which is substituted, Ci-C6-halogenalkyl, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or is substituted with substituents R 6b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted. In a particular embodi- ment, R 6 is selected from Ci-C6-halogenalkyl, phenyl-CH 2 , halogenphenyl-CH 2 , phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or is substituted with substituents R 6b as defined below.

According to still another embodiment of formula I, R 6 is selected from H, CN, substituted C 1 -C 6 - alkyl, Ci-C6-halogenalkyl or Ci-C6-alkyl which is substituted, Ci-C6-halogenalkyl, phenyl, halogenphenyl, aryloxy, heteroaryloxy, arylamino, heteroarylamino, arylthio, heteroarylthio and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or substituted bysubstituents R 6b as defined below. According to one embodi- ment thereof, the carbo- and heterocycle is unsubstituted. In a particular embodiment, R 6 is se- lected from substituted Ci-C6-halogenalkyl, phenyl, halogenphenyl and three-, four-, five- or six- membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or sub- stituted bysubstituents R 6b as defined below.

According to another embodiment of formula I, R 6 is selected from H, CN, substituted Ci-C6-al- kyl, Ci-C6-halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogen- alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C6-alkylaryl, aryloxy, arylamino, ar- ylthio,five- or six-membered heteroaryl or aryl which is unsubstituted or substituted with halogen or Ci-C6-halogenalkyl, and wherein the acyclic moieties of R 6 are unsubstituted or substituted with identical or different groups R 6a as defined below and wherein wherein the carbocycle, het- erocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R 6b as defined below.

According to still another embodiment of formula I, R 6 is selected from H, CN, substituted C 1 -C 6 - alkyl, Ci-C6-halogenalkyl, CN, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halo- genalkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C6-alkylaryl, phenyl, pyridine, pyrimi- dine, thiophene, imidazole, triazol, oxadiazol wherein the acyclic moieties of R 6 are unsubsti- tuted or substituted with identical or different groups R 6a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R 6b as defined below.

According to still another embodiment of formula I, R 6 is selected from CN, substituted C 1 -C 6 - alkyl, Ci-C6-halogenalkyl, CN, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halo- genalkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C6-alkylaryl, phenyl, pyridine, pyrimi- dine, thiophene, imidazole, triazol, oxadiazol wherein the acyclic moieties of R 6 are unsubsti- tuted or substituted with identical or different groups R 6a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R 6b as defined below. According to still another embodiment of formula I, R 6 is Ci-C 6 -alkyl such as CH 3 , C2H5, n-pro- pyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to still another embodiment of formula I, R 6 is Ci-C 6 -alkyl such as CH 3 .

According to still another embodiment of formula I, R 6 is Ci-C 6 -alkyl such as C2H5.

According to still another embodiment of formula I, R 6 is Ci-C 6 -alkyl such as CH 3 , C2H5, n-pro- pyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl which is substituted with at least one group R 6a , which independently of one another are selected from:

R 6a halogen, OH, CN, N0 2 , SH, NH 2 , NH(C C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)C C 4 -alkyl), N(C(=0)CrC 4 -alkyl) 2 , NH-S0 2 -R X , CrC 6 -alkoxy, CrC 4 -halogenalkoxy, Ci-Ce-alkylthio, C1-C6- halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), C(=0)NH(Ci-C 6 -alkyl), C(=0)N(Ci-C 6 -alkyl) 2 , CR -NOR” a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, five-, six- or ten-membered heteroaryl, aryl or phenoxy, wherein in each case one or two CH2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbocyclic, heterocyclic, heteroaryl, aryl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO2, SH, NH2, NH(Ci-C 4 -alkyl), N(Ci- C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkylthio, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, and S(0)n-Ci-C 6 -alkyl.

According to still another embodiment of formula I, R 6 is CH 3 is substituted with at least one group R 6a , which independently of one another are selected from:

R 6a halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-aryl, N(aryl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -alkyl) 2 , NH-S0 2 -R X , CrC 6 -alkoxy, Ci-C 4 -halogenalkoxy, CrC 6 -alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)CrC 6 -al- kyl, C(=0)0(Ci-C 6 -alkyl), C(=0)NH(Ci-C 6 -alkyl), C(=0)N(Ci-C 6 -alkyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocy- cle or heterocycle, five-, six- or ten-membered heteroaryl, an aryl or phenoxy, wherein in each case one or two CH2 groups of the carbo- and heterocycle may be replaced by a group inde- pendently selected from C(=0) and C(=S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbo- cyclic, heterocyclic, heteroaryl, heteroaryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen,

OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 - alkyl)2, NH-S0 2 -R X , Ci-Ce-alkylthio, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halo- genalkoxy, and S(0)n-Ci-C 6 -alkyl.

According to still another embodiment of formula I, R 6 is C2H5 is substituted with at least one group R 6a , which independently of one another are selected from:

R 6a halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-aryl, N(aryl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -alkyl) 2 , NH-S0 2 -R X , CrC 6 -alkoxy, Ci-C 4 -halogenalkoxy, CrC 6 -alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)CrC 6 -al- kyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(Ci-C 6 -aikyl), C(=0)N(Ci-C 6 -alkyl) 2, CR’=NOR”a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocy- cle or heterocycle, five-, six- or ten-membered heteroaryl, phenyl or phenoxy; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group inde- pendently selected from C(=0) and C(=S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbo- cyclic, heterocyclic, heteroaryl, aryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, N0 2 , SH, NH 2I NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkylthio, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, and S(0)n-Ci-C 6 -alkyl.

According to still another embodiment of formula I, R 6 is CH 2 CN.

According to still another embodiment of formula I, R 6 is CH 2 OH.

According to still another embodiment of formula I, R 6 is Ci-C 6 -halogenalkyl, in particular Ci-C 4 - halogenalkyl, more specifically Ci-C 2 -halogenalkyl, such as CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH,

CI 2 CH, CF 3 CH 2I CCI 3 CH 2 or CF 2 CHF 2 .

According to still another embodiment of formula I, R 6 is CH 2 F.

According to still another embodiment of formula I, R 6 is CHF 2 .

According to still another embodiment of formula I, R 6 is CF 3 .

According to still a further embodiment of formula I, R 6 is C 2 -C 6 -alkenyl, in particular C 2 -C 4 -alk- enyl, such as CH=CH 2 , CH 2 CH=CH 2 or C(CH 3 )C=CH 2 .

According to a further specific embodiment of formula I, R 6 is C 2 -C 6 -halogenalkenyl, in particular C 2 -C 4 -halogenalkenyl, more specifically C 2 -C3-halogenalkenyl such as CH=CHF, CH=CHCI, CH=CF 2 , CH=CCI 2I CF=CF 2I CCI=CCI 2 , CH 2 CH=CHF, CH 2 CH=CHCI, CH 2 CH=CF 2I

CH 2 CH=CCI 2I CH 2 CF=CF 2I CH 2 CCI=CCI 2I CF 2 CF=CF 2 or CCI 2 CCI=CCI 2 .

According to still a further embodiment of formula I, R 6 is C 2 -C 6 -cycloalkenyl, in particular C 2 -C 4 - cycloalkenyl, such as CH=CH 2 -cPr.

According to still a further embodiment of formula I, R 6 is C 2 -C 6 -alkynyl or C 2 -C 6 -halogenalkynyl, in particular C 2 -C 4 -alkynyl or C 2 -C 4 -halogenalkynyl, such as C CH, C C-CI, C=C-CH 3 , CH 2 - CºCH, CH 2 -CºCCI or CH 2 - CºC-CH 3 .

According to still a further embodiment of formula I, R 6 is C 2 -C 6 -cycloalkynyl in particular C 2 -C 4 - cycloalkynyl, such as C C-cPr.

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkoxy, in particular Ci-C 4 - alkoxy, more specifically Ci-C 2 -alkoxy such as OCH 3 , CH 2 CH 3 or CH 2 OCH3.

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl-CrC 6 -alkoxy, in particular Ci-C 4 -alkyl-CrC 4 -alkoxy, more specifically Ci-C 2 -alkyl-CrC 2 -alkoxy, such as

CH 2 OCH 3 or CH 2 OCH 2 CH 3.

According to a further specific embodiment of formula I, R 6 is C 2 -C 6 -alkenyloxy, in particular C 2 - C 4 -alkenyloxy, more specifically Ci-C 2 -alkenyloxy such as OCH=CH 2 , OCH 2 CH=CH 2

OC(CH 3 )CH=CH 2 , CH 2 OCH=CH 2I or CH 2 OCH 2 CH=CH 2 .

According to a further specific embodiment of formula I, R 6 is C 2 -C 6 -alkynyloxy, in particular C 2 - C 4 -alkynyloxy, more specifically Ci-C 2 -alkynyloxy such as OC CH, OCH 2 C=CH or CH 2 OC=CH According to a further specific embodiment of formula I, R 6 is Ci-C 6 -halogenalkoxy, in particular Ci-C4-halogenalkoxy, more specifically Ci-C2-halogenalkoxy such as OCF3, OCHF2, OCH2F, OCCIs, OCHCh or OCH2CI, in particular OCF 3 , OCHF 2 , OCCI 3 or OCHCI 2 .

According to a further specific embodiment of formula I, R 6 is Ci-C6-alkyl-Ci-C6-halogenalkoxy, in particular Ci-C 4 -alkyl-Ci-C 4 -halogenalkoxy, more specifically Ci-C 2 -alkyl-Ci-C 2 -halogenalkoxy such as CH 2 OCF 3I CH 2 OCHF 2I CH 2 OCH 2 F, CH2OCCI3, CH2OCHCI2 or CH2OCH2CI, in particular CH2OCF3, CH 2 OCHF 2 , CH2OCCI3 or CH2OCHCI2.

According to a further specific embodiment of formula I, R 6 is CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(Ci-C 6 -aikyl) or C(=0)N(Ci-C 6 -alkyl) 2 , wherein alkyl is CH 3 , C 2 H 5 , n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to a further specific embodiment of formula I, R 6 is Ci-C 4 -alkyl-CH(=0), Ci-C4-alkyl- C(=0)Ci-C 6 -alkyl, Ci-C 4 -alkyl-C(=0)0(Ci-C 6 -alkyl), Ci-C 4 -alkyl-C(=0)NH(Ci-C 6 -alkyl) or C1-C4- alkyl-C(=0)N(Ci-C 6 -alkyl)2, especially CH 2 CH(=0), CH 2 C(=0)Ci-C 6 -alkyl, CH 2 C(=0)0(Ci-C 6 - alkyl), CH 2 C(=0)NH(Ci-C 6 -alkyl) or CH 2 C(=0)N(Ci-C 6 -alkyl) 2 wherein alkyl is CH 3 , C 2 H 5 , n-pro- pyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to a further specific embodiment of formula I, R 6 is CR’=NOR” such as

C(CH 3 )=NOCH 3 , C(CH 3 )=NOCH 2 CH 3 or C(CH 3 )=NOCF 3 .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl-NH(Ci-C 4 -alkyl) orCi- C 6 -alkyl-N(Ci-C 4 -alkyl) 2 , wherein alkyl is CH 3 , C 2 H 5 , n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkylthio, in particular C1-C4- alkoxy, more specifically Ci-C3-alkylthio such as CH2SCH3 or CH2SCH2CH3 .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl-S(0) n -Ci-C 6 -alkyl, wherein alkyl is CH 3 , C2H5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl and n is 1 , 2 or 3.

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl-S(0) n -Ci-C 6 - halogenalkyl, wherein halogenalkyl is CF 3 or CHF2 and n is 1 , 2 or 3.

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl-S(0) n -aryl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R 6b which independently of one another are selected from halogen, Ci-C2-alkyl, C1-C2- alkoxy, Ci-C2-halogenalkyl, Ci-C2-halogenalkoxy and S(0) n -Ci-C 6 -alkyl, in particular F, Cl, Br, CH 3 , OCH 3I CF 3 , CHF 2I OCHF 2I OCF 3 . According to one embodiment, R 6 is unsubstituted phe- nyl. According to another embodiment, R 6 is phenyl, that is substituted with one, two or three, in particular one, halogen, in particular selected from F, Cl and Br, more specifically selected from F and Cl.

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl-NH-S0 2 -R x wherein R x is Ci-C4-alkyl, Ci-C4-halogenalkyl, unsubstituted aryl or aryl that is substituted with one, two, three, four or five substituents R x2 independently selected from Ci-C4-alkyl, halogen, OH, CN, Ci-C4-halogenalkyl, Ci-C4-alkoxy, or Ci-C4-halogenalkoxy, such as CH 2 NHS0 2 CF 3 or

CH2NHSO2CH3. According to still another embodiment of formula I, R 6 is selected from Ci-C 6 -alkyl which is sub- stituted, a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-membered, wherein the carbocycle is unsubstituted or sub- stituted with substituents R 6b as defined below. According to one embodiment thereof, the car- bocycle is unsubstituted.

According to one embodiment, R 6 is selected from Ci-C 6 -alkyl, especially CH 2 which is substi- tuted with a 3-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b .

According to one embodiment, R 6 is selected from Ci-C 6 -alkyl, especially CH 2 which is substi- tuted with a 4-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b .

According to one embodiment, R 6 is selected from Ci-C 6 -alkyl, especially CH 2 which is substi- tuted with a 5-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b .

According to one embodiment, R 6 is selected from Ci-C 6 -alkyl, especially CH 2 which is substi- tuted with a 6-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkylheterocycle, especially CH 2 substituted with a 4-membered saturated heterocycle which contains 1 or 2 heteroatoms, in particular 1 heteroatom, from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. For example, the formed heterocycle is oxetane. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkylheterocycle, especially CH 2 substituted with a 5-membered saturated heterocycle which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkylheterocycle, especially CH 2 subsitited by a 6-membered saturated heterocycle which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b . According to one specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2, in particu- lar 1 , heteroatom(s) O. According to one embodiment thereof, the respective 6-membered heterocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkylheterocycle, especially Chh substituted with a 5-membered saturated heterocycle which contains one N as ring mem- ber and optionally one or two groups CFh are replaced by C(=0).

According to still another embodiment of formula I, R 6 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-membered, wherein the carbocycle is unsubstituted or substituted with substituents R 6b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted.

According to still another embodiment of formula I, R 6 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroa- toms selected from N, O and S, and wherein the carbocycle and heterocycle are unsubstituted or substituted with substituents R 6b as defined below. According to one embodiment thereof, the carbocycle or heterocycle is unsubstituted.

According to still a further embodiment, R 6 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, in particular three-, four-, five- or six-mem- bered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the carbocycle and heterocycle are unsubstituted or substituted with substit- uents R 6b as defined below. According to one embodiment thereof, the carbocycle or heterocy- cle is unsubstituted.

According to still another embodiment of formula I, R 6 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-mem- bered, wherein the carbocycle is unsubstituted or substituted with substituents R 6b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted.

According to one embodiment, R 6 is a 3-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b .

According to one embodiment, R 6 is a 3-membered saturated carbocycle, which is

unsubstituted such as cyclopropyl.

According to one embodiment, R 6 is a 3-membered saturated carbocycle, which is substituted with halogen, more specifically by F, such as C 3 H 3 F2.

According to one embodiment, R 6 is a 3-membered saturated carbocycle, which is substituted with halogen. More specifically by Cl, such as C 3 H 3 CI2.

According to one embodiment, R 6 is a 4-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b .

According to one embodiment, R 6 is a 5-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b . According to one embodiment, R 6 is a 6-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b .

According to still another embodiment of formula I, R 6 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the heterocycle is unsubstituted or substituted with substituents R 6b as defined below. According to one embodiment thereof, the heterocycle is unsubstituted.

According to still another embodiment of formula I, R 6 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered heterocycle, in particular three-, four-, five- or six-mem- bered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the heterocycle is unsubstituted or substituted with substituents R 6b as de- fined below. According to one embodiment thereof, the heterocycle is unsubstituted.

According to still another embodiment of formula I, in the embodiments of R 6 described above, the heterocycle contains preferably one, two or three, more specifically one or two heteroatoms selected from N, O and S. More specifically, the hetereocycle contains one heteroatom selected from N, O and S. In particular, the heterocycle contains one or two, in particular one O.

According to one embodiment, R 6 is a 4-membered saturated heterocycle which contains 1 or 2 heteroatoms, in particular 1 heteroatom, from the group consisting of N, O and S, as ring mem- bers. According to one embodiment, the heterocycle contains one O as heteroatom. For exam- pie, the formed heterocycle is oxetane. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b .

According to still another embodiment of formula I, R 6 is a 5-membered saturated heterocycle which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroa- tom. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b .

According to still another embodiment of formula I, R 6 is a 6-membered saturated heterocycle which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b . According to one specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2, in particular 1 , heteroatom(s) O. According to one embodiment thereof, the respective 6-membered heterocycle is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted with R 6b .

According to still another embodiment of formula I, R 6 is phenyl-Ci-C 6 -alkyl, such as phenyl- CH2, wherein the phenyl moiety in each case is unsubstituted or substituted with one, two or three identical or different groups R 6b which independently of one another are selected from CN, halogen, Ci-C2-alkyl, CrC2-alkoxy, Ci-C2-halogenalkyl, Ci-C2-halogenalkoxy and S(0) n -CrC 6 - alkyl, in particular from CN, F, Cl, Br, CH3, OCH3, CF3, CHF2, OCHF2, OCF3 and S(0) 2 CH 3 . According to still another embodiment of formula I, R 6 is aryl, in particular phenyl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R 6b which independently of one another are selected from CN, halogen, Ci-C2-alkyl, Ci- C2-alkoxy, Ci-C2-halogenalkyl, Ci-C2-halogenalkoxy and S(0) n -Ci-C 6 -alkyl, in particular from CN, F, Cl, Br, CH3, OCH3, CF3, CHF2, OCHF2, OCF3. According to one embodiment, R 6 is un- substituted phenyl. According to another embodiment, R 6 is phenyl, that is substituted with one, two or three, in particular one, halogen, in particular selected from F, Cl and Br, more specifi- cally selected from F and Cl.

According to still another embodiment of formula I, R 6 is a 5-membered heteroaryl such as pyr- rol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol- 3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2- yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isoth iazol-3-yl , isothiazol-4-yl, isoth iazol-5-y 1 , 1 ,2,4-triazolyl-1-yl, 1 ,2,4-triazol-3-yl 1 ,2,4-triazol-5-yl, 1 ,2,4-oxadiazol-3-yl, 1 ,2,4-oxadiazol-5-yl and 1 ,2,4-thiadiazol-3-yl, 1 ,2,4-thia- diazol-5-yl.

According to still another embodiment of formula I, R 6 is a 6-membered heteroaryl, such as pyri- din-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, py- rimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl and 1 ,2,4-triazin-3-yl.

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH2 subsitited by a 5-membered saturated heteroaryl which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH2 subsitited by a 5-membered saturated heteroaryl which contains one N as ring member.

According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH2 subsitited by a 5-membered saturated heteroaryl which contains two N as ring members.

According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH2 subsitited by a 5-membered saturated heteroaryl which contains three N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b .

According to one specific embodiment thereof, said 5-membered saturated heterocycle contains 1 or 2, in particular 1 , heteroatom(s) O.

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains one S as ring member.

According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH2 subsitited by a 5-membered saturated heteroaryl which contains one S and one N as ring mem- bers. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains one S and two N as ring mem- bers. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains one oxygen and one N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains one oxygen and two N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 6-membered saturated heteroaryl which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 6-membered saturated heteroaryl which one N as ring member. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 6-membered saturated heteroaryl which two N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b .

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 10-membered saturated heteroaryl which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b . According to one specific embodiment thereof, said 10-membered saturated heterocycle contains 1 or 2, in partic- ular 1 , heteroatom(s) N.

According to a further specific embodiment of formula I, R 6 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 10-membered saturated heteroaryl which one N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 6b . According to still another embodiment of formula I, it is substituted by R 6b . According to still another embodiment of formula I, R 6 is Chh substituted by a 5-membered heteroaryl such as pyrrol-1 -yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isoth iazol-5-yl , 1 ,2,4-triazolyl- 1 -yl, 1 ,2,4-triazol-3-yl 1 ,2,4-triazol-5-yl, 1 ,2,4-oxadiazol-3-yl, 1 ,2,4-oxadiazol-5-yl and 1 ,2,4- thiadiazol-3-yl, 1 ,2,4-thiadiazol-5-yl.

According to still another embodiment of formula I, R 6 is CH 2 substituted by a 6-membered het- eroaryl, such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2- yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl and 1 ,2,4-triazin-3-yl.

According to a further particular embodiment, R 6 is selected from Ci-C 6 -alkyl, Ci-C 6 -halogen- alkyl, CN, C2-C6-alkenyl, C2-C6-halogenalkenyl, C3-C6-cycloalkenyl, C2-C6-alkynyl, C2-C6-halo- genalkynyl, Ci-C 6 -alkoxy, C3-C6-cycloalkynyl, C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl),

CR’=NOR”, C3-C6-halogencycloalkyl a saturated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl;, and Ci-C 6 -alkyl substituted by CN, CrC 6 -alkoxy, Ci-C 4 -halogenalkoxy, Ci-C 6 -alkylthio, S(0) n -Ci-C 6 -alkyl, NH-SO2-RX, NH(C I -C 6 - alkyl), N(Ci-C 6 -alkyl) 2 , C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), a saturated three-, four-, five-, six-, membered carbocycle, heterocycle, aryl or heteroaryl; wherein the carbocycle, heterocycle, aryl and heteroaryl is unsubstituted or carries one, two, three or four substituents R 6b as defined below. According to one embodiment thereof, the carbocycle, heterocycle, heteroaryl and aryl are unsubstituted. In a particular embodiment, R 6 is selected from CN, Ci-C 6 -alkyl, Ci-C 6 -halo- genalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, C1-C6- alkoxy, a saturated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six- membered heteroaryl or aryl; and Ci-C 6 -alkyl substituted by a saturated three-, four-, five-, six-, membered carbocycle, heterocycle, aryl or heteroaryl; wherein the carbocycle, heterocacle, aryl and heteroaryl are unsubstituted or carries one, two, three or four substituents R 6b as defined below.

According to a further particular embodiment, R 6 is selected from Ci-C 6 -halogenalkyl, CN, C2- C 6 -alkenyl, C2-C6-halogenalkenyl, C3-C6-cycloalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, C1- C 6 -alkoxy, C3-C6-cycloalkynyl, C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), CR’=NOR”, C3-C6- halogencycloalkyl a saturated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl;, and Ci-C 6 -alkyl substituted by CN, CrC 6 -alkoxy, Cr C 4 -halogenalkoxy, Ci-Ce-alkylthio, S(0) n -Ci-C 6 -alkyl, NH-SO2-RX, NH(Ci-C 6 -alkyl), N(CrC 6 -al- kyl)2, C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), a saturated three-, four-, five-, six-, membered carbocycle, heterocycle, aryl or heteroaryl; wherein the carbocycle, heterocycle, aryl and het- eroaryl is unsubstituted or carries one, two, three or four substituents R 6b as defined below. Ac- cording to one embodiment thereof, the carbocycle, heterocycle, heteroaryl and aryl are unsub- stituted. In a particular embodiment, R 6 is selected from CN, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, Ci-C 6 -alkoxy, a satu- rated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six-membered het- eroaryl or aryl; and Ci-C 6 -alkyl substituted by a saturated three-, four-, five-, six-, membered carbocycle, heterocycle, aryl or heteroaryl; wherein the carbocycle, heterocacle, aryl and het- eroaryl are unsubstituted or carries one, two, three or four substituents R 6b as defined below. Particularly preferred embodiments of R 6 according to the invention are in Table P6 below, wherein each line of lines P6-1 to P6-209 corresponds to one particular embodiment of the in- vention, wherein P6-1 to P6-209 are also in any combination with one another a preferred em- bodiment of the present invention. The connection point to the carbon atom, to which R 6 is bound is marked with“#” in the drawings.

Table P6 (py = pyridyl):

R 7 is independently selected from halogen, OH, CN, N0 2 , SH, Ci-Ce-alkylthio, NH 2, NH(CI-C 4 - alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halo- genalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy, 0 2 -O Q - alkenyloxy, C 2 -C 6 -alkynyloxy, aryloxy, heteroaryloxy, arylamino, heteroarylamino, arylthio, het- eroarylthio, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), C(=0)NH(Ci-C 6 -alkyl), C(=0)N(Cr C 6 -alkyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight- , nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and het- eroaryl contain independently one, two, three or four heteroatoms selected from N, O and S; and wherein R’ and R” are independently selected from H, Ci-C 4 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -al- kynyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten- membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl; wherein the hetero- cycle or heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein R’ and R” are independently unsubstituted or substituted with R’” which is inde- pendently selected from halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH- S0 2 -R x , CrC 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 - C 6 -halogenalkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy, C3-C6-cycloalkyl, C3-C6-halogencycloal- kyl and phenyl;

wherein R x is as defined above;

wherein the acyclic moieties of R 7 are independently not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R 7a , which inde- pendently of one another are selected from:

R 7a halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , CrC 6 -alkoxy, CrC4-halogenalkoxy, C3-C6-cycloalkyl, C3-C6- halogencycloalkyl, Ci-C 6 -alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl,

CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(Ci-C 6 -aikyl), C(=0)N(Ci-C 6 -aikyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- or heterocycle, a five-, six- or ten-membered heteroaryl, aryl or phenoxy, wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and het- eroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbo-, heterocyclic, heteroaryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 - alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkylthio, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halo- genalkoxy, and S(0)n-Ci-C 6 -alkyl; and wherein R x , R’ and R” are as defined above; n is 0, 1 , 2; and

wherein the carbo-, heterocyclic, heteroaryl and aryl moieties of R 7 are independently unsubsti- tuted or substituted with identical or different groups R 7b , which independently of one another are selected from:

R 7b halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -alkyl), N(C(=0)Ci-C 4 -alkyl) 2 , NH-SC>2-R X , CrC4-alkyl, Ci-C 4 -alkoxy, Ci-C4-halogenalkyl, C 3 -C 6 -cycloal- kyl, C3-C6- alogencycloalkyl, Ci-C4-halogenalkoxy, Ci-C 6 -alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, Ci-C4-alkoxy-Ci-C4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consist- ing of halogen, OH, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy and Ci-C4-halogenalkoxy; and wherein R x and n are as defined above.

According to one embodiment of formula I, R 7 is independently selected from halogen, OH, CN, N0 2 , SH, Ci-Ce-alkylthio, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , substituted C C 6 - alkyl, CrC 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogen- alkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy, C 2 -C 6 -alkenyloxy, C 2 -C 6 -alkynyloxy, CH(=0), C(=0)Ci-C 6 -aikyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(Ci-C 6 -aikyl), C(=0)N(Ci-C 6 -aikyl) 2 ,

CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group in- dependently selected from C(=0) and C(=S), and wherein the heterocycle and the heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S; and wherein R’ and R” are independently selected from H, Ci-C4-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl; wherein the heterocycle or het- eroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein R’ and R” are independently unsubstituted or substituted by R’” which is independently selected from halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkyl, Ci- C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, Ci- C 6 -alkoxy, Ci-C 6 -halogenalkoxy, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl and phenyl; or wherein the aliphatic moieties of R 7 are independently not further substituted or carry 1 , 2, 3 or up to the maximum possible number of identical or different groups R 7a , respectively, which in- dependently of one another are selected from:

R 7a halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-aryl, N(aryl) 2 ,

NH(C(=0)Ci-C 4 -alkyl), N(C(=0)Ci-C 4 -alkyl) 2 , Ci-C 6 -alkoxy, C3-C6-halogencycloalkyl, Ci- C4-halogenalkoxy, Ci-Ce-alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)Ci-C 6 -aikyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(Ci-C 6 -aikyl), C(=0)N(Ci-C 6 - alkyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, aryl, phenoxy, a five-, six- or ten-membered heteroaryl; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), five- or six-membered heteroaryl and aryl; wherein the heterocycle and the heteroaryl con- tain independently 1 , 2, 3 or 4 heteroatoms selected from N, O and S; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S); wherein the carbocyclic, heterocyclic, aryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkylthio, Ci-C4-alkyl, Ci-C4-halogenalkyl, Ci-C4-alkoxy, Ci-C4-halogenalkoxy, and S(0) n -Ci-C 6 -alkyl; and wherein R x , R’, R” and R” are as defined above wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R 7 are independently not further substituted or carry 1 , 2, 3, 4, 5 or up to the maximum number of identical or different groups R 7b , respectively, which independently of one another are selected from:

R 7b halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-C 4 -alkyl, Ci-C4-alkoxy, Ci-C 4 -halogenalkyl, C3-C6- cycloalkyl, C3-C6-halogencycloalkyl, Ci-C4-halogenalkoxy, Ci-C 6 -alkylthio, Ci-C 6 -halogen- alkylthio, S(0) n -Ci-C 6 -alkyl, Ci-C4-alkoxy-Ci-C4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or substituted with substituents selected from the group consisting of halogen, OH, Ci-C4-alkyl, CrC4-halogenalkyl, CrC4-alkoxy and Ci-C4-halo- genalkoxy.

According to one embodiment of formula I, R 7 is selected from substituted Ci-C 6 -alkyl, O-I-OQ- halogenalkyl, C 2 -C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C3-C6-cycloalkenyl, C 2 - C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, C3-C6-cycloalkynyl, Ci-C 6 -alkoxy, aryloxy, heteroaryloxy, ar- ylamino, heteroarylamino, arylthio, heteroarylthio, CN, CH(=0), C(=0)C 2 -C 6 -alkyl, C(=0)0(C 2 - C 6 -alkyl), CR’=NOR”, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C 6 -alkyl-five- and six-mem- bered heteroaryl ,a five- or six-membered heteroaryl, benzyl, aryl; wherein R’ and R” are de- fined below; and wherein the acyclic moieties of R 7 are unsubstituted or substituted with identi cal or different groups R 7a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R 7b as de- fined below.

According to one embodiment of formula I, R 7 is selected from Ci-C 6 -alkyl substituted with halo- gen, CN, Ci-C 6 -alkoxy, aryloxy, arylamino, arylthio, Ci-C4-halogenalkoxy, Ci-C 6 -alkylthio, S(0) n - CrCe-alkyl, NH-S0 2 -R x , N(Ci-C 6 -alkyl) 2 , NH-S0 2 -R x , NH(Ci-C 6 -alkyl), N(Ci-C 6 -alkyl) 2 , CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), a saturated three-, four-, five-, six-, membered carbo- or heterocycle, aryl, a five- or six-membered heteroaryl; wherein R x is defined below; and wherein the acyclic moieties of R 7 are unsubstituted or substituted with identical or different groups R 7a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moi- eties are unsubstituted or substituted with substituents R 7b as defined below.

According to another embodiment of formula I, R 7 is F.

According to another embodiment of formula I, R 7 is Cl.

According to another embodiment of formula I, R 7 is Br.

According to still another embodiment of formula I, R 7 is OH.

According to still another embodiment of formula I, R 7 is CN.

According to still another embodiment of formula I, R 7 is N0 2 .

According to still another embodiment of formula I, R 7 is SH.

According to still another embodiment of formula I, R 7 is Ci-C 6 -alkylthio, such as SCH3, SC 2 Hs,

S-n-propyl, S-i-propyl, S-n-butyl, S-i-butyl, S-tert-butyl, S-n-pentyl, S-i-pentyl, CH 2 SCH 3 or CH 2 SCH 2 CH 3 .

According to still another embodiment of formula I, R 7 is Ci-C 6 -halogenalkylthio, such as SCF 3 , SCCI 3 , CH 2 SCF 3 or CH 2 SCF 3 . According to still another embodiment of formula I, R 7 is selected from CN, substituted C1-C 6 - alkyl, Ci-C 6 -halogenalkyl or Ci-C 6 -alkyl which is substituted, Ci-C 6 -halogenalkyl, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or is substituted with substituents R 7b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted. In a particular embodi- ment, R 7 is selected from Ci-C 6 -halogenalkyl, phenyl-Chh, halogenphenyl-Chh, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or is substituted with substituents R 7b as defined below.

According to still another embodiment of formula I, R 7 is selected from CN, substituted C1-C 6 - alkyl, Ci-C 6 -halogenalkyl or Ci-C 6 -alkyl which is substituted, Ci-C 6 -halogenalkyl, phenyl, halogenphenyl, aryloxy, heteroaryloxy, arylamino, heteroarylamino, arylthio, heteroarylthio and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or substituted bysubstituents R 7b as defined below. According to one embodi- ment thereof, the carbo- and heterocycle is unsubstituted. In a particular embodiment, R 7 is se- lected from substituted Ci-C 6 -halogenalkyl, phenyl, halogenphenyl and three-, four-, five- or six- membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or sub- stituted bysubstituents R 7b as defined below.

According to another embodiment of formula I, R 7 is selected from CN, substituted Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C 6 -alkylaryl, aryloxy, arylamino, arylthio, five- or six-membered heteroaryl or aryl which is unsubstituted or substituted with halogen or Ci-C 6 -hal- ogenalkyl, and wherein the acyclic moieties of R 7 are unsubstituted or substituted with identical or different groups R 7a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R 7b as defined be- low.

According to still another embodiment of formula I, R 7 is selected from CN, substituted C1-C6- alkyl, Ci-C 6 -halogenalkyl, CN, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halo- genalkynyl, C3-C6-cycloalkyl, C3-C6-halogencycloalkyl, Ci-C 6 -alkylaryl, phenyl, pyridine, pyrimi- dine, thiophene, imidazole, triazol, oxadiazol wherein the acyclic moieties of R 7 are unsubsti- tuted or substituted with identical or different groups R 7a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R 7b as defined below.

According to still another embodiment of formula I, R 7 is Ci-C 6 -alkyl such as CH 3 , C2H5, n-pro- pyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to still another embodiment of formula I, R 7 is Ci-C 6 -alkyl such as CH 3 .

According to still another embodiment of formula I, R 7 is Ci-C 6 -alkyl such as C2H5.

According to still another embodiment of formula I, R 7 is Ci-C 6 -alkyl such as CH 3 , C2H5, n-pro- pyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl which is substituted with at least one group R 7a , which independently of one another are selected from:

R 7a halogen, OH, CN, N0 2 , SH, NH 2 , NH(C C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)C C 4 -aikyl), N(C(=0)Ci-C 4 -alkyl)2, NH-S02-R X , Ci-C6-alkoxy, Ci-C 4 -halogenalkoxy, Ci-Ce-alkylthio, C1-C6- halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), C(=0)NH(CrC 6 -alkyl), C(=0)N(Ci-C 6 -alkyl) 2 , CR -NOR” a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, five-, six- or ten-membered heteroaryl, aryl or phenoxy, wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbocyclic, heterocyclic, heteroaryl, aryl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C4-alkyl), N(Ci- C 4 -alkyl) 2 , NH(C(=0)C r C 4 -alkyl), N(C(=0)C r C 4 -alkyl) 2 , NH-S0 2 -R x , C C 6 -alkylthio, C C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, and S(0)n-Ci-C 6 -alkyl.

According to still another embodiment of formula I, R 7 is CH3 is substituted with at least one group R 7a , which independently of one another are selected from:

R 7a halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-aryl, N(aryl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkoxy, Ci-C 4 -halogenalkoxy, Ci-C 6 -alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)Ci-C 6 -al- kyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(C C 6 -alkyl), C(=0)N(Ci-C 6 -aikyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocy- cle or heterocycle, five-, six- or ten-membered heteroaryl, an aryl or phenoxy, wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group inde- pendently selected from C(=0) and C(=S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbo- cyclic, heterocyclic, heteroaryl, heteroaryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen,

OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 - alkyl) 2 , NH-S0 2 -R x , Ci-Ce-alkylthio, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, CrC 4 -alkoxy, CrC 4 -halo- genalkoxy, and S(0)n-Ci-C 6 -alkyl.

According to still another embodiment of formula I, R 7 is C 2 Hs is substituted with at least one group R 7a , which independently of one another are selected from:

R 7a halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH-aryl, N(aryl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkoxy, Ci-C 4 -halogenalkoxy, Ci-C 6 -alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)Ci-C 6 -al- kyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(Ci-C 6 -aikyl), C(=0)N(Ci-C 6 -aikyl) 2, CR’=NOR”a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocy- cle or heterocycle, five-, six- or ten-membered heteroaryl, phenyl or phenoxy; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group inde- pendently selected from C(=0) and C(=S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbo- cyclic, heterocyclic, heteroaryl, aryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(C C 4 -alkyl) 2 , NH(C(=0)C C 4 -alkyl), N(C(=0)C r C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkylthio, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, CrC 4 -alkoxy, Ci-C 4 -halogenalkoxy, and S(0)n-Ci-C 6 -alkyl.

According to still another embodiment of formula I, R 7 is CH 2 CN. According to still another embodiment of formula I, R 7 is CH 2 OH.

According to still another embodiment of formula I, R 7 is Ci-C6-halogenalkyl, in particular C 1 -C 4 - halogenalkyl, more specifically Ci-C 2 -halogenalkyl, such as CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI2CH, CF3CH2, CCI3CH2 or CF2CHF2.

According to still another embodiment of formula I, R 7 is CH 2 F.

According to still another embodiment of formula I, R 7 is CHF 2 .

According to still another embodiment of formula I, R 7 is CF 3 .

According to still a further embodiment of formula I, R 7 is C 2 -C 6 -alkenyl, in particular C 2 -C 4 -alk- enyl, such as CH=CH 2 , CH 2 CH=CH 2 or C(CH 3 )C=CH 2 .

According to a further specific embodiment of formula I, R 7 is C 2 -C 6 -halogenalkenyl, in particular C 2 -C 4 -halogenalkenyl, more specifically C 2 -C 3 -halogenalkenyl such as CH=CHF, CH=CHCI,

According to still a further embodiment of formula I, R 7 is C 2 -C 6 -cycloalkenyl, in particular C 2 -C 4 - cycloalkenyl, such as CH=CH 2 -cPr.

According to still a further embodiment of formula I, R 7 is C 2 -C 6 -alkynyl or C 2 -C 6 -halogenalkynyl, in particular C 2 -C 4 -alkynyl or C 2 -C 4 -halogenalkynyl, such as C CH, C C-CI, C=C-CH 3 , CH 2 - CºCH, CH 2 -CºCCI or CH 2 - CºC-CH 3 .

According to still a further embodiment of formula I, R 7 is C 2 -C 6 -cycloalkynyl in particular C 2 -C 4 - cycloalkynyl, such as C C-cPr.

According to a further specific embodiment of formula I, R 7 is Ci-C6-alkoxy, in particular Ci-C 4 - alkoxy, more specifically Ci-C 2 -alkoxy such as OCH 3 , CH 2 CH 3 or CH 2 OCH 3 .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl-Ci-C 6 -alkoxy, in particular Ci-C 4 -alkyl-Ci-C 4 -alkoxy, more specifically Ci-C 2 -alkyl-Ci-C 2 -alkoxy, such as

CH 2 OCH 3 or CH 2 OCH 2 CH 3.

According to a further specific embodiment of formula I, R 7 is C 2 -C 6 -alkenyloxy, in particular C 2 - C 4 -alkenyloxy, more specifically Ci-C 2 -alkenyloxy such as OCH=CH 2 , OCH 2 CH=CH 2

OC(CH 3 )CH=CH 2 , CH 2 OCH=CH 2I or CH 2 OCH 2 CH=CH 2 .

According to a further specific embodiment of formula I, R 7 is C 2 -C 6 -alkynyloxy, in particular C 2 - C 4 -alkynyloxy, more specifically Ci-C 2 -alkynyloxy such as OC CH, OCFhC CH or CFhOC CH

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -halogenalkoxy, in particular Ci-C 4 -halogenalkoxy, more specifically Ci-C 2 -halogenalkoxy such as OCF 3 , OCHF 2 , OCH 2 F, OCCI 3 , OCHC or OCH 2 CI, in particular OCF 3 , OCHF 2 , OCCI 3 or OCHCI 2 .

According to a further specific embodiment of formula I, R 7 is Ci-C6-alkyl-Ci-C6-halogenalkoxy, in particular Ci-C 4 -alkyl-Ci-C 4 -halogenalkoxy, more specifically Ci-C 2 -alkyl-Ci-C 2 -halogenalkoxy such as CH 2 OCF 3I CH 2 OCHF 2I CH 2 OCH 2 F, CH2OCCI3, CH2OCHCI2 or CH 2 OCH 2 CI, in particular CH2OCF3, CH 2 OCHF 2 , CH2OCCI3 or CH2OCHCI2. According to a further specific embodiment of formula I, R 7 is CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), C(=0)NH(Ci-C 6 -alkyl) or C(=0)N(Ci-C 6 -aikyl) 2 , wherein alkyl is CH 3 , C 2 H 5 , n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to a further specific embodiment of formula I, R 7 is Ci-C 4 -alkyl-CH(=0), Ci-C 4 -alkyl- C(=0)Ci-C 6 -aikyl, Ci-C 4 -alkyl-C(=0)0(Ci-C 6 -alkyl), Ci-C 4 -alkyl-C(=0)NH(Ci-C 6 -alkyl) or C1-C4- alkyl-C(=0)N(Ci-C 6 -alkyl) 2 , especially CH 2 CH(=0), CH 2 C(=0)Ci-C 6 -aikyl, CH 2 C(=0)0(Ci-C 6 - alkyl), CH 2 C(=0)NH(Ci-C 6 -aikyl) or CH 2 C(=0)N(Ci-C 6 -aikyl) 2 wherein alkyl is CH 3 , C 2 H 5 , n-pro- pyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to a further specific embodiment of formula I, R 7 is CR’=NOR” such as

C(CH 3 )=NOCH 3 , C(CH 3 )=NOCH 2 CH 3 or C(CH 3 )=NOCF 3 .

According to a further specific embodiment of formula I, R 7 is Ci-C6-alkyl-NH(Ci-C4-alkyl) or Ci- C6-alkyl-N(Ci-C4-alkyl) 2 , wherein alkyl is CH 3 , C 2 H 5 , n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkylthio, in particular C1-C4- alkoxy, more specifically Ci-C 3 -alkylthio such as CH 2 SCH 3 or CH 2 SCH 2 CH 3.

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl-S(0) n -Ci-C 6 -alkyl, wherein alkyl is CH 3 , C 2 H 5 , n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl and n is 1 , 2 or 3.

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl-S(0) n -Ci-C 6 - halogenalkyl, wherein halogenalkyl is CF 3 or CHF 2 and n is 1 , 2 or 3.

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl-S(0) n -aryl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R 7b which independently of one another are selected from halogen, Ci-C 2 -alkyl, Ci-C 2 - alkoxy, Ci-C 2 -halogenalkyl, Ci-C 2 -halogenalkoxy and S(0) n -Ci-C 6 -alkyl, in particular F, Cl, Br, CH 3 , OCH 3 , CF 3 , CHF 2 , OCHF 2 , OCF 3 . According to one embodiment, R 7 is unsubstituted phe- nyl. According to another embodiment, R 7 is phenyl, that is substituted with one, two or three, in particular one, halogen, in particular selected from F, Cl and Br, more specifically selected from F and Cl.

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl-NH-S0 2 -R x wherein R x is Ci-C4-alkyl, Ci-C4-halogenalkyl, unsubstituted aryl or aryl that is substituted with one, two, three, four or five substituents R x2 independently selected from Ci-C4-alkyl, halogen, OH, CN, Ci-C4-halogenalkyl, Ci-C4-alkoxy, or CrC4-halogenalkoxy, such as CH 2 NHS0 2 CF 3 or

CH 2 NHS0 2 CH 3 .

According to still another embodiment of formula I, R 7 is selected from Ci-C 6 -alkyl which is sub- stituted, a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-membered, wherein the carbocycle is unsubstituted or sub- stituted with substituents R 7b as defined below. According to one embodiment thereof, the car- bocycle is unsubstituted.

According to one embodiment, R 7 is selected from Ci-C 6 -alkyl, especially CH 2 which is substi- tuted with a 3-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to one embodiment, R 7 is selected from Ci-C 6 -alkyl, especially CH 2 which is substi- tuted with a 4-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to one embodiment, R 7 is selected from Ci-C 6 -alkyl, especially CH 2 which is substi- tuted with a 5-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to one embodiment, R 7 is selected from Ci-C 6 -alkyl, especially CH 2 which is substi- tuted with a 6-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkylheterocycle, especially CH 2 substituted with a 4-membered saturated heterocycle which contains 1 or 2 heteroatoms, in particular 1 heteroatom, from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. For example, the formed heterocycle is oxetane. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkylheterocycle, especially CH 2 substituted with a 5-membered saturated heterocycle which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkylheterocycle, especially CH 2 subsitited by a 6-membered saturated heterocycle which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b . According to one specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2, in particu- lar 1 , heteroatom(s) O. According to one embodiment thereof, the respective 6-membered heterocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkylheterocycle, especially CH 2 substituted with a 5-membered saturated heterocycle which contains one N as ring mem- ber and optionally one or two groups CH 2 are replaced by C(=0).

According to still another embodiment of formula I, R 7 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-membered, wherein the carbocycle is unsubstituted or substituted with substituents R 7b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted.

According to still another embodiment of formula I, R 7 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroa- toms selected from N, O and S, and wherein the carbocycle and heterocycle are unsubstituted or substituted with substituents R 7b as defined below. According to one embodiment thereof, the carbocycle or heterocycle is unsubstituted.

According to still a further embodiment, R 7 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, in particular three-, four-, five- or six-mem- bered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the carbocycle and heterocycle are unsubstituted or substituted with substit- uents R 7b as defined below. According to one embodiment thereof, the carbocycle or heterocy- cle is unsubstituted.

According to still another embodiment of formula I, R 7 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-mem- bered, wherein the carbocycle is unsubstituted or substituted with substituents R 7b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted.

According to one embodiment, R 7 is a 3-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to one embodiment, R 7 is a 3-membered saturated carbocycle, which is

unsubstituted such as cyclopropyl.

According to one embodiment, R 7 is a 3-membered saturated carbocycle, which is substituted with halogen, more specifically by F, such as C 3 H 3 F2.

According to one embodiment, R 7 is a 3-membered saturated carbocycle, which is substituted with halogen. More specifically by Cl, such as C 3 H 3 CI2.

According to one embodiment, R 7 is a 4-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to one embodiment, R 7 is a 5-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to one embodiment, R 7 is a 6-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to still another embodiment of formula I, R 7 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the heterocycle is unsubstituted or substituted with substituents R 7b as defined below. According to one embodiment thereof, the heterocycle is unsubstituted.

According to still another embodiment of formula I, R 7 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered heterocycle, in particular three-, four-, five- or six-mem- bered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the heterocycle is unsubstituted or substituted with substituents R 7b as de- fined below. According to one embodiment thereof, the heterocycle is unsubstituted.

According to still another embodiment of formula I, in the embodiments of R 7 described above, the heterocycle contains preferably one, two or three, more specifically one or two heteroatoms selected from N, O and S. More specifically, the hetereocycle contains one heteroatom selected from N, O and S. In particular, the heterocycle contains one or two, in particular one O.

According to one embodiment, R 7 is a 4-membered saturated heterocycle which contains 1 or 2 heteroatoms, in particular 1 heteroatom, from the group consisting of N, O and S, as ring mem- bers. According to one embodiment, the heterocycle contains one O as heteroatom. For exam- pie, the formed heterocycle is oxetane. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to still another embodiment of formula I, R 7 is a 5-membered saturated heterocycle which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroa- tom. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to still another embodiment of formula I, R 7 is a 6-membered saturated heterocycle which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b . According to one specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2, in particular 1 , heteroatom(s) O. According to one embodiment thereof, the respective 6-membered heterocycle is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted with R 7b .

According to still another embodiment of formula I, R 7 is phenyl-Ci-C 6 -alkyl, such as phenyl- CH 2 , wherein the phenyl moiety in each case is unsubstituted or substituted with one, two or three identical or different groups R 7b which independently of one another are selected from CN, halogen, Ci-C2-alkyl, Ci-C2-alkoxy, Ci-C2-halogenalkyl, Ci-C2-halogenalkoxy and S(0) n -Ci-C 6 - alkyl, in particular from CN, F, Cl, Br, CH3, OCH3, CF3, CHF2, OCHF2, OCF3 and S(0) 2 CH 3 .

According to still another embodiment of formula I, R 7 is aryl, in particular phenyl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R 7b which independently of one another are selected from CN, halogen, Ci-C2-alkyl, C1- C2-alkoxy, Ci-C2-halogenalkyl, Ci-C2-halogenalkoxy and S(0) n -Ci-C 6 -alkyl, in particular from CN, F, Cl, Br, CH 3 , OCH 3 , CF 3 , CHF 2 , OCHF 2 , OCF 3 . According to one embodiment, R 7 is un- substituted phenyl. According to another embodiment, R 7 is phenyl, that is substituted with one, two or three, in particular one, halogen, in particular selected from F, Cl and Br, more specifi- cally selected from F and Cl.

According to still another embodiment of formula I, R 7 is a 5-membered heteroaryl such as pyr- rol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol- 3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2- yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isoth iazol-3-yl , isothiazol-4-yl, isoth iazol-5-y 1 , 1 ,2,4-triazolyl-1-yl, 1 ,2,4-triazol-3-yl 1 ,2,4-triazol-5-yl, 1 ,2,4-oxadiazol-3-yl, 1 ,2,4-oxadiazol-5-yl and 1 ,2,4-thiadiazol-3-yl, 1 ,2,4-thia- diazol-5-yl.

According to still another embodiment of formula I, R 7 is a 6-membered heteroaryl, such as pyri- din-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, py- rimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl and 1 ,2,4-triazin-3-yl.

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CFh subsitited by a 5-membered saturated heteroaryl which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CFh subsitited by a 5-membered saturated heteroaryl which contains one N as ring member.

According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains two N as ring members.

According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CFh subsitited by a 5-membered saturated heteroaryl which contains three N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b .

According to one specific embodiment thereof, said 5-membered saturated heterocycle contains 1 or 2, in particular 1 , heteroatom(s) O.

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CFh subsitited by a 5-membered saturated heteroaryl which contains one S as ring member.

According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CFh subsitited by a 5-membered saturated heteroaryl which contains one S and one N as ring mem- bers. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CFh subsitited by a 5-membered saturated heteroaryl which contains one S and two N as ring mem- bers. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains one oxygen and one N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains one oxygen and two N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 6-membered saturated heteroaryl which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 6-membered saturated heteroaryl which one N as ring member. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 6-membered saturated heteroaryl which two N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b .

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 10-membered saturated heteroaryl which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b . According to one specific embodiment thereof, said 10-membered saturated heterocycle contains 1 or 2, in partic- ular 1 , heteroatom(s) N.

According to a further specific embodiment of formula I, R 7 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 10-membered saturated heteroaryl which one N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 7b . According to still another embodiment of formula I, it is substituted by R 7b .

According to still another embodiment of formula I, R 7 is CH 2 substituted by a 5-membered heteroaryl such as pyrrol-1 -yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isoth iazol-5-yl , 1 ,2,4-triazolyl- 1-yl, 1 ,2,4-triazol-3-yl 1 ,2,4-triazol-5-yl, 1 ,2,4-oxadiazol-3-yl, 1 ,2,4-oxadiazol-5-yl and 1 ,2,4- thiadiazol-3-yl, 1 ,2,4-thiadiazol-5-yl.

According to still another embodiment of formula I, R 7 is Chh substituted by a 6-membered het- eroaryl, such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2- yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl and 1 ,2,4-triazin-3-yl.

According to a further particular embodiment, R 7 is selected from Ci-C 6 -alkyl, Ci-C 6 -halogen- alkyl, CN, C2-C6-alkenyl, C2-C6-halogenalkenyl, C3-C6-cycloalkenyl, C2-C6-alkynyl, C2-C6-halo- genalkynyl, CrC 6 -alkoxy, C3-C6-cycloalkynyl, C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl),

CR’=NOR”, C3-C6-halogencycloalkyl a saturated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl;, and Ci-C 6 -alkyl substituted by CN, Ci-C 6 -alkoxy, Ci-C 4 -halogenalkoxy, Ci-C 6 -alkylthio, S(0) n -Ci-C 6 -alkyl, NH-SO2-RX, NH(CI-C 6 - alkyl), N(Ci-C6-alkyl)2, C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), a saturated three-, four-, five-, six-, membered carbocycle, heterocycle, aryl or heteroaryl; wherein the carbocycle, heterocycle, aryl and heteroaryl is unsubstituted or carries one, two, three or four substituents R 7b as defined below. According to one embodiment thereof, the carbocycle, heterocycle, heteroaryl and aryl are unsubstituted. In a particular embodiment, R 7 is selected from CN, Ci-C 6 -alkyl, CrC 6 -halo- genalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, C1-C6- alkoxy, a saturated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six- membered heteroaryl or aryl; and Ci-C 6 -alkyl substituted by a saturated three-, four-, five-, six-, membered carbocycle, heterocycle, aryl or heteroaryl; wherein the carbocycle, heterocacle, aryl and heteroaryl are unsubstituted or carries one, two, three or four substituents R 7b as defined below.

According to a further particular embodiment, R 7 is selected from Ci-C 6 -halogenalkyl, CN, C2- C 6 -alkenyl, C2-C6-halogenalkenyl, C3-C6-cycloalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, Cr C 6 -alkoxy, C3-C6-cycloalkynyl, C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), CR’=NOR”, C3-C6- halogencycloalkyl a saturated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl;, and Ci-C 6 -alkyl substituted by CN, Ci-C 6 -alkoxy, C1- C 4 -halogenalkoxy, Ci-Ce-alkylthio, S(0) n -Ci-C 6 -alkyl, NH-SO2-RX, NH(Ci-C 6 -alkyl), N(Ci-C 6 -al- kyl)2, C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), a saturated three-, four-, five-, six-, membered carbocycle, heterocycle, aryl or heteroaryl; wherein the carbocycle, heterocycle, aryl and het- eroaryl is unsubstituted or carries one, two, three or four substituents R 7b as defined below. Ac- cording to one embodiment thereof, the carbocycle, heterocycle, heteroaryl and aryl are unsub- stituted. In a particular embodiment, R 7 is selected from CN, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, Ci-C 6 -alkoxy, a satu- rated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six-membered het- eroaryl or aryl; and Ci-C 6 -alkyl substituted by a saturated three-, four-, five-, six-, membered carbocycle, heterocycle, aryl or heteroaryl; wherein the carbocycle, heterocacle, aryl and het- eroaryl are unsubstituted or carries one, two, three or four substituents R 7b as defined below.

Particularly preferred embodiments of R 7 according to the invention are in Table P6 below, wherein each line of lines P6-1 to P6-208 corresponds to one particular embodiment of the in- vention, wherein P6-1 to P6-208 are also in any combination with one another a preferred embodiment of the present invention. The connection point to the carbon atom, to which R 7 is bound is marked with“#” in the drawings.

Table P7 (py = pyridyl):

R 8 is independently selected from CN, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C2-C6-alkenyl, C2-C6-hal- ogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 - alkyl), C(=0)NH(Ci-C 6 -alkyl), C(=0)N(Ci-C 6 -alkyl) 2 , CR’=NOR”, a saturated or partially unsatu- rated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl; wherein in each case one or two CFh groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S, and wherein heterocycle and heteroaryl are connected via C atom; and wherein R’ and R” are independently selected from H, Ci-C 4 -alkyl, C 2 -C 6 - alkenyl, C 2 -C 6 -alkynyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl;

wherein the heterocycle or heteroaryl contains one, two or three heteroatoms selected from N,

O and S, and wherein R’ and R” are independently unsubstituted or substituted with R’” which is independently selected from halogen, OH, CN, NO 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(CrC 4 -al- kyl)2, NH-S0 2 -R x , Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 - alkynyl, C 2 -C 6 -halogenalkynyl, Ci-C 6 -alkoxy, Ci-C 6 -halogenalkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 - halogencycloalkyl and phenyl;

wherein R x is as defined above;

wherein the acyclic moieties of R 8 are independently not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R 8a , which inde- pendently of one another are selected from:

R 8a halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C4-alkyl)2, NH-S02-R X , Ci-C6-alkoxy, Ci-C4-halogenalkoxy, C3-C6-cycloalkyl, C3-C6- halogencycloalkyl, Ci-Ce-alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl,

CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(Ci-C 6 -aikyl), C(=0)N(Ci-C 6 -alkyl) 2 , CR’=NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- or heterocycle, a five-, six- or ten-membered heteroaryl, aryl or phenoxy, wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and het- eroaryl contains independently one, two, three or four heteroatoms selected from N, O and S, and wherein heterocycle and heteroaryl are connected via C atom; wherein the carbo-, hetero- cyclic, heteroaryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci- C 6 -alkylthio, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, and S(0)n-Ci- C 6 -alkyl; and wherein R x , R’ and R” are as defined above; n is 0, 1 , 2; and

wherein the carbo-, heterocyclic, heteroaryl and aryl moieties of R 8 are independently unsubsti- tuted or substituted with identical or different groups R 8b , which independently of one another are selected from:

R 8b halogen, OH, CN, N0 2 , SH, NH 2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -alkyl) 2 , NH-S0 2 -R X , Ci-C 4 -alkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkyl, C 3 -C 6 -cycloal- kyl, C 3 -C 6 -halogencycloalkyl, Ci-C 4 -halogenalkoxy, Ci-C 6 -alkylthio, Ci-C 6 -halogenalkylthio, S(0) n -Ci-C 6 -alkyl, Ci-C 4 -alkoxy-Ci-C 4 -alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consist- ing of halogen, OH, CrC 4 -alkyl, CrC 4 -halogenalkyl, Ci-C 4 -alkoxy and CrC 4 -halogenalkoxy; and wherein R x and n are as defined above.

According to one embodiment of formula I, R 8 is selected from substituted Ci-C 6 -alkyl, O-I-OQ- halogenalkyl, C 2 -C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 3 -C 6 -cycloalkenyl, C 2 - C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, C 3 -C 6 -cycloalkynyl, CN, CH(=0), C(=0)C 2 -C 6 -alkyl,

C(=0)0(C 2 -C 6 -alkyl), CR -NOR”, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 6 -alkyl-five- and six-membered heteroaryl ,a five- or six-membered heteroaryl, benzyl, aryl; wherein R’ and R” are defined below; and wherein the acyclic moieties of R 8 are unsubstituted or substituted with identical or different groups R 8a as defined below and wherein wherein the carbocycle, het- erocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R 8b as defined below.

According to still another embodiment of formula I, R 8 is CN.

According to still another embodiment of formula I, R 8 is selected from CN, substituted C 1 -C 6 - alkyl, Ci-C 6 -halogenalkyl or Ci-C 6 -alkyl which is substituted, Ci-C 6 -halogenalkyl, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or is substituted with substituents R 8b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted. In a particular embodi- ment, R 8 is selected from Ci-C 6 -halogenalkyl, phenyl-Chh, halogenphenyl-Chh, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or is substituted with substituents R 8b as defined below.

According to still another embodiment of formula I, R 8 is selected from CN, substituted C 1 -C 6 - alkyl, Ci-C 6 -halogenalkyl or Ci-C 6 -alkyl which is substituted, Ci-C 6 -halogenalkyl, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or substituted bysubstituents R 8b as defined below. Ac- cording to one embodiment thereof, the carbo- and heterocycle is unsubstituted. In a particular embodiment, R 8 is selected from substituted Ci-C 6 -halogenalkyl, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or substituted bysubstituents R 8b as defined below.

According to another embodiment of formula I, R 8 is selected from CN, substituted Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 6 -alkylaryl, five- or six-membered heteroaryl or aryl which is unsubstituted or substituted with halogen or Ci-C 6 -halogenalkyl, and wherein the acyclic moieties of R 8 are unsubstituted or substituted with identical or different groups R 8a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moie- ties are unsubstituted or substituted with substituents R 8b as defined below.

According to still another embodiment of formula I, R 8 is selected from CN, substituted C 1 -C 6 - alkyl, Ci-C 6 -halogenalkyl, CN, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halo- genalkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, Ci-C 6 -alkylaryl, phenyl, pyridine, pyrimi- dine, thiophene, imidazole, triazol, oxadiazol wherein the acyclic moieties of R 8 are unsubsti- tuted or substituted with identical or different groups R 8a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R 8b as defined below.

According to still another embodiment of formula I, R 8 is Ci-C 6 -alkyl such as CH 3 , C 2 H 5 , n-pro- pyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to still another embodiment of formula I, R 8 is Ci-C 6 -alkyl such as CH 3 .

According to still another embodiment of formula I, R 8 is Ci-C 6 -alkyl such as C 2 H 5. According to still another embodiment of formula I, R 8 is Ci-C 6 -alkyl such as CH 3 , C2H5, n-pro- pyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl which is substituted with at least one group R 8a , which independently of one another are selected from:

R 8a halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -alkyl)2, NH-S02-R X , Ci-C6-alkoxy, Ci-C4-halogenalkoxy, Ci-C6-alkylthio, C1-C6- halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), C(=0)NH(Ci-C6-alkyl), C(=0)N(Ci-C6-alkyl)2, CR -NOR” a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, five-, six- or ten-membered heteroaryl, aryl or phenoxy, wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbocyclic, heterocyclic, heteroaryl, aryl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO2, SH, NH2, NH(Ci-C 4 -alkyl), N(Ci- C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -alkyl) 2 , NH-S0 2 -R x , Ci-C 6 -alkylthio, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, and S(0)n-Ci-C 6 -alkyl.

According to still another embodiment of formula I, R 8 is CH 3 is substituted with at least one group R 8a , which independently of one another are selected from:

R 8a halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -alkyl)2, NH-S02-R X , Ci-C6-alkoxy, Ci-C 4 -halogenalkoxy, Ci-C6-alkylthio, C1-C6- halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), C(=0)NH(Ci-C6-alkyl), C(=0)N(Ci-C6-alkyl)2, CR -NOR”, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, five-, six- or ten-membered heteroaryl, an aryl or phenoxy, wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbocyclic, heterocyclic, het- eroaryl, heteroaryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO2, SH, NH2, NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R x , C1- C 6 -alkylthio, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, and S(0)n-Ci- C 6 -alkyl.

According to still another embodiment of formula I, R 8 is C2H5 is substituted with at least one group R 8a , which independently of one another are selected from:

R 8a halogen, OH, CN, N0 2 , SH, NH 2 , NH(Ci-C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -alkyl)2, NH-S02-R X , Ci-C6-alkoxy, Ci-C 4 -halogenalkoxy, Ci-C6-alkylthio, C1-C6- halogenalkylthio, S(0) n -Ci-C 6 -alkyl, S(0) n -aryl, CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), C(=0)NH(Ci-C6-alkyl), C(=0)N(Ci-C6-alkyl)2, CR’=NOR”a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, five-, six- or ten-membered heteroaryl, phenyl or phenoxy; wherein in each case one or two CH 2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(=0) and C(=S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbocyclic, heterocyclic, het- eroaryl, aryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO2, SH, NH 2 , NH(Ci- C 4 -alkyl), N(Ci-C 4 -alkyl) 2 , NH(C(=0)Ci-C 4 -aikyl), N(C(=0)Ci-C 4 -aikyl) 2 , NH-S0 2 -R*, Ci-C 6 -al- kylthio, Ci-C 4 -alkyl, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, Ci-C 4 -halogenalkoxy, and S(0)n-Ci-C 6 - alkyl.

According to still another embodiment of formula I, R 8 is CH 2 CN.

According to still another embodiment of formula I, R 8 is CH 2 OH.

According to still another embodiment of formula I, R 8 is Ci-C 6 -halogenalkyl, in particular CrC 4 - halogenalkyl, more specifically Ci-C 2 -halogenalkyl, such as CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF 3 CH 2I CCI 3 CH 2 or CF 2 CHF 2 .

According to still another embodiment of formula I, R 8 is CH 2 F.

According to still another embodiment of formula I, R 8 is CHF 2 .

According to still another embodiment of formula I, R 8 is CF 3 .

According to still a further embodiment of formula I, R 8 is C 2 -C 6 -alkenyl, in particular C 2 -C 4 -alk- enyl, such as CH=CH 2 , CH 2 CH=CH 2 or C(CH 3 )C=CH 2 .

According to a further specific embodiment of formula I, R 8 is C 2 -C 6 -halogenalkenyl, in particular C 2 -C 4 -halogenalkenyl, more specifically C 2 -C 3 -halogenalkenyl such as CH=CHF, CH=CHCI, CH=CF 2 , CH=CCI 2I CF=CF 2I CCI=CCI 2 , CH 2 CH=CHF, CH 2 CH=CHCI, CH 2 CH=CF 2I

CH 2 CH=CCI 2 , CH 2 CF=CF 2I CH 2 CCI=CCI 2 , CF 2 CF=CF 2 or CCI 2 CCI=CCI 2 .

According to still a further embodiment of formula I, R 8 is C 2 -C 6 -cycloalkenyl, in particular C 2 -C 4 - cycloalkenyl, such as CH=CH 2 -cPr.

According to still a further embodiment of formula I, R 8 is C 2 -C 6 -alkynyl or C 2 -C 6 -halogenalkynyl, in particular C 2 -C 4 -alkynyl or C 2 -C 4 -halogenalkynyl, such as C CH, C C-CI, C=C-CH 3 , CH 2 - CºCH, CH 2 -CºCCI or CH 2 - CºC-CH 3 .

According to still a further embodiment of formula I, R 8 is C 2 -C 6 -cycloalkynyl in particular C 2 -C 4 - cycloalkynyl, such as C C-cPr.

According to a further specific embodiment of formula I, R 8 is CH(=0), C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -aikyl), C(=0)NH(Ci-C 6 -aikyl) or C(=0)N(Ci-C 6 -alkyl) 2 , wherein alkyl is CH 3 , C 2 H 5 , n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to a further specific embodiment of formula I, R 8 is Ci-C 4 -alkyl-CH(=0), Ci-C 4 -alkyl- C(=0)Ci-C 6 -aikyl, Ci-C 4 -aikyl-C(=0)0(Ci-C 6 -alkyl), Ci-C 4 -alkyl-C(=0)NH(Ci-C 6 -alkyl) or Ci-C 4 - alkyl-C(=0)N(Ci-C 6 -alkyl) 2 , especially CH 2 CH(=0), CH 2 C(=0)Ci-C 6 -aikyl, CH 2 C(=0)0(Ci-C 6 - alkyl), CH 2 C(=0)NH(Ci-C 6 -aikyl) or CH 2 C(=0)N(Ci-C 6 -aikyl) 2 wherein alkyl is CH 3 , C 2 H 5 , n-pro- pyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

According to a further specific embodiment of formula I, R 8 is CR’=NOR” such as

C(CH 3 )=NOCH 3 , C(CH 3 )=NOCH 2 CH 3 or C(CH 3 )=NOCF 3 .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl-NH(Ci-C 4 -alkyl) or Ci- C 6 -alkyl-N(Ci-C 4 -alkyl) 2 , wherein alkyl is CH 3 , C 2 Hs, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl. According to a further specific embodiment of formula I, R 8 is Ci-C6-alkylthio, in particular C1-C4- alkoxy, more specifically Ci-C 3 -alkylthio such as CH 2 SCH 3 or CH 2 SCH 2 CH 3.

According to a further specific embodiment of formula I, R 8 is Ci-C6-alkyl-S(0) n -Ci-C6-alkyl, wherein alkyl is CH3, C2H5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl and n is 1 , 2 or 3.

According to a further specific embodiment of formula I, R 8 is Ci-C6-alkyl-S(0) n -Ci-C6- halogenalkyl, wherein halogenalkyl is CF3 or CHF 2 and n is 1 , 2 or 3.

According to a further specific embodiment of formula I, R 8 is Ci-C6-alkyl-S(0) n -aryl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R 8b which independently of one another are selected from halogen, Ci-C 2 -alkyl, C 1 -C 2 - alkoxy, Ci-C 2 -halogenalkyl, Ci-C 2 -halogenalkoxy and S(0) n -Ci-C6-alkyl, in particular F, Cl, Br, CH 3 , OCH 3 , CF 3 , CHF 2 , OCHF 2 , OCF 3 . According to one embodiment, R 8 is unsubstituted phe- nyl. According to another embodiment, R 8 is phenyl, that is substituted with one, two or three, in particular one, halogen, in particular selected from F, Cl and Br, more specifically selected from F and Cl.

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl-NH-S0 2 -R x wherein R x is Ci-C 4 -alkyl, CrC 4 -halogenalkyl, unsubstituted aryl or aryl that is substituted with one, two, three, four or five substituents R x2 independently selected from Ci-C 4 -alkyl, halogen, OH, CN, Ci-C 4 -halogenalkyl, Ci-C 4 -alkoxy, or Ci-C 4 -halogenalkoxy, such as CH 2 NHSC> 2 CF 3 or

CH2NHSO2CH3.

According to still another embodiment of formula I, R 8 is selected from Ci-C6-alkyl which is sub- stituted, a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-membered, wherein the carbocycle is unsubstituted or sub- stituted with substituents R 8b as defined below. According to one embodiment thereof, the car- bocycle is unsubstituted.

According to one embodiment, R 8 is selected from Ci-C6-alkyl, especially CH 2 which is substi- tuted with a 3-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b .

According to one embodiment, R 8 is selected from Ci-C6-alkyl, especially CH 2 which is substi- tuted with a 4-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b .

According to one embodiment, R 8 is selected from Ci-C6-alkyl, especially CH 2 which is substi- tuted with a 5-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b .

According to one embodiment, R 8 is selected from Ci-C 6 -alkyl, especially CH 2 which is substi- tuted with a 6-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b . According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkylheterocycle, especially CH 2 substituted with a 4-membered saturated heterocycle which contains 1 or 2 heteroatoms, in particular 1 heteroatom, from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. For example, the formed heterocycle is oxetane. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkylheterocycle, especially CH 2 substituted with a 5-membered saturated heterocycle which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkylheterocycle, especially CH2 subsitited by a 6-membered saturated heterocycle which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b . According to one specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2, in particu- lar 1 , heteroatom(s) O. According to one embodiment thereof, the respective 6-membered heterocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkylheterocycle, especially CH2 substituted with a 5-membered saturated heterocycle which contains one N as ring mem- ber and optionally one or two groups CH 2 are replaced by C(=0).

According to still another embodiment of formula I, R 8 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-membered, wherein the carbocycle is unsubstituted or substituted with substituents R 8b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted.

According to still another embodiment of formula I, R 8 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroa- toms selected from N, O and S, and wherein the carbocycle and heterocycle are unsubstituted or substituted with substituents R 8b as defined below. According to one embodiment thereof, the carbocycle or heterocycle is unsubstituted.

According to still a further embodiment, R 8 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, in particular three-, four-, five- or six-mem- bered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the carbocycle and heterocycle are unsubstituted or substituted with substit- uents R 8b as defined below. According to one embodiment thereof, the carbocycle or heterocy- cle is unsubstituted.

According to still another embodiment of formula I, R 8 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-mem- bered, wherein the carbocycle is unsubstituted or substituted with substituents R 8b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted.

According to one embodiment, R 8 is a 3-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b .

According to one embodiment, R 8 is a 3-membered saturated carbocycle, which is

unsubstituted such as cyclopropyl.

According to one embodiment, R 8 is a 3-membered saturated carbocycle, which is substituted with halogen, more specifically by F, such as C 3 H 3 F2.

According to one embodiment, R 8 is a 3-membered saturated carbocycle, which is substituted with halogen. More specifically by Cl, such as C 3 H 3 CI2.

According to one embodiment, R 8 is a 4-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b .

According to one embodiment, R 8 is a 5-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b .

According to one embodiment, R 8 is a 6-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b .

According to still another embodiment of formula I, R 8 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the heterocycle is unsubstituted or substituted with substituents R 8b as defined below. According to one embodiment thereof, the heterocycle is unsubstituted.

According to still another embodiment of formula I, R 8 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered heterocycle, in particular three-, four-, five- or six-mem- bered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the heterocycle is unsubstituted or substituted with substituents R 8b as de- fined below. According to one embodiment thereof, the heterocycle is unsubstituted.

According to still another embodiment of formula I, in the embodiments of R 8 described above, the heterocycle contains preferably one, two or three, more specifically one or two heteroatoms selected from N, O and S. More specifically, the hetereocycle contains one heteroatom selected from N, O and S. In particular, the heterocycle contains one or two, in particular one O.

According to one embodiment, R 8 is a 4-membered saturated heterocycle which contains 1 or 2 heteroatoms, in particular 1 heteroatom, from the group consisting of N, O and S, as ring mem- bers. According to one embodiment, the heterocycle contains one O as heteroatom. For exam- pie, the formed heterocycle is oxetane. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b .

According to still another embodiment of formula I, R 8 is a 5-membered saturated heterocycle which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroa- tom. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b .

According to still another embodiment of formula I, R 8 is a 6-membered saturated heterocycle which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b . According to one specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2, in particular 1 , heteroatom(s) O. According to one embodiment thereof, the respective 6-membered heterocycle is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted with R 8b .

According to still another embodiment of formula I, R 8 is phenyl-Ci-C 6 -alkyl, such as phenyl- CH 2 , wherein the phenyl moiety in each case is unsubstituted or substituted with one, two or three identical or different groups R 8b which independently of one another are selected from CN, halogen, Ci-C 2 -alkyl, Ci-C 2 -alkoxy, Ci-C 2 -halogenalkyl, Ci-C 2 -halogenalkoxy and S(0) n -Ci-C 6 - alkyl, in particular from CN, F, Cl, Br, CH 3 , OCH 3 , CF 3 , CHF 2 , OCHF 2 , OCF 3 and S(0) 2 CH 3 .

According to still another embodiment of formula I, R 8 is aryl, in particular phenyl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R 8b which independently of one another are selected from CN, halogen, Ci-C 2 -alkyl, Cr C 2 -alkoxy, Ci-C 2 -halogenalkyl, Ci-C 2 -halogenalkoxy and S(0) n -Ci-C 6 -alkyl, in particular from CN, F, Cl, Br, CH 3 , OCH 3 , CF 3 , CHF 2 , OCHF 2 , OCF 3 . According to one embodiment, R 8 is un- substituted phenyl. According to another embodiment, R 8 is phenyl, that is substituted with one, two or three, in particular one, halogen, in particular selected from F, Cl and Br, more specifi- cally selected from F and Cl.

According to still another embodiment of formula I, R 8 is a 5-membered heteroaryl such as pyr- rol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol- 3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2- yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isoth iazol-3-yl , isothiazol-4-yl, isoth iazol-5-y 1 , 1 ,2,4-triazolyl-1 -yl, 1 ,2,4-triazol-3-yl 1 ,2,4-triazol-5-yl, 1 ,2,4-oxadiazol-3-yl, 1 ,2,4-oxadiazol-5-yl and 1 ,2,4-thiadiazol-3-yl, 1 ,2,4-thia- diazol-5-yl.

According to still another embodiment of formula I, R 8 is a 6-membered heteroaryl, such as pyri- din-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, py- rimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl and 1 ,2,4-triazin-3-yl.

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains one N as ring member.

According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains two N as ring members.

According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains three N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b . According to one specific embodiment thereof, said 5-membered saturated heterocycle contains 1 or 2, in particular 1 , heteroatom(s) O.

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains one S as ring member.

According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains one S and one N as ring mem- bers. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains one S and two N as ring mem- bers. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains one oxygen and one N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 5-membered saturated heteroaryl which contains one oxygen and two N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 6-membered saturated heteroaryl which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 6-membered saturated heteroaryl which one N as ring member. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 6-membered saturated heteroaryl which two N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b .

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 10-membered saturated heteroaryl which contains 1 , 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b . According to one specific embodiment thereof, said 10-membered saturated heterocycle contains 1 or 2, in partic- ular 1 , heteroatom(s) N.

According to a further specific embodiment of formula I, R 8 is Ci-C 6 -alkyl, especially CH 2 subsitited by a 10-membered saturated heteroaryl which one N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R 8b . According to still another embodiment of formula I, it is substituted by R 8b .

According to still another embodiment of formula I, R 8 is CH 2 substituted by a 5-membered heteroaryl such as pyrrol-1 -yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isoth iazol-5-yl , 1 ,2,4-triazolyl- 1 -yl, 1 ,2,4-triazol-3-yl 1 ,2,4-triazol-5-yl, 1 ,2,4-oxadiazol-3-yl, 1 ,2,4-oxadiazol-5-yl and 1 ,2,4- thiadiazol-3-yl, 1 ,2,4-thiadiazol-5-yl.

According to still another embodiment of formula I, R 8 is CH 2 substituted by a 6-membered het- eroaryl, such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2- yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl and 1 ,2,4-triazin-3-yl.

According to a further particular embodiment, R 8 is selected from Ci-C 6 -alkyl, CrC 6 -halogen- alkyl, CN, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C3-C6-cycloalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halo- genalkynyl, Ci-C 6 -alkoxy, C3-C6-cycloalkynyl, C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl),

CR’=NOR”, C3-C6-halogencycloalkyl a saturated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl;, and Ci-C 6 -alkyl substituted by CN, Ci-C 6 -alkoxy, Ci-C 4 -halogenalkoxy, Ci-C 6 -alkylthio, S(0) n -Ci-C 6 -alkyl, NH-S0 2 -Rx, NH(C I -C 6 - alkyl), N(Ci-C 6 -alkyl) 2 , C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), a saturated three-, four-, five-, six-, membered carbocycle, heterocycle, aryl or heteroaryl; wherein the carbocycle, heterocycle, aryl and heteroaryl is unsubstituted or carries one, two, three or four substituents R 8b as defined below. According to one embodiment thereof, the carbocycle, heterocycle, heteroaryl and aryl are unsubstituted. In a particular embodiment, R 8 is selected from CN, Ci-C 6 -alkyl, CrC 6 -halo- genalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, C1-C6- alkoxy, a saturated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six- membered heteroaryl or aryl; and Ci-C 6 -alkyl substituted by a saturated three-, four-, five-, six-, membered carbocycle, heterocycle, aryl or heteroaryl; wherein the carbocycle, heterocacle, aryl and heteroaryl are unsubstituted or carries one, two, three or four substituents R 8b as defined below.

According to a further particular embodiment, R 8 is selected from Ci-C 6 -halogenalkyl, CN, C2- C 6 -alkenyl, C2-C6-halogenalkenyl, C3-C6-cycloalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, Cr C 6 -alkoxy, C3-C6-cycloalkynyl, C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), CR’=NOR”, C3-C6- halogencycloalkyl a saturated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six-membered heteroaryl or aryl;, and Ci-C 6 -alkyl substituted by CN, Ci-C 6 -alkoxy, C1- C 4 -halogenalkoxy, Ci-Ce-alkylthio, S(0) n -Ci-C 6 -alkyl, NH-SO2-RX, NH(Ci-C 6 -alkyl), N(Ci-C 6 -al- kyl)2, C(=0)Ci-C 6 -alkyl, C(=0)0(Ci-C 6 -alkyl), a saturated three-, four-, five-, six-, membered carbocycle, heterocycle, aryl or heteroaryl; wherein the carbocycle, heterocycle, aryl and het- eroaryl is unsubstituted or carries one, two, three or four substituents R 8b as defined below. Ac- cording to one embodiment thereof, the carbocycle, heterocycle, heteroaryl and aryl are unsub- stituted. In a particular embodiment, R 8 is selected from CN, Ci-C 6 -alkyl, Ci-C 6 -halogenalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6-alkynyl, C2-C6-halogenalkynyl, Ci-C 6 -alkoxy, a satu- rated three-, four-, five-, six-, membered carbocycle or heterocycle, a five- or six-membered het- eroaryl or aryl; and Ci-C 6 -alkyl substituted by a saturated three-, four-, five-, six-, membered carbocycle, heterocycle, aryl or heteroaryl; wherein the carbocycle, heterocacle, aryl and het- eroaryl are unsubstituted or carries one, two, three or four substituents R 8b as defined below.

Particularly preferred embodiments of R 8 according to the invention are in Table P8 below, wherein each line of lines P8-1 to P8-188 corresponds to one particular embodiment of the in- vention, wherein P8-1 to P8-188 are also in any combination with one another a preferred em- bodiment of the present invention. The connection point to the carbon atom, to which R 8 is bound is marked with“#” in the drawings.

Table P8 (py = pyridyl):

Preferred embodiments of the present invention are the following compounds I .A-1 , I.A-2, I.A-3, I.A-4, I.B-1 , I.B-2, I.B-3, I.B-4 and I.C-1 , I.C-2, I.C-3, I.C-4. In these formulae, the substituents R 2 , R 3 , R 6 , R 7 and R 8 are independently as defined above or preferably defined herein:

In particular with a view to their use, according to one embodiment, preference is given to the compounds of the formulae I. A-1 , I.A-2, I.A-3, I.A-4, I.B-1 , I.B-2, I.B-3, I.B-4 and I.C-1 , I.C-2, I.C- 3, 1.C-4 that are compiled in the Tables 1 a to 3a. Each of the groups mentioned for a substituent in the tables is furthermore per se, independently of the combination in which it is mentioned, a particularly preferred aspect of the substituent in question. Table B

Table 1a Compounds of the formula I.A-1, I.A-2, I.A-3, I.A-4, I.B-1, I.B-2, I.B-3, I.B-4and I.C- 1, I.C-2, I.C-3, I.C-4 in which R 6 is H and the meaning for the combination of R 2 , R 3 , R 7 and R 8 for each individual compound corresponds in each case to one line of Table B (compounds I.A-

1.1 a.B-1 to I.A-1.1a. B-1184, I.A-2.1a.B-1 to I.A-2.1a. B-1184, I.A-3.1a.B-1 to I.A-3.1a.B-1184, I.A-4.1a.B-1 to I.A-4.1 a.B-1184; I. B-1.1a. B-1 to I. B-1.1a. B-1184, I.B-2.1a.B-1 to I.B-2.1a. B-

1184, I.B-3.1a. B-1 to I.B-3.1a. B-1184, I.B-4.1a.B-1 to I. B-4.1a. B-1184; I.C-1.1a.B-1 to I.C- 1.1a. B-1184, I.C-2.1a. B-1 to I.C-2.1a.B-1184, I.C-3.1a.B-1 to I.C-3.1a.B-1184, I.C-4.1a.B-1 to I.C-4.1a. B-1184).

Table 2a Compounds of the formula I.A-1, I.A-2, I.A-3, I.A-4, I.B-1, I.B-2, I.B-3, I. B-4 and I.C- 1, I.C-2, I.C-3, I.C-4 in which R 6 is CH 3 and the meaning for the combination of R 2 , R 3 , R 7 and

R 8 for each individual compound corresponds in each case to one line of Table B (compounds I.A-1.1 b.B-1 to I.A-1.1 b.B-1184, I.A-2.1 b.B-1 to I.A-2.1b.B-1184, I.A-3.1 b.B-1 to I.A-3.1b.B- 1184, I.A-4.1 b.B-1 to I.A-4.1 b.B-1184; I.B-1.1 b.B-1 to I.B-1.1 b.B-1184, I.B-2.1b.B-1 to I.B-

2.1 b.B-1184, I.B-3.1 b.B-1 to I.B-3.1 b.B-1184, I.B-4.1b.B-1 to I.B-4.1 b.B-1184; I.C-1.1 b.B-1 to I.C-1.1b. B-1184, I.C-2.1 b.B-1 to I.C-2.1 b.B-1184, I.C-3.1b.B-1 to I .C-3.1 b.B-1184, I.C-4.1b.B-1 to I.C-4.1 b.B-1184). Table 3a Compounds of the formula I.A-1 , I.A-2, I.A-3, I.A-4, I.B-1 , I.B-2, I.B-3, I.B-4 and I.C- 1 , I.C-2, I.C-3, I.C-4 in which R 6 is -CH 2 -CH 3 and the meaning for the combination of R 2 , R 3 , R 7 and R 8 for each individual compound corresponds in each case to one line of Table B (corn- pounds I.A-1.1 b.B-1 to I.A-1 .1 b.B-1 184, I.A-2.1 b.B-1 to I.A-2.1 b.B-1 184, I.A-3.1 b.B-1 to I.A- 3.1 b.B-1 184, I.A-4.1 b.B-1 to I.A-4.1 b.B-1 184; I.B-1.1 b.B-1 to I.B-1.1 b.B-1184, 1.B-2.1 b.B-1 to I.B-2.1 b.B-1 184, I.B-3.1 b.B-1 to I.B-3.1 b.B-1 184, I.B-4.1 b.B-1 to I.B-4.1 b.B-1 184; I.C-1 .1 b.B-1 to I.C-1 .1 b.B-1 184, I.C-2.1 b.B-1 to I.C-2.1 b.B-1 184, I.C-3.1 b.B-1 to I.C-3.1 b.B-1 184, I.C-4.1 b.B- 1 to I.C-4.1 b.B-1 184).

The compounds I and the compositions according to the invention, respectively, are suitable as fungicides. They are distinguished by an outstanding effectiveness against a broad spectrum of phytopathogenic fungi, including soil-borne fungi, which derive especially from the classes of the Plasmodiophoromycetes, Peronosporomycetes (syn. Oomycetes), Chytridiomycetes, Zygo- mycetes, Ascomycetes, Basidiomycetes, and Deuteromycetes (syn. Fungi imperfecti). Some are systemically effective and they can be used in crop protection as foliar fungicides, fungi- cides for seed dressing, and soil fungicides. Moreover, they are suitable for controlling harmful fungi, which inter alia occur in wood or roots of plants.

The compounds I and the compositions according to the invention are particularly important in the control of a multitude of phytopathogenic fungi on various cultivated plants, such as cere- als, e. g. wheat, rye, barley, triticale, oats, or rice; beet, e. g. sugar beet or fodder beet; fruits, e. g. pomes (apples, pears, etc.), stone fruits (plums, peaches, almonds, cherries, etc.), or soft fruits, which are also called berries (strawberries, raspberries, blackberries, gooseberries, etc.); leguminous plants, e. g. lentils, peas, alfalfa, or soybeans; oil plants, e. g. rape, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts, or soybeans; cucur- bits, e. g. squashes, cucumber, or melons; fiber plants, e. g. cotton, flax, hemp, or jute; citrus fruits, e. g. oranges, lemons, grapefruits, or mandarins; vegetables, e. g. spinach, lettuce, aspa- ragus, cabbages, carrots, onions, tomatoes, potatoes, cucurbits, or paprika; lauraceous plants, e. g. avocados, cinnamon, or camphor; energy and raw material plants, e. g. corn, soybean, rape, sugar cane, or oil palm; corn; tobacco; nuts; coffee; tea; bananas; vines (table grapes and grape juice grape vines); hop; turf; sweet leaf (also called Stevia); natural rubber plants; or orna- mental and forestry plants, e. g. flowers, shrubs, broad-leaved trees, or evergreens (conifers, eucalypts, etc.); and on the plant propagation material, such as seeds; and on the crop material of these plants.

Preferably, compounds I and compositions thereof, respectively are used for controlling a multitude of fungi on field crops, such as potatoes, sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes.

The term "plant propagation material" is to be understood to denote all the generative parts of the plant, such as seeds; and vegetative plant materials, such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants; including seedlings and young plants, which are to be transplanted after germination or after emergence from soil. These young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring.

Preferably, treatment of plant propagation materials with compounds I and compositions thereof, respectively, is used for controlling a multitude of fungi on cereals, such as wheat, rye, barley and oats; rice, corn, cotton and soybeans.

The term "cultivated plants" is to be understood as including plants which have been modi- fied by mutagenesis or genetic engineering to provide a new trait to a plant or to modify an al- ready present trait. Mutagenesis includes techniques of random mutagenesis using X-rays or mutagenic chemicals, but also techniques of targeted mutagenesis, to create mutations at a specific locus of a plant genome. Targeted mutagenesis techniques frequently use oligonucleo- tides or proteins like CRISPR/Cas, zinc-finger nucleases, TALENs or meganucleases to achieve the targeting effect. Genetic engineering usually uses recombinant DNA techniques to create modifications in a plant genome which under natural circumstances cannot readily be ob- tained by cross breeding, mutagenesis or natural recombination. Typically, one or more genes are integrated into the genome of a plant to add a trait or improve a trait. These integrated genes are also referred to as transgenes in the art, while plant comprising such transgenes are referred to as transgenic plants. The process of plant transformation usually produces several transformation events, wich differ in the genomic locus in which a transgene has been inte- grated. Plants comprising a specific transgene on a specific genomic locus are usually de- scribed as comprising a specific“event”, which is referred to by a specific event name. Traits which have been introduced in plants or have been modified include herbicide tolerance, insect resistance, increased yield and tolerance to abiotic conditions, like drought.

Herbicide tolerance has been created by using mutagenesis as well as using genetic engi- neering. Plants which have been rendered tolerant to acetolactate synthase (ALS) inhibitor herbicides by mutagenesis and breeding comprise plant varieties commercially available under the name Clearfield®.

Herbicide tolerance has been created via the use of transgenes to glyphosate, glufosinate, 2,4-D, dicamba, oxynil herbicides, like bromoxynil and ioxynil, sulfonylurea herbicides, ALS in- hibitors and 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors, like isoxaflutole and mes- otrione.

Transgenes wich have been used to provide herbicide tolerance traits comprise: for toler- ance to glyphosate: cp4 epsps, epsps grg23ace5, mepsps, 2mepsps, gat4601 , gat4621 , goxv247; for tolerance to glufosinate: pat and bar, for tolerance to 2,4-D: aad-1 , aad-12; for tol- erance to dicamba: dmo; for tolerance to oxynil herbicies: bxn; for tolerance to sulfonylurea herbicides: zm-hra, csr1-2, gm-hra, S4-HrA; for tolerance to ALS inhibitors: csr1-2; and for toler- ance to HPPD inhibitors: hppdPF, W336, avhppd-03.

Transgenic corn events comprising herbicide tolerance genes include, but are not limited to, DAS40278, MON801 , MON802, MON809, MON810, MON832, MON87411 , MON87419, MON87427, MON88017, MON89034, NK603, GA21 , MZHG0JG, HCEM485, VCO-01981-5, 676, 678, 680, 33121 , 41 14, 59122, 98140, Bt10, Bt176, CBH-351 , DBT418, DLL25, MS3,

MS6, MZIR098, T25, TC1507 and TC6275. Transgenic soybean events comprising herbicide tolerance genes include, but are not limited to, GTS 40-3-2, MON87705, MON87708,

MON87712, MON87769, MON89788, A2704-12, A2704-21 , A5547-127, A5547-35, DP356043, DAS44406-6, DAS68416-4, DAS-81419-2, GU262, SYHT0H2, W62, W98, FG72 and CV127. Transgenic cotton events comprising herbicide tolerance genes include, but are not limited to, 19-51 a, 31707, 42317, 81910, 281-24-236, 3006-210-23, BXN10211 , BXN10215, BXN10222, BXN10224, MON1445, MON1698, MON88701 , MON88913, GHB119, GHB614, LLCotton25, T303-3 and T304-40. Transgenic canola events comprising herbicide tolerance genes are for example, but not excluding others, MON88302, HCR-1 , HCN10, HCN28, HCN92, MS1 , MS8, PHY14, PHY23, PHY35, PHY36, RF1 , RF2 and RF3.

Insect resistance has mainly been created by transferring bacterial genes for insecticidal proteins to plants: Transgenes which have most frequently been used are toxin genes of Bacil- /us spp. and synthetic variants thereof, like cry1A, crylAb, cry1Ab-Ac, crylAc, cry1A.105, cry1 F, cry1 Fa2, cry2Ab2, cry2Ae, mcry3A, ecry3.1Ab, cry3Bb1 , cry34Ab1 , cry35Ab1 , cry9C, vip3A(a), vip3Aa20. However, also genes of plant origin, such as genes coding for protease inhibitors, like CpTI and pinll, have been transferred to other plants. A further approach uses transgenes such as dvsnf7 to produce double-stranded RNA in plants.

Transgenic corn events comprising genes for insecticidal proteins or double stranded RNA include, but are not limited to, Bt10, Bt11 , Bt176, MON801 , MON802, MON809, MON810, MON863, MON87411 , MON88017, MON89034, 33121 , 41 14, 5307, 59122, TC1507, TC6275, CBH-351 , MIR162, DBT418 and MZIR098. Transgenic soybean events comprising genes for insecticidal proteins include, but are not limited to, MON87701 , MON87751 and DAS-81419. Transgenic cotton events comprising genes for insecticidal proteins include, but are not limited to, SGK321 , MON531 , MON757, MON1076, MON15985, 31707, 31803, 31807, 31808, 42317, BNLA-601 , Eventl , COT67B, COT102, T303-3, T304-40, GFM Cry1A, GK12, MLS 9124, 281- 24-236, 3006-210-23, GHB1 19 and SGK321.

Increased yield has been created by using the transgene athb17, being present for example in corn event MON87403, or by using the transgene bbx32, being present for example in the soybean event MON87712.

Cultivated plants comprising a modified oil content have been created by using the transgenes: gm-fad2-1 , Pj.D6D, Nc.Fad3, fad2-1A and fatb1-A. Soybean events comprising at least one of these genes are: 260-05, MON87705 and MON87769.

Tolerance to abiotic conditions, such as drought, has been created by using the transgene cspB, comprised by the corn event MON87460 and by using the transgene Hahb-4, comprised by soybean event IND-00410-5.

Traits are frequently combined by combining genes in a transformation event or by combin- ing different events during the breeding process resulting in a cultivated plant with stacked traits. Preferred combinations of traits are combinations of herbicide tolerance traits to different groups of herbicides, combinations of insect tolerance to different kind of insects, in particular tolerance to lepidopteran and coleopteran insects, combinations of herbicide tolerance with one or several types of insect resistance, combinations of herbicide tolerance with increased yield as well as combinations of herbicide tolerance and tolerance to abiotic conditions.

Plants comprising singular or stacked traits as well as the genes and events providing these traits are well known in the art. For example, detailed information as to the mutagenized or inte- grated genes and the respective events are available from websites of the organizations“Inter- national Service for the Acquisition of Agri-biotech Applications (ISAAA)” (http://www.isaaa.org/gmapprovaldatabase) and the“Center for Environmental Risk Assess- ment (CERA)” (http://cera-gmc.org/GMCropDatabase). Further information on specific events and methods to detect them can be found for canola events MS1 , MS8, RF3, GT73,

MON88302, KK179 in W001/031042, W001/041558, W001/041558, W002/036831 ,

W01 1/153186, W013/003558, for cotton events MON1445, MON15985, MON531

(MON15985), LLCotton25, MON88913, COT102, 281-24-236, 3006-210-23, COT67B,

GHB614, T304-40, GHB1 19, MON88701 , 81910 in WO02/034946, W002/100163,

W002/100163, WO03/013224, WO04/072235, WO04/039986, WO05/103266, WO05/103266, WO06/128573, W007/017186, W008/122406, W008/151780, WO12/134808, W013/112527; for corn events GA21 , MON810, DLL25, TC1507, MON863, MIR604, LY038, MON88017, 3272, 59122, NK603, MIR162, MON89034, 98140, 32138, MON87460, 5307, 4114, MON87427, DAS40278, MON87411 , 33121 , MON87403, MON87419 in W098/044140, US02/102582, US03/126634, WO04/099447, WO04/01 1601 , WO05/103301 , W005/061720, W005/059103, WO06/098952, WO06/039376, US2007/292854, WO07/142840, WO07/140256,

WO08/1 12019, WO09/103049, WO09/11 1263, W010/077816, W011/084621 , W01 1/062904, W01 1/022469, W013/169923, W014/116854, W015/053998, W015/142571 ; for potato events E12, F10, J3, J55, V11 , X17, Y9 in WO14/178910, W014/178913, W014/178941 ,

W014/179276, W016/183445, W017/062831 , W017/062825; for rice events LLRICE06, LLRICE601 , LLRICE62 in WO00/026345, WO00/026356, WO00/026345; and for soybean events H7-1 , MON89788, A2704-12, A5547-127, DP305423, DP356043, MON87701 ,

MON87769, CV127, MON87705, DAS68416-4, MON87708, MON87712, SYHT0H2,

DAS81419, DAS81419 x DAS44406-6, MON87751 in WO04/074492, WO06/130436,

WO06/108674, WO06/108675, WO08/054747, W008/002872, WO09/064652, WO09/102873, W010/080829, W010/037016, W01 1/066384, W011/034704, WO12/051 199, WO12/082548, W013/016527, WO13/016516, WO14/201235.

The use of compounds I and compositions according to the invention, respectively, on culti- vated plants may result in effects which are specific to a cultivated plant comprising a certain gene or event. These effects might involve changes in growth behavior or changed resistance to biotic or abiotic stress factors. Such effects may in particular comprise enhanced yield, en- hanced resistance or tolerance to insects, nematodes, fungal, bacterial, mycoplasma, viral or viroid pathogens as well as early vigour, early or delayed ripening, cold or heat tolerance as well as changed amino acid or fatty acid spectrum or content.

The compounds I and compositions thereof, respectively, are particularly suitable for control- ling the following plant diseases:

Albugo spp. (white rust) on ornamentals, vegetables (e. g. A. Candida) and sunflowers (e. g. A. tragopogonis), A Hern aria spp. (Alternaria leaf spot) on vegetables, rape {A. brassicoia or brassi- cae ), sugar beets (A tenuis ), fruits, rice, soybeans, potatoes (e. g. A. so/aniox A. aiternata), to- matoes (e. g. A sola ni x A. aiternata) and wheat; Aphanomyces spp. on sugar beets and vege- tables; Ascochyta spp. on cereals and vegetables, e. g. A //y?/c/ (anthracnose) on wheat and A. hordeiox\ barley; Bipoiaris and Drechsiera spp. (teleomorph: Cochiioboius spp.), e. g. Southern leaf blight ( D . maydis) ox Northern leaf blight (B. zeicoia) on corn, e. g. spot blotch (B. sorokin- iana) on cereals and e. g. B. oryzae on rice and turfs; Biumeria (formerly Erysiphe) graminis (powdery mildew) on cereals (e. g. on wheat or barley); Botrytis cinerea (teleomorph: Botryotinia fuckeliana. grey mold) on fruits and berries (e. g. strawberries), vegetables (e. g. lettuce, car- rots, celery and cabbages), rape, flowers, vines, forestry plants and wheat; Bremia lactucae (downy mildew) on lettuce; Ceratocystis { syn. Ophiostoma ) spp. (rot or wilt) on broad-leaved trees and evergreens, e. g. C. ulmi (Dutch elm disease) on elms; Cercospora spp. (Cercospora leaf spots) on corn (e. g. Gray leaf spot: C. zeae-maydis ), rice, sugar beets (e. g. C. beticola ), sugar cane, vegetables, coffee, soybeans (e. g. C. sojina or C. kikuchit ) and rice; Cladosporium spp. on tomatoes (e. g. C. fulvurrr. leaf mold) and cereals, e. g. C. herbarum (black ear) on wheat; daviceps purpurea (ergot) on cereals; Cochliobolus (anamorph: Helminthosporium of Bipolaris) spp. (leaf spots) on corn (C. carbonum), cereals (e. g. C. sativus, anamorph: B. soro- kiniana) and rice (e. g. C. miyabeanus, anamorph: H. oryzae), Colletotrichum (teleomorph: Gio- merella) spp. (anthracnose) on cotton (e. g. C. gossypii), corn (e. g. C. graminicola: Anthrac- nose stalk rot), soft fruits, potatoes (e. g. C. coccodes. black dot), beans (e. g. C. Undemuthi- anum) and soybeans (e. g. C. truncatum or C. g/oeosporioides), Corticium spp., e. g. C. sasakii (sheath blight) on rice; Corynespora cassiicola (leaf spots) on soybeans and ornamentals; Cy- doconium spp., e. g. C. oleaginum on olive trees; Cyh ' ndrocarpon spp. (e. g. fruit tree canker or young vine decline, teleomorph: Nectria o Neonectria spp.) on fruit trees, vines (e. g. C. iirio- dendri, teleomorph: Neonectria Hriodendri Black Foot Disease) and ornamentals; Dematophora (teleomorph: RoseHinia) necatrix (root and stem rot) on soybeans; Diaporthe spp., e. g. D.

phasedorum (damping off) on soybeans; Drechs!era (syn. Helminthosporium, teleomorph: Pyr- enophora) spp. on corn, cereals, such as barley (e. g. D. teres, net blotch) and wheat (e. g. D. tritici-repentis. tan spot), rice and turf; Esca (dieback, apoplexy) on vines, caused by Formiti- poria (syn. Pheiiinus ) punctata, F. mediterranea, Phaeomonieiia chiamydospora (earlier Phaeo- acremonium chiamydosporum), Phaeoacremonium aieophiium and/or Botryosphaeria obtusa, E/sinoe spp. on pome fruits (E. pyri), soft fruits ( E veneta. anthracnose) and vines ( E . ampeiina anthracnose); Entyioma oryzae (leaf smut) on rice; Epicoccum spp. (black mold) on wheat; Ery- siphe spp. (powdery mildew) on sugar beets {E. betae), vegetables (e. g. E. pisi), such as cu- curbits (e. g. E. cichoracearum), cabbages, rape (e. g. E. cruciferarum)\ Eutypa iata (Eutypa canker or dieback, anamorph: Cytosporina iata, syn. Liberteiia biepharis) on fruit trees, vines and ornamental woods; Exserohiium (syn. Helminthosporium) spp. on corn (e. g. E. turcicum) Fusarium (teleomorph: Gibbereiia) spp. (wilt, root or stem rot) on various plants, such as F. gra- minearum or F. cuimorum (root rot, scab or head blight) on cereals (e. g. wheat or barley), F. oxysporum on tomatoes, F. soiani (f . sp. glycines now syn. F. virguiiforme ) and F. tucumaniae and F. brasiiiense each causing sudden death syndrome on soybeans, and F. verticiiiioides on corn; Gaeumannomyces graminis (take-all) on cereals (e. g. wheat or barley) and corn; Gibber- eiia spp. on cereals (e. g. G. zeae) and rice (e. g. G. fujikuroi Bakanae disease); Giomereiia cinguiata on vines, pome fruits and other plants and G. gossypii on cotton; Grainstaining com- plex on rice; Guignardia bidweiiii (black rot) on vines; Gymnosporangium spp. on rosaceous plants and junipers, e. g. G. sabinae (rust) on pears; Helminthosporium s . (syn. Drechsiera, teleomorph: Cochliobolus ) on corn, cereals and rice; Hemiieia spp., e. g. H. vastatrix (coffee leaf rust) on coffee; isariopsis ciavispora (syn. Cladosporium vitis ) on vines; Macrophomina phaseoiina (syn . phased!) (root and stem rot) on soybeans and cotton; Microdochium (syn. Fusarium) nivaie (pink snow mold) on cereals (e. g. wheat or barley); Microsphaera diffusa (powdery mildew) on soybeans; Moniiinia spp., e. g. M. iaxa, M. fructicda and M. fructigena (bloom and twig blight, brown rot) on stone fruits and other rosaceous plants; Mycosphaerella spp. on cereals, bananas, soft fruits and ground nuts, such as e. g. M. graminicola (anamorph: Septoria tritici, Septoria blotch) on wheat or M. fijiensis (black Sigatoka disease) on bananas; Peronospora spp. (downy mildew) on cabbage (e. g. P. brassicae), rape (e. g. P. parasitica ), onions (e. g. P. destructor), tobacco {P. tabacina) and soybeans (e. g. P. manshurica)\

Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans; Phiaiophora spp. e. g. on vines (e. g. P. tracheiphiia and P. tetraspora ) and soybeans (e. g. P. gregata. stem rot); Phoma iingam (root and stem rot) on rape and cabbage and P. betae (root rot, leaf spot and damping-off) on sugar beets; Phomopsis spp. on sunflowers, vines (e. g. P. viticoia. can and leaf spot) and soybeans (e. g. stem rot: P. phaseoii, teleomorph: Diaporthe phaseoiorum)·, Phy- soderma maydis (brown spots) on corn; Phytophthora spp. (wilt, root, leaf, fruit and stem root) on various plants, such as paprika and cucurbits (e. g. P. capsici), soybeans (e. g. P.

megasperma, syn. P. sojae), potatoes and tomatoes (e. g. P. infestana. late blight) and broad- leaved trees (e. g. P. ramorunrr. sudden oak death); Piasmodiophora brassicae (club root) on cabbage, rape, radish and other plants; Piasmoparas ., e. g. P. viticoia (grapevine downy mil- dew) on vines and P. haistedii on sunflowers; Podosphaera spp. (powdery mildew) on rosa- ceous plants, hop, pome and soft fruits, e. g. P. ieucotricha on apples; Poiymyxas ., e. g. on cereals, such as barley and wheat {P. graminis ) and sugar beets {P. betae) and thereby trans- mitted viral diseases; Pseudocercosporeiia herpotrichoides {e yespot, teleomorph: Tapesia yai- iundae) on cereals, e. g. wheat or barley; Pseudoperonospora ( downy mildew) on various plants, e. g. P. cube ns is on cucurbits or P. humiii on hop; Pseudopezicuia tracheiphiia (ted fire disease or .rotbrenner’, anamorph: Phiaiophora) on vines; Puccinia spp. (rusts) on various plants, e. g. P. triticina (brown or leaf rust), P. striiformis (stripe or yellow rust), P. hordei (dwarf rust), P. graminis (stem or black rust) or P. recondita (brown or leaf rust) on cereals, such as e. g. wheat, barley or rye, P. kuehnii (orange rust) on sugar cane and P. asparagi on asparagus; Pyrenophora (anamorph: Drechsiera) tritici-repentis (tan spot) on wheat or P. teres (net blotch) on barley; Pyricuiaria spp., e. g. P. oryzae (teleomorph: Magnaporthe grisea, rice blast) on rice and P. grisea on turf and cereals; Pythium s . (damping-off) on turf, rice, corn, wheat, cotton, rape, sunflowers, soybeans, sugar beets, vegetables and various other plants (e. g. P. uitimum or P. aphanidermatum) Ramuiaria spp., e. g. R. coiio-cygni ( Ra m u I a ri a leaf spots, Physiological leaf spots) on barley and R. beticoia on sugar beets; Rhizoctonia spp. on cotton, rice, potatoes, turf, corn, rape, potatoes, sugar beets, vegetables and various other plants, e. g. R. soiani(tooi and stem rot) on soybeans, R. soiani (sheath blight) on rice or R. cereaiis (Rhizoctonia spring blight) on wheat or barley; Rhizopus stoionifer (b\ac mold, soft rot) on strawberries, carrots, cabbage, vines and tomatoes; Rhynchosporium secaiis (scald) on barley, rye and triticale; Saro- ctadium oryzae and S. attenuatum (sheath rot) on rice; Scierotinia spp. (stem rot or white mold) on vegetables and field crops, such as rape, sunflowers (e. g. S. scierotiorum) and soybeans (e. g. S. roifsiiox S. scierotiorum)·, Septoria spp. on various plants, e. g. S. glycines (brown spot) on soybeans, S. tritici (Septoria blotch) on wheat and S. (syn. Stagonospora) nodorum

(Stagonospora blotch) on cereals; Uncinuia (syn. Erysiphe) necator (powdery mildew, ana- morph: Oidium tuckeri) on vines; Setospaeria spp. (leaf blight) on corn (e. g. S. turcicum, syn. Heiminthosporium turcicum) and turf; Sphaceiotheca spp. (smut) on corn, (e. g. S. reiiiana·. head smut), sorghum und sugar cane; Sphaerotheca fuiiginea (powdery mildew) on cucurbits; Spongospora subterranea (powdery scab) on potatoes and thereby transmitted viral diseases; Stagonospora spp. on cereals, e. g. S. nodorum (Stagonospora blotch, teleomorph: Lepto- sphaeria [syn. Phaeosphaeria] nodorum) on wheat; Synchytrium endobioticum on potatoes (po- tato wart disease); Taphrina spp., e. g. T. deformans (leaf curl disease) on peaches and T. pruni (plum pocket) on plums; Thielaviopsis spp. (black root rot) on tobacco, pome fruits, vegetables, soybeans and cotton, e. g. T. basicola (syn. Chalara elegans), TiHetia spp. (common bunt or stinking smut) on cereals, such as e. g. T. trit/c/ ( syn. T. caries, wheat bunt) and T. controversa (dwarf bunt) on wheat; Typhula incarnata (grey snow mold) on barley or wheat; Urocystis spp., e. g. U. occulta (stem smut) on rye; Uromyces spp. (rust) on vegetables, such as beans (e. g. U. appendicutatus, syn. U. phased i) and sugar beets (e. g. U. betae)\ UstHago spp. (loose smut) on cereals (e. g. U. nuda an U. avaenae), corn (e. g. U. maydis. corn smut) and sugar cane; Venturia spp. (scab) on apples (e. g. V inaequah ' s ) and pears; and Vertici Ilium spp. (wilt) on var- ious plants, such as fruits and ornamentals, vines, soft fruits, vegetables and field crops, e. g. V dahh ' ae on strawberries, rape, potatoes and tomatoes.

The compounds I and compositions thereof, respectively, are also suitable for controlling harmful microorganisms in the protection of stored products or harvest, and in the protection of materials.

The term "stored products or harvest" is understood to denote natural substances of plant or animal origin and their processed forms, which have been taken from the natural life cycle and for which long-term protection is desired. Stored products of crop plant origin, such as plants or parts thereof, for example stalks, leafs, tubers, seeds, fruits or grains, can be protected in the freshly harvested state or in processed form, such as pre-dried, moistened, comminuted, ground, pressed or roasted, which process is also known as post-harvest treatment. Also falling under the definition of stored products is timber, whether in the form of crude timber, such as construction timber, electricity pylons and barriers, or in the form of finished articles, such as fur- niture or objects made from wood. Stored products of animal origin are hides, leather, furs, hairs and the like. Preferably, "stored products" is understood to denote natural substances of plant origin and their processed forms, more preferably fruits and their processed forms, such as pomes, stone fruits, soft fruits and citrus fruits and their processed forms. The compounds I and compositions thereof according the present invention can prevent disadvantageous effects such as decay, discoloration or mold.

The term "protection of materials" is to be understood to denote the protection of technical and non-living materials, such as adhesives, glues, wood, paper, paperboard, textiles, leather, paint dispersions, plastics, cooling lubricants, fiber, or fabrics; against the infestation and de- struction by harmful microorganisms, such as fungi and bacteria. As to the protection of materi- als, particular attention is paid to the following harmful fungi: Ascomycetes, such as Ophiostoma spp., Ceratocystis spp., Aureobasidium pu Hu la ns, Sderophoma spp., Chaetomium spp., Humi- cda spp., Pet riel I a spp., Trichurus spp.; Basidiomycetes, such as Coniophora spp., Coridus spp., Gloeophyllum spp., Lentinus spp., P leu rot us spp., Poria spp., Serpu!a spp. and Tyromy- ces spp.; Deuteromycetes, such as Aspergillus spp., dadosporium spp., PeniciHium spp., Trichoderma spp., A I tern aria spp., PaecHomyces spp.; and Zygomycetes, such as Mucorspp..

In the protection of stored products and harvest in addition the following yeast fungi are worthy of note: Candida s . and Saccharomyces cerevisae. The compounds I and compositions thereof, respectively, may be used for improving the health of a plant. The invention also relates to a method for improving plant health by treating a plant, its propagation material, and/or the locus where the plant is growing or is to grow with an effective amount of compounds I and compositions thereof, respectively.

The term "plant health" is to be understood to denote a condition of the plant and/or its prod- ucts which is determined by several indicators alone or in combination with each other, such as yield (e. g. increased biomass and/or increased content of valuable ingredients), plant vigor (e. g. improved plant growth and/or greener leaves (“greening effect”)), quality (e. g. improved content or composition of certain ingredients), and tolerance to abiotic and/or biotic stress. The above identified indicators for the health condition of a plant may be interdependent or may re- suit from each other.

The compounds of formula I can be present in different crystal modifications whose biologi- cal activity may differ. They are likewise subject matter of the present invention.

The compounds I are employed as such or in form of compositions by treating the fungi, the plants, plant propagation materials, such as seeds; soil, surfaces, materials, or rooms to be pro- tected from fungal attack with a fungicidally effective amount of the active substances. The ap- plication can be carried out both before and after the infection of the plants, plant propagation materials, such as seeds; soil, surfaces, materials or rooms by the fungi.

Plant propagation materials may be treated with compounds I as such or a composition corn- prising at least one compound I prophylactically either at or before planting or transplanting.

The invention also relates to agrochemical compositions comprising an auxiliary and at least one compound I according to the invention.

An agrochemical composition comprises a fungicidally effective amount of a compound I.

The term "fungicidally effective amount" denotes an amount of the composition or of the corn- pounds I, which is sufficient for controlling harmful fungi on cultivated plants or in the protection of stored products or harvest or of materials and which does not result in a substantial damage to the treated plants, the treated stored products or harvest, or to the treated materials. Such an amount can vary in a broad range and is dependent on various factors, such as the fungal spe- cies to be controlled, the treated cultivated plant, stored product, harvest or material, the cli matic conditions and the specific compound I used.

The compounds I, their N-oxides and salts can be converted into customary types of agro- chemical compositions, e. g. solutions, emulsions, suspensions, dusts, powders, pastes, gran- ules, pressings, capsules, and mixtures thereof. Examples for composition types are suspen- sions (e. g. SC, OD, FS), emulsifiable concentrates (e. g. EC), emulsions (e. g. EW, EO, ES, ME), capsules (e. g. CS, ZC), pastes, pastilles, wettable powders or dusts (e. g. WP, SP, WS, DP, DS), pressings (e. g. BR, TB, DT), granules (e. g. WG, SG, GR, FG, GG, MG), insecticidal articles (e. g. LN), as well as gel formulations for the treatment of plant propagation materials, such as seeds (e. g. GF). These and further compositions types are defined in the“Catalogue of pesticide formulation types and international coding system”, Technical Monograph No. 2, 6 th Ed. May 2008, CropLife International.

The compositions are prepared in a known manner, such as described by Mollet and Grube- mann, Formulation technology, Wiley VCH, Weinheim, 2001 ; or by Knowles, New develop- ments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.

Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, disper- sants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibil- izers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers, and binders.

Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil frac- tions of medium to high boiling point, e. g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e. g. toluene, paraffin, tetrahydronaphthalene, and alkylated naphthalenes; alcohols, e. g. ethanol, propanol, butanol, benzyl alcohol, cyclohexanol, glycols; DMSO; ketones, e. g. cyclohexanone; esters, e. g. lactates, carbonates, fatty acid es- ters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides, e. g. /V-methyl pyrroli- done, fatty acid dimethyl amides; and mixtures thereof.

Suitable solid carriers or fillers are mineral earths, e. g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magne- sium sulfate, magnesium oxide; polysaccharides, e. g. cellulose, starch; fertilizers, e. g. ammo- nium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e. g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.

Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective col- loid, or adjuvant. Examples of surfactants are listed in McCutcheon’s, Vol.1 : Emulsifiers & De- tergents, McCutcheon’s Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).

Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sul- fates, phosphates, carboxylates, and mixtures thereof. Examples of sulfonates are alkylaryl sul- fonates, diphenyl sulfonates, alpha-olefin sulfonates, lignin sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sul- fonates of condensed naphthalenes, sulfonates of dodecyl- and tridecylbenzenes, sulfonates of naphthalenes and of alkyl naphthalenes, sulfosuccinates, or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids, of oils, of ethoxylated alkylphenols, of alcohols, of ethoxy- lated alcohols, or of fatty acid esters. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates.

Suitable nonionic surfactants are alkoxylates, /V-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide. Exam- pies of /V-substituted fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Ex- amples of esters are fatty acid esters, glycerol esters, or monoglycerides. Examples of sugar- based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters, or al- kylpolyglucosides. Examples of polymeric surfactants are home- or copolymers of vinyl pyrroli- done, vinyl alcohols, or vinyl acetate. Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkylbetains and imidazolines. Suitable block polymers are block pol- ymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene ox ide, or of the A-B-C type comprising alkanol, polyethylene oxide, and polypropylene oxide. Suit- able polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of poly- acrylic acid or polyacid comb polymers. Examples of polybases are polyvinyl amines or polyeth- ylene amines.

Suitable adjuvants are compounds, which have a negligible or even no pesticidal activity themselves, and which improve the biological performance of the compound I on the target. Ex- amples are surfactants, mineral or vegetable oils, and other auxiliaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.

Suitable thickeners are polysaccharides (e. g. xanthan gum, carboxymethyl cellulose), inor- ganic clays (organically modified or unmodified), polycarboxylates, and silicates.

Suitable bactericides are bronopol and isothiazolinone derivatives, such as alkylisothiazoli- nones and benzisothiazolinones.

Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.

Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.

Suitable colorants (e. g. in red, blue, or green) are pigments of low water solubility and wa ter-soluble dyes. Examples are inorganic colorants (e. g. iron oxide, titan oxide, iron hexacy- anoferrate) and organic colorants (e. g. alizarin-, azo- and phthalocyanine colorants).

Suitable tackifiers or binders are polyvinyl pyrrolidones, polyvinyl acetates, polyvinyl alco- hols, polyacrylates, biological or synthetic waxes, and cellulose ethers.

Examples for composition types and their preparation are:

i) Water-soluble concentrates (SL, LS)

10-60 wt% of a compound I and 5-15 wt% wetting agent (e. g. alcohol alkoxylates) are dis- solved in water and/or in a water-soluble solvent (e. g. alcohols) ad 100 wt%. The active sub- stance dissolves upon dilution with water.

ii) Dispersible concentrates (DC)

5-25 wt% of a compound I and 1-10 wt% dispersant (e. g. polyvinyl pyrrolidone) are dis- solved in organic solvent (e. g. cyclohexanone) ad 100 wt%. Dilution with water gives a disper- sion.

iii) Emulsifiable concentrates (EC)

15-70 wt% of a compound I and 5-10 wt% emulsifiers (e. g. calcium dodecylbenzenesul- fonate and castor oil ethoxylate) are dissolved in water-insoluble organic solvent (e. g. aromatic hydrocarbon) ad 100 wt%. Dilution with water gives an emulsion.

iv) Emulsions (EW, EO, ES)

5-40 wt% of a compound I and 1-10 wt% emulsifiers (e. g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40 wt% water-insoluble organic solvent (e. g. aro- matic hydrocarbon). This mixture is introduced into water ad 100 wt% by means of an emulsify- ing machine and made into a homogeneous emulsion. Dilution with water gives an emulsion. v) Suspensions (SC, OD, FS)

In an agitated ball mill, 20-60 wt% of a compound I are comminuted with addition of 2-10 wt% dispersants and wetting agents (e. g. sodium lignosulfonate and alcohol ethoxylate), 0.1- 2 wt% thickener (e. g. xanthan gum) and water ad 100 wt% to give a fine active substance sus- pension. Dilution with water gives a stable suspension of the active substance. For FS type composition, up to 40 wt% binder (e. g. polyvinyl alcohol) is added.

vi) Water-dispersible granules and water-soluble granules (WG, SG)

50-80 wt% of a compound I are ground finely with addition of dispersants and wetting agents (e. g. sodium lignosulfonate and alcohol ethoxylate) ad 100 wt% and prepared as water-dis- persible or water-soluble granules by means of technical appliances (e. g. extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active sub- stance.

vii) Water-dispersible powders and water-soluble powders (WP, SP, WS)

50-80 wt% of a compound I are ground in a rotor-stator mill with addition of 1-5 wt% disper- sants (e. g. sodium lignosulfonate), 1-3 wt% wetting agents (e. g. alcohol ethoxylate) and solid carrier (e. g. silica gel) ad 100 wt%. Dilution with water gives a stable dispersion or solution of the active substance.

viii) Gel (GW, GF)

In an agitated ball mill, 5-25 wt% of a compound I are comminuted with addition of 3-10 wt% dispersants (e. g. sodium lignosulfonate), 1-5 wt% thickener (e. g. carboxymethyl cellulose) and water ad 100 wt% to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.

ix) Microemulsion (ME)

5-20 wt% of a compound I are added to 5-30 wt% organic solvent blend (e. g. fatty acid di- methyl amide and cyclohexanone), 10-25 wt% surfactant blend (e. g. alcohol ethoxylate and ar- ylphenol ethoxylate), and water ad 100 %. This mixture is stirred for 1 h to produce spontane- ously a thermodynamically stable microemulsion.

x) Microcapsules (CS)

An oil phase comprising 5-50 wt% of a compound I, 0-40 wt% water insoluble organic solvent (e. g. aromatic hydrocarbon), 2-15 wt% acrylic monomers (e. g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e. g. polyvinyl alcohol). Radical polymerization results in the formation of poly(meth)acrylate micro- capsules. Alternatively, an oil phase comprising 5-50 wt% of a compound I according to the in- vention, 0-40 wt% water insoluble organic solvent (e. g. aromatic hydrocarbon), and an isocya- nate monomer (e. g. diphenylmethene-4,4’-diisocyanatae) are dispersed into an aqueous solu- tion of a protective colloid (e. g. polyvinyl alcohol). The addition of a polyamine (e. g. hexameth- ylenediamine) results in the formation of polyurea microcapsules. The monomers amount to 1- 10 wt%. The wt% relate to the total CS composition.

xi) Dustable powders (DP, DS)

1-10 wt% of a compound I are ground finely and mixed intimately with solid carrier (e. g. finely divided kaolin) ad 100 wt%.

xii) Granules (GR, FG)

0.5-30 wt% of a compound I is ground finely and associated with solid carrier (e. g. silicate) ad 100 wt%. Granulation is achieved by extrusion, spray-drying or fluidized bed. xiii) Ultra-low volume liquids (UL)

1-50 wt% of a compound I are dissolved in organic solvent (e. g. aromatic hydrocarbon) ad 100 wt%.

The compositions types i) to xiii) may optionally comprise further auxiliaries, such as 0.1-1 wt% bactericides, 5-15 wt% anti-freezing agents, 0.1-1 wt% anti-foaming agents, and 0.1-1 wt% colorants.

The agrochemical compositions generally comprise between 0.01 and 95 %, preferably be- tween 0.1 and 90%, more preferably between 1 and 70 %, and in particular between 10 and 60 %, by weight of active substance. The active substances are employed in a purity of from 90 % to 100 %, preferably from 95-% to 100 % (according to NMR spectrum).

For the purposes of treatment of plant propagation materials, particularly seeds, solutions for seed treatment (LS), Suspoemulsions (SE), flowable concentrates (FS), powders for dry treat- ment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions (ES), emulsifiable concentrates (EC), and gels (GF) are usually employed. The corn- positions in question give, after two-to-tenfold dilution, active substance concentrations of from 0.01 to 60 % by weight, preferably from 0.1 to 40 %, in the ready-to-use preparations. Applica- tion can be carried out before or during sowing. Methods for applying compound I and composi- tions thereof, respectively, onto plant propagation material, especially seeds, include dressing, coating, pelleting, dusting, soaking, as well as in-furrow application methods. Preferably, corn- pound I or the compositions thereof, respectively, are applied on to the plant propagation mate- rial by a method such that germination is not induced, e. g. by seed dressing, pelleting, coating, and dusting.

When employed in plant protection, the amounts of active substances applied are, depend- ing on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha, and in particular from 0.1 to 0.75 kg per ha.

In treatment of plant propagation materials, such as seeds, e. g. by dusting, coating, or drenching, amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kg of plant propa- gation material (preferably seeds) are generally required.

When used in the protection of materials or stored products, the amount of active substance applied depends on the kind of application area and on the desired effect. Amounts customarily applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material.

Various types of oils, wetters, adjuvants, fertilizer, or micronutrients, and further pesticides (e. g. herbicides, insecticides, fungicides, growth regulators, safeners, biopesticides) may be added to the active substances or the compositions comprising them as premix, or, if appropri- ate, not until immediately prior to use (tank mix). These agents can be admixed with the compo- sitions according to the invention in a weight ratio of 1 :100 to 100:1 , preferably 1 :10 to 10:1.

A pesticide is generally a chemical or biological agent (such as pestidal active ingredient, compound, composition, virus, bacterium, antimicrobial, or disinfectant) that through its effect deters, incapacitates, kills or otherwise discourages pests. Target pests can include insects, plant pathogens, weeds, mollusks, birds, mammals, fish, nematodes (roundworms), and mi- crobes that destroy property, cause nuisance, spread disease or are vectors for disease. The term“pesticide” includes also plant growth regulators that alter the expected growth, flowering, or reproduction rate of plants; defoliants that cause leaves or other foliage to drop from a plant, usually to facilitate harvest; desiccants that promote drying of living tissues, such as unwanted plant tops; plant activators that activate plant physiology for defense of against certain pests; safeners that reduce unwanted herbicidal action of pesticides on crop plants; and plant growth promoters that affect plant physiology e.g. to increase plant growth, biomass, yield or any other quality parameter of the harvestable goods of a crop plant.

Biopesticides have been defined as a form of pesticides based on microorganisms (bacteria, fungi, viruses, nematodes, etc.) or natural products (compounds, such as metabolites, proteins, or extracts from biological or other natural sources) (U.S. Environmental Protection Agency: http://www.epa.gov/pesticides/biopesticides/). Biopesticides fall into two major classes, micro- bial and biochemical pesticides:

(1 ) Microbial pesticides consist of bacteria, fungi or viruses (and often include the metabo- lites that bacteria and fungi produce). Entomopathogenic nematodes are also classified as microbial pesticides, even though they are multi-cellular.

(2) Biochemical pesticides are naturally occurring substances that control pests or provide other crop protection uses as defined below, but are relatively non-toxic to mammals.

The user applies the composition according to the invention usually from a predosage de- vice, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system. Usually, the agro- chemical composition is made up with water, buffer, and/or further auxiliaries to the desired ap- plication concentration and the ready-to-use spray liquor or the agrochemical composition ac- cording to the invention is thus obtained. Usually, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.

According to one embodiment, individual components of the composition according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank or any other kind of vessel used for applications (e. g. seed treater drums, seed pelleting machinery, knapsack sprayer) and further auxiliaries may be added, if ap- propriate.

When living microorganisms, such as microbial pesticides from groups L1), L3) and L5), form part of such kit, it must be taken care that choice and amounts of the components (e. g. chemical pesticides) and of the further auxiliaries should not influence the viability of the micro- bial pesticides in the composition mixed by the user. Especially for bactericides and solvents, compatibility with the respective microbial pesticide has to be taken into account.

Consequently, one embodiment of the invention is a kit for preparing a usable pesticidal composition, the kit comprising a) a composition comprising component 1) as defined herein and at least one auxiliary; and b) a composition comprising component 2) as defined herein and at least one auxiliary; and optionally c) a composition comprising at least one auxiliary and op- tionally a further active component 3) as defined herein.

Mixing the compounds I or the compositions comprising them in the use form as fungicides with other fungicides results in many cases in an expansion of the fungicidal spectrum of activity being obtained or in a prevention of fungicide resistance development. Furthermore, in many cases, synergistic effects are obtained.

The following list of pesticides II (e. g. pesticidally-active substances and biopesticides), in conjunction with which the compounds I can be used, is intended to illustrate the possible com- binations but does not limit them:

A) Respiration inhibitors

Inhibitors of complex III at Q 0 site: azoxystrobin (A.1.1), coumethoxystrobin (A.1.2), coumoxystrobin (A.1.3), dimoxystrobin (A.1.4), enestroburin (A.1.5), fenaminstrobin (A.1.6), fenoxystrobin/flufenoxystrobin (A.1.7), fluoxastrobin (A.1.8), kresoxim-methyl (A.1.9), man- destrobin (A.1.10), metominostrobin (A.1.1 1), orysastrobin (A.1.12), picoxystrobin (A.1.13), pyraclostrobin (A.1.14), pyrametostrobin (A.1.15), pyraoxystrobin (A.1.16), trifloxystrobin (A.1.17), 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxymeth yl)-phenyl)-2-meth- oxyimino-/V-methyl-acetamide (A.1.18), pyribencarb (A.1.19), triclopyricarb/chlorodincarb (A.1.20), famoxadone (A.1.21 ), fenamidone (A.1.21), methyl-/V-[2-[(1 ,4-dimethyl-5-phenyl- pyrazol-3-yl)oxylmethyl]phenyl]-/V-methoxy-carbamate (A.1.22), metyltetrapole (A.1.25), (2^2£)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-oxy-2-methoxy imino- V,3-dimethyl-pent-3-en- amide (A.1.34), (Z;2£)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino -/V, 3-dimethyl- pent-3-enamide (A.1.35), pyriminostrobin (A.1.36), bifujunzhi (A.1.37), 2-(ortho-((2,5-dimeth- ylphenyl-oxymethylen)phenyl)-3-methoxy-acrylic acid methylester (A.1.38);

- inhibitors of complex III at Q, site: cyazofamid (A.2.1 ), amisulbrom (A.2.2),

[(65,7/?,8A -8-benzyl-3-[(3-hydroxy-4-methoxy-pyridine-2-carbonyl)amino] -6-methyl-4,9-di- oxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate (A.2.3), fenpicoxamid (A.2.4), florylpicoxamid (A.2.5);

- inhibitors of complex II: benodanil (A.3.1), benzovindiflupyr (A.3.2), bixafen (A.3.3), boscalid (A.3.4), carboxin (A.3.5), fenfuram (A.3.6), fluopyram (A.3.7), flutolanil (A.3.8), fluxapyroxad (A.3.9), furametpyr (A.3.10), isofetamid (A.3.1 1), isopyrazam (A.3.12), mepronil (A.3.13), ox- ycarboxin (A.3.14), penflufen (A.3.15), penthiopyrad (A.3.16), pydiflumetofen (A.3.17), pyra- ziflumid (A.3.18), sedaxane (A.3.19), tecloftalam (A.3.20), thifluzamide (A.3.21 ), inpyrfluxam (A.3.22), pyrapropoyne (A.3.23), fluindapyr (A.3.28), methyl (£)-2-[2-[(5-cyano-2-methyl-phe- noxy)methyl]phenyl]-3-methoxy-prop-2-enoate (A.3.30), isoflucypram (A.3.31), 2-(difluoro- methyl)-/V-(1 ,1 ,3-trimethyl-indan-4-yl)pyridine-3-carboxamide (A.3.32), 2-(difluoromethyl)-/V- [(3A -1 ,1 ,3-trimethylindan-4-yl]pyridine-3-carboxamide (A.3.33), 2-(difluoromethyl)-/V-(3- ethyl-1 ,1-dimethyl-indan-4-yl)pyridine-3-carboxamide (A.3.34), 2-(difluoromethyl)-/V-[(3A -3- ethyl-1 ,1-dimethyl-indan-4-yl]pyridine-3-carboxamide (A.3.35), 2-(difluoromethyl)-/V-(1 ,1-di- methyl-3-propyl-indan-4-yl)pyridine-3-carboxamide (A.3.36), 2-(difluoromethyl)-/V-[(3A -1 ,1- dimethyl-3-propyl-indan-4-yl]pyridine-3-carboxamide (A.3.37), 2-(difluoromethyl)-/V-(3-isobu- tyl-1 ,1-dimethyl-indan-4-yl)pyridine-3-carboxamide (A.3.38), 2-(difluoromethyl)-/V-[(3A -3-iso- butyl-1 ,1-dimethyl-indan-4-yl]pyridine-3-carboxamide (A.3.39);

- other respiration inhibitors: diflumetorim (A.4.1 ); nitrophenyl derivates: binapacryl (A.4.2), di- nobuton (A.4.3), dinocap (A.4.4), fluazinam (A.4.5), meptyldinocap (A.4.6), ferimzone (A.4.7); organometal compounds: fentin salts, e. g. fentin-acetate (A.4.8), fentin chloride (A.4.9) or fentin hydroxide (A.4.10); ametoctradin (A.4.1 1); silthiofam (A.4.12);

B) Sterol biosynthesis inhibitors (SBI fungicides) - C14 demethylase inhibitors: triazoles: azaconazole (B.1.1 ), bitertanol (B.1.2), bromucona- zole (B.1.3), cyproconazole (B.1.4), difenoconazole (B.1.5), diniconazole (B.1.6), dinicona- zole-M (B.1.7), epoxiconazole (B.1.8), fenbuconazole (B.1.9), fluquinconazole (B.1.10), flusi- lazole (B.1.11), flutriafol (B.1.12), hexaconazole (B.1.13), imibenconazole (B.1.14), ipcona- zole (B.1.15), metconazole (B.1.17), myclobutanil (B.1.18), oxpoconazole (B.1.19), paclobu- trazole (B.1.20), penconazole (B.1.21 ), propiconazole (B.1.22), prothioconazole (B.1.23), simeconazole (B.1.24), tebuconazole (B.1.25), tetraconazole (B.1.26), triadimefon (B.1.27), triadimenol (B.1.28), triticonazole (B.1.29), uniconazole (B.1.30), 2-(2,4-difluorophenyl)-1 ,1- difluoro-3-(tetrazol-1-yl)-1-[5-[4-(2,2,2-trifluoroethoxy)ph enyl]-2-pyridyl]propan-2-ol (B.1.31 ), 2-(2,4-difluorophenyl)-1 ,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(trifluoromethoxy)phen yl]-2- pyridyl]propan-2-ol (B.1.32), ipfentrifluconazole (B.1.37), mefentrifluconazole (B.1.38), 2- (chloromethyl)-2-methyl-5-(p-tolylmethyl)-1-(1 ,2,4-triazol-1-ylmethyl)cyclopentanol (B.1.43); imidazoles: imazalil (B.1.44), pefurazoate (B.1.45), prochloraz (B.1.46), triflumizol (B.1.47); pyrimidines, pyridines, piperazines: fenarimol (B.1.49), pyrifenox (B.1.50), triforine (B.1.51), [3-(4-chloro-2-fluoro-phenyl)-5-(2,4-difluorophenyl)isoxazol -4-yl]-(3-pyridyl)methanol (B.1.52);

- Delta 14-reductase inhibitors: aldimorph (B.2.1), dodemorph (B.2.2), dodemorph-acetate (B.2.3), fenpropimorph (B.2.4), tridemorph (B.2.5), fenpropidin (B.2.6), piperalin (B.2.7), spi- roxamine (B.2.8);

- Inhibitors of 3-keto reductase: fenhexamid (B.3.1);

- Other Sterol biosynthesis inhibitors: chlorphenomizole (B.4.1 );

C) Nucleic acid synthesis inhibitors

- phenylamides or acyl amino acid fungicides: benalaxyl (C.1.1), benalaxyl-M (C.1.2), kiralaxyl (C.1.3), metalaxyl (C.1.4), metalaxyl-M (C.1.5), ofurace (C.1.6), oxadixyl (C.1.7);

- other nucleic acid synthesis inhibitors: hymexazole (C.2.1 ), octhilinone (C.2.2), oxolinic acid (C.2.3), bupirimate (C.2.4), 5-fluorocytosine (C.2.5), 5-fluoro-2-(p-tolylmethoxy)pyrimidin- 4-amine (C.2.6), 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin-4-amine (C.2.7), 5-fluoro- 2-(4-chlorophenylmethoxy)pyrimidin-4 amine (C.2.8);

D) Inhibitors of cell division and cytoskeleton

- tubulin inhibitors: benomyl (D.1.1 ), carbendazim (D.1.2), fuberidazole (D1.3), thiabendazole (D.1.4), thiophanate-methyl (D.1.5), pyridachlometyl (D.1.6), /V-ethyl-2-[(3-ethynyl-8-methyl- 6-quinolyl)oxy]butanamide (D.1.8), /V-ethyl-2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-2-methyl- sulfanyl-acetamide (D.1.9), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-/V-(2-fluoroethyl)bu- tanamide (D.1.10), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-/V-(2-fluoroethyl)-2- methoxy-acet- amide (D.1.1 1), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-/V-propyl-butanamide (D.1.12), 2-[(3- ethynyl-8-methyl-6-quinolyl)oxy]-2-methoxy-/V-propyl-acetami de (D.1.13), 2-[(3-ethynyl-8- methyl-6-quinolyl)oxy]-2-methylsulfanyl-/V-propyl-acetamide (D.1.14), 2-[(3-ethynyl-8-methyl- 6-quinolyl)oxy]-/V-(2-fluoroethyl)-2-methylsulfanyl-acetamid e (D.1.15), 4-(2-bromo-4-fluoro- phenyl)-/V-(2-chloro-6-fluoro-phenyl)-2,5-dimethyl-pyrazol-3 -amine (D.1.16);

- other cell division inhibitors: diethofencarb (D.2.1), ethaboxam (D.2.2), pencycuron (D.2.3), fluopicolide (D.2.4), zoxamide (D.2.5), metrafenone (D.2.6), pyriofenone (D.2.7);

E) Inhibitors of amino acid and protein synthesis

- methionine synthesis inhibitors: cyprodinil (E.1.1 ), mepanipyrim (E.1.2), pyrimethanil (E.1.3); - protein synthesis inhibitors: blasticidin-S (E.2.1 ), kasugamycin (E.2.2), kasugamycin hydro- chloride-hydrate (E.2.3), mildiomycin (E.2.4), streptomycin (E.2.5), oxytetracyclin (E.2.6);

F) Signal transduction inhibitors

- MAP / histidine kinase inhibitors: fluoroimid (F.1.1), iprodione (F.1.2), procymidone (F.1.3), vinclozolin (F.1.4), fludioxonil (F.1.5);

- G protein inhibitors: quinoxyfen (F.2.1);

G) Lipid and membrane synthesis inhibitors

- Phospholipid biosynthesis inhibitors: edifenphos (G.1.1 ), iprobenfos (G.1.2), pyrazophos (G.1.3), isoprothiolane (G.1.4);

- lipid peroxidation: dicloran (G.2.1), quintozene (G.2.2), tecnazene (G.2.3), tolclofos-methyl (G.2.4), biphenyl (G.2.5), chloroneb (G.2.6), etridiazole (G.2.7);

- phospholipid biosynthesis and cell wall deposition: dimethomorph (G.3.1), flumorph (G.3.2), mandipropamid (G.3.3), pyrimorph (G.3.4), benthiavalicarb (G.3.5), iprovalicarb (G.3.6), valifenalate (G.3.7);

- compounds affecting cell membrane permeability and fatty acides: propamocarb (G.4.1 );

- inhibitors of oxysterol binding protein: oxathiapiprolin (G.5.1), 2-{3-[2-(1-{[3,5-bis(difluorome- thyl-1 /- -pyrazol-1 -yl]acetyl}piperidin-4-yl)-1 ,3-thiazol-4-yl]-4,5-dihydro-1 ,2-oxazol-5-yl}phenyl methanesulfonate (G.5.2), 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1 Apyrazol-1-yl]acetyl}piperi- din-4-yl) 1 ,3-thiazol-4-yl]-4,5-dihydro-1 ,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate (G.5.3), 4-[1-[2-[3-(difluoromethyl)-5-methyl-pyrazol-1-yl]acetyl]-4- piperidyl]-/V-tetralin-1-yl- pyridine-2-carboxamide (G.5.4), 4-[1-[2-[3,5-bis(difluoromethyl)pyrazol-1-yl]acetyl]-4-pi- peridyl]-/V-tetralin-1-yl-pyridine-2-carboxamide (G.5.5), 4-[1-[2-[3-(difluoromethyl)-5-(trifluoro- methyl)pyrazol-1-yl]acetyl]-4-piperidyl]-/V-tetralin-1-yl-py ridine-2-carboxamide (G.5.6), 4-[1- [2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetyl]-4-p iperidyl]-/V-tetralin-1-yl-pyridine-2- carboxamide (G.5.7), 4-[1-[2-[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4- piperidyl]-/V- tetralin-1 -yl-pyridine-2-carboxamide (G.5.8), 4-[1 -[2-[5-(difluoromethyl)-3-(trifluoromethyl)py- razol-1-yl]acetyl]-4-piperidyl]-/V-tetralin-1-yl-pyridine-2- carboxamide (G.5.9), 4-[1-[2-[3,5- bis(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]-/V-tet ralin-1-yl-pyridine-2-carboxamide (G.5.10), (4-[1-[2-[5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]acet yl]-4-piperidyl]-/V-tetralin- 1-yl-pyridine-2-carboxamide (G.5.1 1);

H) Inhibitors with Multi Site Action

- inorganic active substances: Bordeaux mixture (H.1.1 ), copper (H.1.2), copper acetate

(H.1.3), copper hydroxide (H.1.4), copper oxychloride (H.1.5), basic copper sulfate (H.1.6), sulfur (H.1.7);

- thio- and dithiocarbamates: ferbam (H.2.1 ), mancozeb (H.2.2), maneb (H.2.3), metam

(H.2.4), metiram (H.2.5), propineb (H.2.6), thiram (H.2.7), zineb (H.2.8), ziram (H.2.9);

- organochlorine compounds: anilazine (H.3.1 ), chlorothalonil (H.3.2), captafol (H.3.3), captan (H.3.4), folpet (H.3.5), dichlofluanid (H.3.6), dichlorophen (H.3.7), hexachlorobenzene (H.3.8), pentachlorphenole (H.3.9) and its salts, phthalide (H.3.10), tolylfluanid (H.3.1 1);

- guanidines and others: guanidine (H.4.1), dodine (H.4.2), dodine free base (H.4.3),

guazatine (H.4.4), guazatine-acetate (H.4.5), iminoctadine (H.4.6), iminoctadine-triacetate (H.4.7), iminoctadine-tris(albesilate) (H.4.8), dithianon (H.4.9), 2,6-dimethyl-1 A/,5 A[1 ,4]di- thiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2A/,6 A)-tetraone (H.4.10); I) Cell wall synthesis inhibitors

- inhibitors of glucan synthesis: validamycin (1.1.1 ), polyoxin B (1.1.2);

- melanin synthesis inhibitors: pyroquilon (1.2.1 ), tricyclazole (1.2.2), carpropamid (I.2.3), dicy- clomet (1.2.4), fenoxanil (1.2.5);

J) Plant defence inducers

- acibenzolar-S-methyl (J.1.1 ), probenazole (J.1.2), isotianil (J.1.3), tiadinil (J.1.4), prohexadi- one-calcium (J.1.5); phosphonates: fosetyl (J.1.6), fosetyl-aluminum (J.1.7), phosphorous acid and its salts (J.1.8), calcium phosphonate (J.1.11 ), potassium phosphonate (J.1.12), potassium or sodium bicarbonate (J.1.9), 4-cyclopropyl-/V-(2,4-dimethoxyphenyl)thiadiazole-

5-carboxamide (J.1.10);

K) Unknown mode of action

- bronopol (K.1.1 ), chinomethionat (K.1.2), cyflufenamid (K.1.3), cymoxanil (K.1.4), dazomet (K.1.5), debacarb (K.1.6), diclocymet (K.1.7), diclomezine (K.1.8), difenzoquat (K.1.9), difen- zoquat-methylsulfate (K.1.10), diphenylamin (K.1.11 ), fenitropan (K.1.12), fenpyrazamine (K.1.13), flumetover (K.1.14), flusulfamide (K.1.15), flutianil (K.1.16), harpin (K.1.17), metha- sulfocarb (K.1.18), nitrapyrin (K.1.19), nitrothal-isopropyl (K.1.20), tolprocarb (K.1.21), oxin- copper (K.1.22), proquinazid (K.1.23), tebufloquin (K.1.24), tecloftalam (K.1.25), triazoxide (K.1.26), A/ i (4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-p henyl)-/V-ethyl-/V-methyl formamidine (K.1.27), A/ i (4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-p henyl)-/V-eth- yl-/V-methyl formamidine (K.1.28), A/-[4-[[3-[(4-chlorophenyl)methyl]-1 ,2,4-thiadiazol-5-yl]- oxy]-2,5-dimethyl-phenyl]-/V-ethyl-/V-methyl-formamidine (K.1.29), A/’-(5-bromo-6-indan-2- yloxy-2-methyl-3-pyridyl)-/V-ethyl-/V-methyl-formamidine (K.1.30), A/ i [5-bromo-6-[1-(3,5-diflu- orophenyl)ethoxy]-2-methyl-3-pyridyl]-/V-ethyl-/V-methyl-for mamidine (K.1.31 ), A/’-[5-bromo-

6-(4-isopropylcyclohexoxy)-2-methyl-3-pyridyl]-/V-ethyl-/ V-methyl-formamidine (K.1.32), /V-[5-bromo-2-methyl-6-(1-phenylethoxy)-3-pyridyl]-/V-ethyl- /V-methyl-formamidine (K.1.33), /V-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy )-phenyl)-/V-ethyl-/V-methyl forma- midine (K.1.34), /V-(5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy) -phenyl)-/V-ethyl- /V-methyl formamidine (K.1.35), 2-(4-chloro-phenyl)-/V-[4-(3,4-dimethoxy-phenyl)-isoxazol- 5-yl]-2-prop-2-ynyloxy-acetamide (K.1.36), 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin- 3-yl]-pyridine (pyrisoxazole) (K.1.37), 3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazolidin-3 yl]- pyridine (K.1.38), 5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1 7-benzoimidazole (K.1.39), ethyl (2)-3-amino-2-cyano-3-phenyl-prop-2-enoate (K.1.40), picarbutrazox (K.1.41), pentyl /V-[6-[[(2)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino] oxymethyl]-2-pyridyl]carba- mate (K.1.42), but-3-ynyl /V-[6-[[(2)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino] oxyme- thyl]-2-pyridyl]carbamate (K.1.43), ipflufenoquin (K.1.44), quinofumelin (K.1.47), 2-(6-benzyl- 2-pyridyl)quinazoline (K.1.50), 2-[6-(3-fluoro-4-methoxy-phenyl)-5-methyl-2-pyridyl]quinazo- line (K.1.51), dichlobentiazox (K.1.52), A/ i (2,5-dimethyl-4-phenoxy-phenyl)-/V-ethyl-/V-me- thyl-formamidine (K.1.53), pyrifenamine (K.1.54);

L) Biopesticides

L1 ) Microbial pesticides with fungicidal, bactericidal, viricidal and/or plant defense activator activity: Ampelomyces quisqua/is, Aspergillus flavus, Aureobasidium pullulans, Bacillus a It it ud in is, B. amyloliquefaciens, B. megaterium, B. mojavensis, B. mycoides, B. pumi- ius, B. simplex, B. so/isa/si, B. subti/is, B. subti/is var. amy/o/iquefaciens, Candida oieo- phiia, C. saitoana, Cia vibacter michiganensis (bacteriophages), Coniothyrium minitans, Cryphonectria parasitica, Cryptococcus aibidus, Diiophosphora aiopecuri, Fusarium ox- ysporum, Cionostachys rosea f . catenulate (also named Giiociadium catenuiatum), Gii- ociadium roseum, Lysobacter antibioticus, L. enzymogenes, Metschnikowia fructicoia, Microdochium dimerum, Microsphaeropsis ochracea, Muscodor aibus, Paenibaciiius aivei, Paenibaciiius epiphyticus, P. poiymyxa, Pantoea vagans, Peniciiiium biiaiae, Ph/ebiopsis gig an tea, Pseudomonas sp., Pseudomonas chioraphis, Pseudozyma fioc- cuiosa, Pichia anomaia, Pythium oiigandrum, Sphaerodes mycoparasitica, Streptomy- ces griseoviridis, S. iydicus, S. vioiaceusniger, Taiaromyces fiavus, Trichoderma aspereiioides, T. aspereiium, T. atroviride, T. fertile, T. gamsii, T. harmatum, T. harzi- anum, T. poiysporum, T. stromaticum, T. virens, T. viride, Typhuia phacorrhiza, Uio- ciadium oudemansii, Verticiiiium dahlia, zucchini yellow mosaic virus (avirulent strain);

L2) Biochemical pesticides with fungicidal, bactericidal, viricidal and/or plant defense acti- vator activity: harpin protein, Reynoutria sachaiinensis extract;

L3) Microbial pesticides with insecticidal, acaricidal, molluscidal and/or nematicidal activity:

Agrobacterium radiobacter, Bacillus cereus, B. ffrmus, B. thuringiensis, B. thuringiensis ssp. aizawai, B. t. ssp. israeiensis, B. t. ssp. gaiieriae, B. t. ssp. kurstaki, B. t. ssp. tene- brionis, Beauveria bassiana, B. brongniartii, Burkhoideria spp., Chromobacterium sub- tsugae, Cydia pomoneiia granulovirus (CpGV), Cryptophiebia ieucotreta granulovirus (CrleGV), Fia vobacterium spp., Heiicoverpa armigera nucleopolyhedrovirus

(HearNPV), Heiicoverpa zea nucleopolyhedrovirus (HzNPV), Heiico verpa zea single capsid nucleopolyhedrovirus (HzSNPV), Heterorhabditis bacteriophora, isaria fumoso- rosea, Lecaniciiiium iongisporum, L. muscarium, Metarhizium anisopiiae, M. anisopiiae var. anisopiiae, M. anisopiiae var. acrid um, Nomuraea riieyi, Paeciiomyces fumosoro- seus, P. iiiacinus, Paenibaciiius popiHiae, Pasteuria s pp., P. nishizawae, P. penetrans, P. ramosa, P. thornea, P. usgae, Pseudomonas fiuorescens, Spodoptera iittoraiis nu- cleopolyhedrovirus (SpliNPV), Steinernema carpocapsae, S. feitiae, S. kraussei, Strep- tom yces g aibus, S. micro fiavus\

L4) Biochemical pesticides with insecticidal, acaricidal, molluscidal, pheromone and/or ne- maticidal activity: L-carvone, citral, (E,2)-7,9-dodecadien-1-yl acetate, ethyl formate, ( ,2)-2, 4-ethyl decadienoate (pear ester), Z,Z,E)-Ί ,l 1 ,13-hexadecatrienal, heptyl buty- rate, isopropyl myristate, lavanulyl senecioate, cis-jasmone, 2-methyl 1 -butanol, methyl eugenol, methyl jasmonate, (E,2)-2,13-octadecadien-1-ol, (E,2)-2,13-octadecadien-1-ol acetate, (E,2)-3,13-octadecadien-1-ol, (/?)-1 -octen-3-ol, pentatermanone,

(E,Z;2)-3,8,1 1 -tetradecatrienyl acetate, (Z;£)-9,12-tetradecadien-1 -yl acetate,

(2)-7-tetradecen-2-one, (2)-9-tetradecen-1-yl acetate, (2)-1 1-tetradecenal, (2)-1 1-tetra- decen-1-ol, extract of Chenopodium ambros/odes, Neem oil, Quillay extract;

L5) Microbial pesticides with plant stress reducing, plant growth regulator, plant growth pro- moting and/or yield enhancing activity: Azospiriiium amazonense, A. brasiiense, A. iipoferum, A. irakense, A. haiopraeferens, Bradyrhizobium spp., B. eikanii, B. japoni- cum, B. iiaoningense, B. iupini, Deiftia acidovorans, G/omus intraradices, Mesorhizo- bium spp., Rhizobium ieguminosarum bv. phaseoii, R. i. bv. trifoiii, R. i. bv. viciae, R. tropici, Sinorhizobium meh!oti,

M) Growth regulators

abscisic acid (M.1.1), amidochlor, ancymidol, 6-benzylaminopurine, brassinolide, butralin, chlormequat, chlormequat chloride, choline chloride, cyclanilide, daminozide, dikegulac, dime- thipin, 2,6-dimethylpuridine, ethephon, flumetralin, flurprimidol, fluthiacet, forchlorfenuron, gib- berellic acid, inabenfide, indole-3-acetic acid , maleic hydrazide, mefluidide, mepiquat, mepiquat chloride, naphthaleneacetic acid, /V-6-benzyladenine, paclobutrazol, prohexadione, prohexadi- one-calcium, prohydrojasmon, thidiazuron, triapenthenol, tributyl phosphorotrithioate,

2,3,5-tri-iodobenzoic acid , trinexapac-ethyl, uniconazole;

N) Herbicides from classes N.1 to N.15

N.1 Lipid biosynthesis inhibitors: alloxydim, alloxydim-sodium, butroxydim, clethodim,

clodinafop, clodinafop-propargyl, cycloxydim, cyhalofop, cyhalofop-butyl, diclofop, diclofop- methyl, fenoxaprop, fenoxaprop-ethyl, fenoxaprop-P, fenoxaprop-P-ethyl, fluazifop, fluazifop- butyl, fluazifop-P, fluazifop-P-butyl, haloxyfop, haloxyfop-methyl, haloxyfop-P, haloxyfop-P- methyl, metamifop, pinoxaden, profoxydim, propaquizafop, quizalofop, quizalofop-ethyl, quizalofop-tefuryl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, sethoxydim, tepra- loxydim, tralkoxydim, 4-(4'-chloro-4-cyclo ~, propyl-2'-fluoro[1 ,1 '-biphenyl]-3-yl)-5-hydroxy- 2,2,6,6-tetramethyl-2 Apyran-3(6A)-one (1312337-72-6); 4-(2',4'-dichloro-4-cyclopropyl[1 ,1'- biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2 Apyran-3(6 A)-one (1312337-45-3);

4-(4'-chloro-4-ethyl-2'-fluoro[1 ,1'-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2A/-pyran- 3(6A)-one (1033757-93-5); 4-(2',4'-dichloro-4-ethyl[1 ,1 '-biphenyl]-3-yl)-2,2,6,6-tetramethyl- 2 Apyran-3,5(4 A/,6 A)-dione (1312340-84-3); 5-(acetyloxy)-4-(4'-chloro-4-cyclopropyl-2'- fluoro[1 ,1'-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2A -pyran-3-one (1312337-48-6);

5-(acetyloxy)-4-(2 ' ,4'-dichloro-4-cyclopropyl- [1 ,1 '-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetra- methyl-2A -pyran-3-one; 5-(acetyloxy)-4-(4'-chloro-4-ethyl-2'-fluoro[1 ,1 '-biphenyl]-3-yl)-3,6-di- hydro-2,2,6,6-tetramethyl-2A/-pyran-3-one (1312340-82-1); 5-(acetyloxy)-4-(2',4'-dichloro-4- ethyl[1 ,1 '-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2A -pyran-3-one (1033760-55-2); 4- (4'-chloro-4-cyclopropyl-2'-fluoro[1 ,1 '-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo- 2 Apyran-3-yl carbonic acid methyl ester (1312337-51-1 ); 4-(2 ' ,4'-dichloro -4-cyclopropyl- [1 ,1 '-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2A/- pyran-3-yl carbonic acid me- thyl ester; 4-(4'-chloro-4-ethyl-2'-fluoro[1 ,1 '-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5- oxo-2 A -pyran-3-yl carbonic acid methyl ester (1312340-83-2); 4-(2',4'-dichloro-4-ethyh[1 ,1'- biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2A -pyran-3-yl carbonic acid methyl es- ter (1033760-58-5); benfuresate, butylate, cycloate, dalapon, dimepiperate, EPTC, espro- carb, ethofumesate, flupropanate, molinate, orbencarb, pebulate, prosulfocarb, TCA, thio- bencarb, tiocarbazil, triallate, vernolate;

N.2 ALS inhibitors: amidosulfuron, azimsulfuron, bensulfuron, bensulfuron-methyl, chlorimuron, chlorimuron-ethyl, chlorsulfuron, cinosulfuron, cyclosulfamuron, ethametsulfuron, ethamet- sulfuron-methyl, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, flupyrsulfuron- methyl-sodium, foramsulfuron, halosulfuron, halosulfuron-methyl, imazosulfuron, iodosulfu- ron, iodosulfuron-methyl-sodium, iofensulfuron, iofensulfuron-sodium, mesosulfuron, meta- zosulfuron, metsulfuron, metsulfuron-methyl, nicosulfuron, orthosulfamuron, oxasulfuron, primisulfuron, primisulfuron-methyl, propyrisulfuron, prosulfuron, pyrazosulfuron, pyrazosul- furon-ethyl, rimsulfuron, sulfometuron, sulfometuron-methyl, sulfosulfuron, thifensulfuron, thifensulfuron-methyl, triasulfuron, tribenuron, tribenuron-methyl, trifloxysulfuron, triflusulfu- ron, triflusulfuron-methyl, tritosulfuron, imazamethabenz, imazamethabenz-methyl, imaza- mox, imazapic, imazapyr, imazaquin, imazethapyr; cloransulam, cloransulam-methyl, diclo- sulam, flumetsulam, florasulam, metosulam, penoxsulam, pyrimisulfan, pyroxsulam; bispyri- bac, bispyribac-sodium, pyribenzoxim, pyriftalid, pyriminobac, pyriminobac-methyl, pyrithio- bac, pyrithiobac-sodium, 4-[[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]methyl]amino ]-ben- zoic acid-1 -methyhethyl ester (420138-41-6), 4-[[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phe- nyllTnethyllaminol-benzoic acid propyl ester (420138-40-5), /V-(4-bromophenyl)-2-[(4,6-di- methoxy-2-pyrimidinyl)oxy]benzenemethanamine (420138-01-8); flucarbazone, flucarba- zone-sodium, propoxycarbazone, propoxycarbazone-sodium, thiencarbazone, thiencarba- zone-methyl; triafamone;

N.3 Photosynthesis inhibitors: amicarbazone; chlorotriazine; ametryn, atrazine, chloridazone, cyanazine, desmetryn, dimethametryn,hexazinone, metribuzin, prometon, prometryn, pro- pazine, simazine, simetryn, terbumeton, terbuthylazin, terbutryn, trietazin; chlorobromuron, chlorotoluron, chloroxuron, dimefuron, diuron, fluometuron, isoproturon, isouron, linuron, metamitron, methabenzthiazuron, metobenzuron, metoxuron, monolinuron, neburon, sidu- ron, tebuthiuron, thiadiazuron, desmedipham, karbutilat, phenmedipham, phenmedipham- ethyl, bromofenoxim, bromoxynil and its salts and esters, ioxynil and its salts and esters, bromacil, lenacil, terbacil, bentazon, bentazon-sodium, pyridate, pyridafol, pentanochlor, pro- panil; diquat, diquat-dibromide, paraquat, paraquat-dichloride, paraquat-dimetilsulfate;

N.4 protoporphyrinogen-IX oxidase inhibitors: acifluorfen, acifluorfen-sodium, azafenidin, ben- carbazone, benzfendizone, bifenox, butafenacil, carfentrazone, carfentrazone-ethyl, chlor- methoxyfen, cinidon-ethyl, fluazolate, flufenpyr, flufenpyr-ethyl, flumiclorac, flumiclorac-pen- tyl, flumioxazin, fluoroglycofen, fluoroglycofen-ethyl, fluthiacet, fluthiacet-methyl, fomesafen, halosafen, lactofen, oxadiargyl, oxadiazon, oxyfluorfen, pentoxazone, profluazol, pyraclonil, pyraflufen, pyraflufen-ethyl, saflufenacil, sulfentrazone, thidiazimin, tiafenacil, trifludimoxazin, ethyl [3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-diox o-1 ,2,3,4-tetrahydropyrimi- din-3-yl)phenoxy]-2-pyridyloxy]acetate (353292-31-6), /V-ethyl-3-(2,6-dichloro-4-trifluoro- methylphenoxy)-5-methyl-1 A/-pyrazole-1 -carboxamide (452098-92-9), /V-tetrahydrofurfuryl- 3-(2,6-dichloro-4-trifluoromethylphenoxy)-5-methyl-1 A/-pyrazole-1 -carboxamide (915396-43- 9), /V-ethyl-3-(2-chloro-6-fluoro-4-trifluoromethyhphenoxy)-5-me thyl-1 A/-pyrazole-1-carbox- amide (452099-05-7), /V-tetrahydro , furfuryl-3-(2-chloro-6-fluoro-4-trifluoro -, methylphenoxy)- 5-methyl-1 A/-pyrazole-1 -carboxamide (452100-03-7), 3-[7-fluoro-3-oxo-4-(prop-2-ynyl)-

3.4-dihydro-2A -benzo[1 ,4]oxazin-6-yl]-1 ,5-dimethyl-6-thioxo-[1 ,3,5]triazinan-2,4-dione (451484-50-7), 2-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2A -benzo[1 ,4]oxazin-6-yl)- 4,5,6,7-tetrahydro-isoindole-1 ,3-dione (13001 18-96-0), 1 -methyl-e-trifluoroTnethyl- 3-(2,2,7-tri-fluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2A -benzo[1 ,4]oxazin-6-yl)-1 7-pyrimidine-

2.4-dione (13041 13-05-0), methyl (£)-4-[2-chloro-5-[4-chloro-5-(difluoromethoxy)-1 7-methyl- pyrazol-3-yl]-4-fluoro-phenoxy]-3-methoxy-but-2-enoate (948893-00-3), 3-[7-chloro-5-fluoro- 2-(trifluoromethyl)-1 A -benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)-1 A -pyrimidine-2,4-di- one (212754-02-4); N.5 Bleacher herbicides: beflubutamid, diflufenican, fluridone, flurochloridone, flurtamone, norflurazon, picolinafen, 4-(3-trifluoromethyhphenoxy)-2-(4-trifluoromethylphenyl)pyri midine (180608-33-7); benzobicyclon, benzofenap, bicyclopyrone, clomazone, fenquintrione, isoxaflutole, mesotrione, pyrasulfotole, pyrazolynate, pyrazoxyfen, sulcotrione, tefuryltrione, tembotrione, tolpyralate, topramezone; aclonifen, amitrole, flumeturon;

N.6 EPSP synthase inhibitors: glyphosate, glyphosate-isopropylammonium, glyposate-potas- sium, glyphosate-trimesium (sulfosate);

N.7 Glutamine synthase inhibitors: bilanaphos (bialaphos), bilanaphos-sodium, glufosinate, glufosinate-P, glufosinate-ammonium;

N.8 DHP synthase inhibitors: asulam;

N.9 Mitosis inhibitors: benfluralin, butralin, dinitramine, ethalfluralin, fluchloralin, oryzalin, pendi- methalin, prodiamine, trifluralin; amiprophos, amiprophos-methyl, butamiphos; chlorthal, chlorthal-dimethyl, dithiopyr, thiazopyr, propyzamide, tebutam; carbetamide, chlorpropham, flamprop, flamprop-isopropyl, flamprop-methyl, flamprop-M-isopropyl, flamprop-M-methyl, propham;

N.10 VLCFA inhibitors: acetochlor, alachlor, butachlor, dimethachlor, dimethenamid, dimethena- mid-P, metazachlor, metolachlor, metolachlor-S, pethoxamid, pretilachlor, propachlor, prop- isochlor, thenylchlor, flufenacet, mefenacet, diphenamid, naproanilide, napropamide, napro- pamide-M, fentrazamide, anilofos, cafenstrole, fenoxasulfone, ipfencarbazone, piperophos, pyroxasulfone, isoxazoline compounds of the formulae 11.1 , II.2, II.3, II.4, II.5, II.6, II.7, II.8 and II.9

II.6 II.7

N.1 1 Cellulose biosynthesis inhibitors: chlorthiamid, dichlobenil, flupoxam, indaziflam, isoxaben, triaziflam, 1 -cyclohexyl-5-pentafluorphenyloxy-14-[1 ,2,4,6]thiatriazin-3-ylamine (175899-01- 1 );

N.12 Decoupler herbicides: dinoseb, dinoterb, DNOC and its salts;

N.13 Auxinic herbicides: 2,4-D and its salts and esters, clacyfos, 2,4-DB and its salts and es- ters, aminocyclopyrachlor and its salts and esters, aminopyralid and its salts such as amino- pyralid-dimethylammonium, aminopyralid-tris(2-hydroxypropyl)ammonium and its esters, benazolin, benazolin-ethyl, chloramben and its salts and esters, clomeprop, clopyralid and its salts and esters, dicamba and its salts and esters, dichlorprop and its salts and esters, dichlorprop-P and its salts and esters, fluroxypyr, fluroxypyr-butometyl, fluroxypyr-meptyl, halauxifen and its salts and esters (943832-60-8); MCPA and its salts and esters, MCPA- thioethyl, MCPB and its salts and esters, mecoprop and its salts and esters, mecoprop-P and its salts and esters, picloram and its salts and esters, quinclorac, quinmerac, TBA (2,3,6) and its salts and esters, triclopyr and its salts and esters, 4-amino-3-chloro- 6-(4-chloro-2-fluoro-3-methoxyphenyl)-5-fluoropyridine-2-car boxylic acid, benzyl 4-amino- 3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-5-fluoropyrid ine-2-carboxylate (1390661 -72- 9);

N.14 Auxin transport inhibitors: diflufenzopyr, diflufenzopyr-sodium, naptalam, naptalam- sodium;

N.15 Other herbicides: bromobutide, chlorflurenol, chlorflurenol-methyl, cinmethylin, cumyluron, cyclopyrimorate (499223-49-3) and its salts and esters, dalapon, dazomet, difenzoquat, di- fenzoquat-metilsulfate, dimethipin, DSMA, dymron, endothal and its salts, etobenzanid, flu- renol, flurenol-butyl, flurprimidol, fosamine, fosamine-ammonium, indanofan, maleic hydra- zide, mefluidide, metam, methiozolin (403640-27-7), methyl azide, methyl bromide, methyl- dymron, methyl iodide, MSMA, oleic acid, oxaziclomefone, pelargonic acid, pyributicarb, quinoclamine, tridiphane;

O) Insecticides from classes 0.1 to 0.29

O.1 Acetylcholine esterase (AChE) inhibitors: aldicarb, alanycarb, bendiocarb, benfuracarb, bu- tocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb, triazamate; acephate, aza- methiphos, azinphos-ethyl, azinphosmethyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/ DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl O-(methoxyaminothio-phosphoryl) salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion, parathion-methyl, phenthoate, phorate, phosa- lone, phosmet, phosphamidon, phoxim, pirimiphos- methyl, profenofos, propetamphos, pro- thiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon, vamidothion;

0.2 GABA-gated chloride channel antagonists: endosulfan, chlordane; ethiprole, fipronil,

flufiprole, pyrafluprole, pyriprole;

0.3 Sodium channel modulators: acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, kappa-bifenthrin, bioallethrin, bioallethrin S-cylclopentenyl, bioresmethrin, cyclo- prothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cy- permethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, etofenprox, fenpropathrin, fen- valerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, heptafluthrin, imiprothrin, me- perfluthrin, metofluthrin, momfluorothrin, epsilon-momfluorothrin, permethrin, phenothrin, prallethrin, profluthrin, pyrethrin (pyrethrum), resmethrin, silafluofen, tefluthrin, kappa-tefluth- rin, tetramethylfluthrin, tetramethrin, tralomethrin, transfluthrin; DDT, methoxychlor;

0.4 Nicotinic acetylcholine receptor agonists (nAChR): acetamiprid, clothianidin, cycloxaprid, dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam; 4,5-dihydro-/V-nitro- 1-(2-oxiranylmethyl)-1 A/-imidazol-2-amine, (2£)-1-[(6-chloropyridin-3-yl)methyl]-/V’-nitro-2- pentylidenehydrazinecarboximidamide; 1-[(6-chloropyridin-3-yl)methyl]-7-methyl-8-nitro-5- propoxy-1 ,2,3,5,6,7-hexahydroimidazo[1 ,2-a]pyridine; nicotine; sulfoxaflor, flupyradifurone, triflumezopyrim;

0.5 Nicotinic acetylcholine receptor allosteric activators: spinosad, spinetoram;

0.6 Chloride channel activators: abamectin, emamectin benzoate, ivermectin, lepimectin, milbe- mectin;

0.7 Juvenile hormone mimics: hydroprene, kinoprene, methoprene; fenoxycarb, pyriproxyfen;

0.8 miscellaneous non-specific (multi-site) inhibitors: methyl bromide and other alkyl halides; chloropicrin, sulfuryl fluoride, borax, tartar emetic;

0.9 Chordotonal organ TRPV channel modulators: pymetrozine, pyrifluquinazon; flonicamid;

0.10 Mite growth inhibitors: clofentezine, hexythiazox, diflovidazin; etoxazole;

0.11 Microbial disruptors of insect midgut membranes: Bacillus thuringiensis, Bacillus sphaeri- cus and the insecticdal proteins they produce: Bacillus thuringiensis subsp. israe/ensis, Ba cillus sphaericus, Bacillus thuringiensis subsp. aizawai, Bacillus thuringiensis subsp.

kurstaki, Bacillus thuringiensis subsp. tenebrionis, the Bt crop proteins: CrylAb, CrylAc, Cryl Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34/35Ab1 ;

0.12 Inhibitors of mitochondrial ATP synthase: diafenthiuron; azocyclotin, cyhexatin, fenbutatin oxide, propargite, tetradifon;

0.13 Uncouplers of oxidative phosphorylation via disruption of the proton gradient: chlorfenapyr, DNOC, sulfluramid;

0.14 Nicotinic acetylcholine receptor (nAChR) channel blockers: bensultap, cartap hydrochlo- ride, thiocyclam, thiosultap sodium;

0.15 Inhibitors of the chitin biosynthesis type 0: bistrifluron, chlorfluazuron, diflubenzuron, flu- cycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, triflu muron; 0.16 Inhibitors of the chitin biosynthesis type 1 : buprofezin;

0.17 Moulting disruptors: cyromazine;

0.18 Ecdyson receptor agonists: methoxyfenozide, tebufenozide, halofenozide, fufenozide, chromafenozide;

0.19 Octopamin receptor agonists: amitraz;

0.20 Mitochondrial complex III electron transport inhibitors: hydramethylnon, acequinocyl,

fluacrypyrim, bifenazate;

0.21 Mitochondrial complex I electron transport inhibitors: fenazaquin, fenpyroximate, pyrim- idifen, pyridaben, tebufenpyrad, tolfenpyrad; rotenone;

0.22 Voltage-dependent sodium channel blockers: indoxacarb, metaflumizone, 2-[2-(4-cyano- phenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-/V-[4-(difl uoromethoxy)phenyl]-hydrazinecar- boxamide, /V-(3-chloro-2-methylphenyl)-2-[(4-chlorophenyl)-[4-[methyl( methylsulfonyl)- amino]phenyl]methylene]-hydrazinecarboxamide;

0.23 Inhibitors of the of acetyl CoA carboxylase: spirodiclofen, spiromesifen, spirotetramat, spi- ropidion;

0.24 Mitochondrial complex IV electron transport inhibitors: aluminium phosphide, calcium

phosphide, phosphine, zinc phosphide, cyanide;

0.25 Mitochondrial complex II electron transport inhibitors: cyenopyrafen, cyflumetofen;

0.26 Ryanodine receptor-modulators: flubendiamide, chlorantraniliprole, cyantraniliprole, cycla- niliprole, tetraniliprole; (A -3-chloro-/V l -{2-methyl-4-[1 ,2,2,2 -tetrafluoro-l-(trifluoromethyl)- ethyl]phenyl}-A e -(1-methyl-2-methylsulfonylethyl)phthalamide, (S)-3-chloro-/V-{2-methyl- 4-[1 ,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-A e -(1-methyl-2-methylsulfonylethyl)- phthalamide, methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)- 1 A/-pyrazol-5-yl]- carbonyl}amino)benzoyl]-1 ,2-dimethylhydrazinecarboxylate; A [4,6-dichloro-2-[(diethyl- lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyri dyl)-5-(trifluoromethyl)pyrazole- 3-carboxamide; /V-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6 -methyl-phenyl]- 2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxa mide; /V-[4-chloro-2-[(di-2-propyl- lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chlo ro-2-pyridyl)-5-(trifluorometh- yl)pyrazole-3-carboxamide; /V-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carb a- moyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyra zole-3-carboxamide; /V-[4,6-dibro- mo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-( 3-chloro-2-pyridyl)-5-(trifluoro- methyl)pyrazole-3-carboxamide; /V-[2-(5-amino-1 ,3,4-thiadiazol-2-yl)-4-chloro-6-methylphe- nyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1 A/-pyrazole-5-carboxamide; 3-chloro-1-(3-chloro-2-pyr- idinyl)- AA[2,4-dichloro-6-[[(1 -cyano-1 -methylethyl)amino]carbonyl]phenyl]-1 A/-pyrazole-5-car- boxamide; 3-bromo-/V-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-1-(3,5-d ichloro-2-pyridyl)- 1 A -pyrazole-5-carboxamide; /V-[4-chloro-2-[[(1 ,1-dimethylethyl)amino]carbonyl]-6-meth- ylphenyl]-1 -(3-chloro-2-pyridinyl)-3-(fluoromethoxy)-1 A -pyrazole-5-carboxamide; cyhalodi- amide;

0.27: Chordotonal organ Modulators - undefined target site: flonicamid;

0.28. insecticidal active compounds of unknown or uncertain mode of action: afidopyropen, afoxolaner, azadirachtin, amidoflumet, benzoximate, broflanilide, bromopropylate, chinome- thionat, cryolite, dicloromezotiaz, dicofol, flufenerim, flometoquin, fluensulfone, fluhexafon, fluopyram, fluralaner, metoxadiazone, piperonyl butoxide, pyflubumide, pyridalyl, tioxazafen, 1 1 -(4-chloro-2,6-dimethylphenyl)-12-hydroxy- 1 ,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-1 1-en- 10-one, 3-(4’-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1 -azaspiro[4.5]dec-3-en-

2-one, 1 -[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl ]-3-(trifluoromethyl)-

1 A -1 ,2,4-triazole-5-amine, Bacillus flrmus 1-1582; flupyrimin; fluazaindolizine; 4-[5-(3,5-di- chlorophenyl)-5-(trifluoromethyl)-4A -isoxazol-3-yl]-2-methyl-/V-(1-oxothietan-3-yl)benzamide; fluxametamide; 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]- 1 AZ-pyrazole; 4-cyano-/V-[2-cyano-5-[[2,6-dibromo-4-[1 ,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phen- yl]carbamoyl]phenyl]-2-methyl-benzamide; 4-cyano-3-[(4-cyano-2-methyl-benzoyl)amino]- /V-[2,6-dichloro-4-[1 ,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]-2-fl uoro-benz- amide; /V-[5-[[2-chloro-6-cyano-4-[1 ,2,2,3,3,3-hexafluoro-1 -(trifluoromethyl)propyl]phenyl]car- bamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; /V-[5-[[2-bromo-6-chloro-4-[2,2,2-tri- fluoro-1 -hydroxy-1 -(trifluoromethyl)ethyl]phenyl]carbamoyl]-2-cyano-phenyl]-4- cyano-2-me- thyl-benzamide; /V-[5-[[2-bromo-6-chloro-4-[1 ,2,2,3,3,3-hexafluoro-1 -(trifluoromethyl)pro- pyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benza mide; 4-cyano-/V-[2-cyano-5- [[2,6-dichloro-4-[1 ,2,2,3,3,3-hexafluoro-1 -(trifluoromethyl)propyl]phenyl]carbamoyl]phenyl]-2- methyl-benzamide; 4-cyano-/V-[2-cyano-5-[[2,6-dichloro-4-[1 ,2,2,2-tetrafluoro-1-(trifluorome- thyl)ethyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; /V-[5-[[2-bromo-6-chloro-4-[1 , 2,2,2- tetrafluoro-1 -(trifluoromethyl)ethyl]phenyl]carbamoyl]-2-cyano-phenyl]-4- cyano-2-methyl-ben- zamide; 2-(1 ,3-dioxan-2-yl)-6-[2-(3-pyridinyl)-5-thiazolyl]-pyridine; 2-[6-[2-(5-fluoro-3-pyridi- nyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine; 2-[6-[2-(3-pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimi- dine; /V-methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-ca rboxamide; /V-methylsulfonyl- 6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide; 1 -[(6-chloro-3-pyridinyl)methyl]- 1 ,2,3,5,6,7-hexahydro-5-methoxy-7-methyl-8-nitro-imidazo[1 ,2-a]pyridine; 1 -[(6-chloropyridin-

3-yl)methyl]-7-methyl-8-nitro-1 ,2,3,5,6,7-hexahydroimidazo[1 ,2-a]pyridin-5-ol; 1-isopropyl- A/,5-dimethyl-/V-pyridazin-4-yl-pyrazole-4-carboxamide; 1 -(1 ,2-dimethylpropyl)-/V-ethyl-5-me- thyl-/V-pyridazin-4-yl-pyrazole-4-carboxamide; /V,5-dimethyl-AApyridazin-4-yl-1 -(2,2,2-tri- fluoro-1-methyl-ethyl)pyrazole-4-carboxamide; 1 -[1-(1-cyanocyclopropyl)ethyl]-/V-ethyl-5-me- thyl-/V-pyridazin-4-yl-pyrazole-4-carboxamide; /V-ethyl-1-(2-fluoro-1-methyl-propyl)-5-meth-yl- /V-pyridazin-4-yl-pyrazole-4-carboxamide; 1 -(1 ,2-dimethylpropyl)-/V,5-dimethyl-/V-pyridazin-4- yl-pyrazole-4-carboxamide; 1 -[1-(1-cyanocyclopropyl)ethyl]-/V,5-dimethyl-/V-pyridazin-4- yl- pyrazole-4-carboxamide; /V-methyl-1-(2-fluoro-1 -methyl-propyl]-5-methyl-/V-pyridazin-4-yl-py- razole-4-carboxamide; 1 -(4,4-difluorocyclohexyl)-/V-ethyl-5-methyl-/V-pyridazin-4-y l-pyrazole-

4-carboxamide; 1 -(4,4-difluorocyclohexyl)-/V,5-dimethyl-/V-pyridazin-4-yl-py razole-4-carbox- amide, /V-(1-methylethyl)-2-(3-pyridinyl)-2A -indazole-4-carboxamide; /V-cyclopropyl-2-(3-pyri- dinyl)-2A -indazole-4-carboxamide; /V-cyclohexyl-2-(3-pyridinyl)-2A/-indazole-4-carboxamide; 2-(3-pyridinyl)-/V-(2,2,2-trifluoroethyl)-2A -indazole-4-carboxamide; 2-(3-pyridinyl)- AA[(tetrahy- dro-2-furanyl)methyl]-2A -indazole-5-carboxamide; methyl 2-[[2-(3-pyridinyl)-2A/-indazol-5- yl]carbonyl]hydrazinecarboxylate; /V-[(2,2-difluorocyclopropyl)methyl]-2-(3-pyridinyl)-2A -inda- zole-5-carboxamide; /V-(2,2-difluoropropyl)-2-(3-pyridinyl)-2A -indazole-5-carboxamide; 2-(3- pyridinyl )-/V-(2-pyrimidinylmethyl )-2A -indazole-5-carboxamide; /V-[(5-methyl-2-pyrazinyl)me- thyl]-2-(3-pyridinyl)-2A/-indazole-5-carboxamide, tyclopyrazoflor; sarolaner, lotilaner,

/V-[4-chloro-3-[[(phenylmethyl)amino]carbonyl]phenyl]-1-m ethyl-3-(1 , 1 ,2,2, 2-pentafluoro- ethyl)-4-(trifluoromethyl)-1 A -pyrazole-5-carboxamide; M. UN.22a 2-(3-ethylsulfonyl-2-pyridyl)- 3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridine, 2-[3-ethylsulfonyl-5-(trifluoromethyl)-2- pyridyl]-3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridine, 4-[5-(3,5-dichlorophenyl)-5-(trifluo- romethyl)-4A -isoxazol-3-yl]-/V-[(4A -2-ethyl-3-oxo-isoxazolidin-4-yl]-2-methyl-benzamide,

4-[5-(3,5-dichloro-4-fluoro-phenyl)-5-(trifluoromethyl)-4 A -isoxazol-3-yl]-/V-[(4A -2-ethyl-3-oxo- isoxazolidin-4-yl]-2-methyl-benzamide; /V-[4-chloro-3-(cyclopropylcarbamoyl)phenyl]-2-me- thyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3-carbo xamide, /V-[4-chloro-3- [(1-cyanocyclopropyl)carbamoyl]phenyl]-2-methyl-5-(1 , 1 ,2,2, 2-pentafluoroethyl)-4-(trifluoro- methyl)pyrazole-3-carboxamide; acynonapyr; benzpyrimoxan; chloro-/V-(1-cyanocyclopro- pyl)-5-[1-[2-methyl-5-(1 , 1 ,2,2, 2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]pyrazol- 4- yl]benzamide, oxazosulfyl, [(25,3/?,4/?,55,65)-3,5-dimethoxy-6-methyl-4-propoxy-tetrahy dro- pyran-2-yl]-/V-[4-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]phenyl]carbamate,

[(25,3/?,4/?,55,6S)-3,4,5-trimethoxy-6-methyl-tetrahydropyra n-2-yl] N-[4-[1-[4-(trifluorometh- oxy)phenyl]-1 ,2,4-triazol-3-yl]phenyl]carbamate, [(25,3/?,4/?,55,65)-3,5-dimethoxy-6-methyl- 4-propoxy-tetrahydropyran-2-yl]-/V-[4-[1-[4-(1 ,1 ,2,2,2-pentafluoroethoxy)phenyl]-1 ,2,4-triazol- 3-yl]phenyl]carbamate, [(25,3/?,4/?,55,6S)-3,4,5-trimethoxy-6-methyl-tetrahydropyra n-2-yl]- /V-[4-[1-[4-(1 ,1 ,2,2,2-pentafluoroethoxy)phenyl]-1 ,2,4-triazol-3-yl]phenyl]carbamate, (22)-3-(2- isopropylphenyl)-2-[(£)-[4-[1-[4-(1 ,1 ,2,2,2-pentafluoroethoxy)phenyl]-1 ,2,4-triazol-3-yl]phe- nyl]methylenehydrazono]thiazolidin-4-one.

a

The active substances referred to as component 2, their preparation and their activity e. g. against harmful fungi is known (cf.: http://www.alanwood.net/pesticides/); these substances are commercially available. The compounds described by IUPAC nomenclature, their preparation and their pesticidal activity are also known (cf. Can. J. Plant Sci. 48(6), 587-94, 1968;

EP-A 141 317; EP-A 152 031 ; EP-A 226 917; EP-A 243 970; EP-A 256 503; EP-A 428 941 ; EP-A 532 022; EP-A 1 028 125; EP-A 1 035 122; EP-A 1 201 648; EP-A 1 122 244,

JP 2002316902; DE 19650197; DE 10021412; DE 102005009458; US 3,296,272;

US 3,325,503; WO 98/46608; WO 99/14187; WO 99/24413; WO 99/27783; WO 00/29404;

WO 00/46148; WO 00/65913; WO 01/54501 ; WO 01/56358; WO 02/22583; WO 02/40431 ;

WO 03/10149; WO 03/11853; WO 03/14103; WO 03/16286; WO 03/53145; WO 03/61388;

WO 03/66609; WO 03/74491 ; WO 04/49804; WO 04/83193; WO 05/120234; WO 05/123689; WO 05/123690; WO 05/63721 ; WO 05/87772; WO 05/87773; WO 06/15866; WO 06/87325;

WO 06/87343; WO 07/82098; WO 07/90624, WO 10/139271 , WO 1 1/028657, WO 12/168188, WO 07/006670, WO 11/77514; WO 13/047749, WO 10/069882, WO 13/047441 , WO 03/16303, WO 09/90181 , WO 13/007767, WO 13/010862, WO 13/127704, WO 13/024009, WO 13/24010, WO 13/047441 , WO 13/162072, WO 13/092224, WO 1 1/135833, CN 1907024, CN 1456054,

CN 103387541 , CN 1309897, WO 12/84812, CN 1907024, WO 09094442, WO 14/60177,

WO 13/116251 , WO 08/013622, WO 15/65922, WO 94/01546, EP 2865265, WO 07/129454, WO 12/165511 , WO 11/081 174, WO 13/47441). Some compounds are identified by their CAS Registry Number which is separated by hyphens into three parts, the first consisting from two up to seven digits, the second consisting of two digits, and the third consisting of a single digit.

The present invention furthermore relates to agrochemical compositions comprising a mix- ture of at least one compound I (component 1) and at least one further active substance useful for plant protection, e. g. selected from the groups A) to O) (component 2), in particular one fur- ther fungicide, e. g. one or more fungicide from the groups A) to K), as described above, and if desired one suitable solvent or solid carrier. Those mixtures are of particular interest, since many of them at the same application rate show higher efficiencies against harmful fungi. Fur- thermore, combating harmful fungi with a mixture of compounds I and at least one fungicide from groups A) to K), as described above, is more efficient than combating those fungi with indi- vidual compounds I or individual fungicides from groups A) to K).

By applying compounds I together with at least one active substance from groups A) to O) a synergistic effect can be obtained, i.e. more then simple addition of the individual effects is ob- tained (synergistic mixtures).

This can be obtained by applying the compounds I and at least one further active substance simultaneously, either jointly (e. g. as tank-mix) or seperately, or in succession, wherein the time interval between the individual applications is selected to ensure that the active substance ap- plied first still occurs at the site of action in a sufficient amount at the time of application of the further active substance(s). The order of application is not essential for working of the present invention.

When applying compound I and a pesticide II sequentially the time between both applications may vary e. g. between 2 hours to 7 days. Also a broader range is possible ranging from 0.25 hour to 30 days, preferably from 0.5 hour to 14 days, particularly from 1 hour to 7 days or from 1.5 hours to 5 days, even more preferred from 2 hours to 1 day. In case of a mixture comprising a pesticide II selected from group L), it is preferred that the pesticide II is applied as last treat- ment.

According to the invention, the solid material (dry matter) of the biopesticides (with the ex- ception of oils such as Neem oil) are considered as active components (e. g. to be obtained af- ter drying or evaporation of the extraction or suspension medium in case of liquid formulations of the microbial pesticides).

In accordance with the present invention, the weight ratios and percentages used herein for a biological extract such as Quillay extract are based on the total weight of the dry content (solid material) of the respective extract(s).

The total weight ratios of compositions comprising at least one microbial pesticide in the form of viable microbial cells including dormant forms, can be determined using the amount of CFU of the respective microorganism to calculate the total weight of the respective active component with the following equation that 1 x 10 10 CFU equals one gram of total weight of the respective active component. Colony forming unit is measure of viable microbial cells, in particular fungal and bacterial cells. In addition, here“CFU” may also be understood as the number of (juvenile) individual nematodes in case of (entomopathogenic) nematode biopesticides, such as

Steinernema feltiae.

In the binary mixtures and compositions according to the invention the weight ratio of the component 1) and the component 2) generally depends from the properties of the active com- ponents used, usually it is in the range of from 1 :10,000 to 10,000:1 , often it is in the range of from 1 :100 to 100:1 , regularly in the range of from 1 :50 to 50:1 , preferably in the range of from 1 :20 to 20:1 , more preferably in the range of from 1 :10 to 10:1 , even more preferably in the range of from 1 :4 to 4:1 and in particular in the range of from 1 :2 to 2:1. According to further embodiments of the binary mixtures and compositions, the weight ratio of the component 1 ) and the component 2) usually is in the range of from 1000:1 to 1 :1 , often in the range of from 100: 1 to 1 :1 , regularly in the range of from 50:1 to 1 :1 , preferably in the range of from 20:1 to 1 :1 , more preferably in the range of from 10:1 to 1 :1 , even more preferably in the range of from 4:1 to 1 :1 and in particular in the range of from 2:1 to 1 :1 .

According to further embodiments of the mixtures and compositions, the weight ratio of the component 1 ) and the component 2) usually is in the range of from 20,000:1 to 1 :10, often in the range of from 10,000:1 to 1 :1 , regularly in the range of from 5,000:1 to 5:1 , preferably in the range of from 5,000:1 to 10:1 , more preferably in the range of from 2,000:1 to 30:1 , even more preferably in the range of from 2,000:1 to 100:1 and in particular in the range of from 1 ,000:1 to 100:1.

According to a further embodiments of the binary mixtures and compositions, the weight ratio of the component 1 ) and the component 2) usually is in the range of from 1 :1 to 1 :1000, often in the range of from 1 :1 to 1 :100, regularly in the range of from 1 :1 to 1 :50, preferably in the range of from 1 :1 to 1 :20, more preferably in the range of from 1 :1 to 1 :10, even more preferably in the range of from 1 :1 to 1 :4 and in particular in the range of from 1 :1 to 1 :2.

According to further embodiments of the mixtures and compositions, the weight ratio of the component 1 ) and the component 2) usually is in the range of from 10:1 to 1 :20,000, often in the range of from 1 :1 to 1 :10,000, regularly in the range of from 1 :5 to 1 :5,000, preferably in the range of from 1 :10 to 1 :5,000, more preferably in the range of from 1 :30 to 1 :2,000, even more preferably in the range of from 1 :100 to 1 :2,000 to and in particular in the range of from 1 :100 to 1 :1 ,000.

In the ternary mixtures, i.e. compositions according to the invention comprising the compo- nent 1 ) and component 2) and a compound III (component 3), the weight ratio of component 1 ) and component 2) depends from the properties of the active substances used, usually it is in the range of from 1 :100 to 100:1 , regularly in the range of from 1 :50 to 50:1 , preferably in the range of from 1 :20 to 20:1 , more preferably in the range of from 1 :10 to 10:1 and in particular in the range of from 1 :4 to 4:1 , and the weight ratio of component 1 ) and component 3) usually it is in the range of from 1 :100 to 100:1 , regularly in the range of from 1 :50 to 50:1 , preferably in the range of from 1 :20 to 20:1 , more preferably in the range of from 1 :10 to 10:1 and in particular in the range of from 1 :4 to 4:1.

Any further active components are, if desired, added in a ratio of from 20:1 to 1 :20 to the component 1 ).

These ratios are also suitable for inventive mixtures applied by seed treatment.

When mixtures comprising microbial pesticides are employed in crop protection, the applica- tion rates preferably range from about 1 x 10 6 to 5 x 10 16 (or more) CFU/ha, preferably from about 1 x 10 8 to about 1 x 10 13 CFU/ha, and even more preferably from about 1 x 10 9 to 5 x 10 15 CFU/ha and particularly preferred even more preferably from 1 x 10 12 to 5 x 10 14 CFU/ha. In the case of (entomopathogenic) nematodes as microbial pesticides (e. g. Steinernema feltiae), the application rates preferably range inform about 1 x 10 5 to 1 x 10 12 (or more), more preferably from 1 x 10 8 to 1 x 10 11 , even more preferably from 5 x 10 8 to 1 x 10 10 individuals (e. g. in the form of eggs, juvenile or any other live stages, preferably in an infetive juvenile stage) per ha. When mixtures comprising microbial pesticides are employed in seed treatment, the applica- tion rates with respect to plant propagation material preferably range from about 1 x 10 6 to 1 x 10 12 (or more) CFU/seed. Preferably, the concentration is about 1 x 10 6 to about 1 x 10 9 CFU/seed. In the case of the microbial pesticides II, the application rates with respect to plant propagation material also preferably range from about 1 x 10 7 to 1 x 10 14 (or more) CFU per 100 kg of seed, preferably from 1 x 10 9 to about 1 x 10 12 CFU per 100 kg of seed.

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from inhibitors of complex III at Q 0 site in group A), more preferably selected from compounds (A.1 .1 ), (A.1 .4), (A.1 .8), (A.1 .9), (A.1 .10), (A.1.12), (A.1 .13), (A.1.14), (A.1 .17), (A.1 .21 ), (A.1.25), (A.1 .34) and (A.1 .35); particularly selected from (A.1.1 ), (A.1.4), (A.1.8), (A.1 .9), (A.1 .13), (A.1.14), (A.1 .17), (A.1.25), (A.1 .34) and (A.1 .35).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from inhibitors of complex III at Q, site in group A), more preferably selected from compounds (A.2.1 ), (A.2.3) and (A.2.4); particularly selected from (A.2.3) and (A.2.4).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from inhibitors of complex II in group A), more preferably selected from corn- pounds (A.3.2), (A.3.3), (A.3.4), (A.3.7), (A.3.9), (A.3.1 1 ), (A.3.12), (A.3.15), (A.3.16), (A.3.17), (A.3.18), (A.3.19), (A.3.20), (A.3.21 ), (A.3.22), (A.3.23), (A.3.28), (A.3.31 ), (A.3.32), (A.3.33), (A.3.34), (A.3.35), (A.3.36), (A.3.37), (A.3.38) and (A.3.39); particularly selected from (A.3.2), (A.3.3), (A.3.4), (A.3.7), (A.3.9), (A.3.12), (A.3.15), (A.3.17), (A.3.19), (A.3.22), (A.3.23),

(A.3.31 ), (A.3.32), (A.3.33), (A.3.34), (A.3.35), (A.3.36), (A.3.37), (A.3.38) and (A.3.39).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from other respiration nhibitors in group A), more preferably selected from corn- pounds (A.4.5) and (A.4.1 1 ); in particular (A.4.1 1 ).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from C14 demethylase inhibitors in group B), more preferably selected from compounds (B.1.4), (B.1.5), (B.1.8), (B.1.10), (B.1 .1 1 ), (B.1.12), (B.1 .13), (B.1.17), (B.1 .18), (B.1 .21 ), (B.1.22), (B.1.23), (B.1 .25), (B.1.26), (B.1 .29), (B.1.34), (B.1 .37), (B.1.38), (B.1 .43) and (B.1 .46); particularly selected from (B.1.5), (B.1.8), (B.1 .10), (B.1.17), (B.1.22), (B.1.23), (B.1 .25), (B.1.33), (B.1 .34), (B.1.37), (B.138), (B.1.43) and (B.1.46).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from Deltal 4-reductase inhibitors in group B), more preferably selected from compounds (B.2.4), (B.2.5), (B.2.6) and (B.2.8); in particular (B.2.4).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from phenylamides and acyl amino acid fungicides in group C), more preferably selected from compounds (C.1.1 ), (C.1 .2), (C.1.4) and (C.1.5); particularly selected from (C.1 .1 ) and (C.1.4).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from other nucleic acid synthesis inhibitors in group C), more preferably se- lected from compounds (C.2.6),(C.2.7) and (C.2.8).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from group D), more preferably selected from compounds (D.1 .1 ), (D.1.2), (D.1.5), (D.2.4) and (D.2.6); particularly selected from (D.1.2), (D.1.5) and (D.2.6).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from group E), more preferably selected from compounds (E.1.1 ), (E.1.3), (E.2.2) and (E.2.3); in particular (E.1.3).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from group F), more preferably selected from compounds (F.1.2), (F.1.4) and (F .1.5).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from group G), more preferably selected from compounds (G.3.1 ), (G.3.3), (G.3.6), (G.5.1), (G.5.2), (G.5.3), (G.5.4), (G.5.5), G.5.6), G.5.7), (G.5.8), (G.5.9), (G.5.10) and (G.5.1 1); particularly selected from (G.3.1), (G.5.1 ), (G.5.2) and (G.5.3).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from group H), more preferably selected from compounds (H.2.2), (H.2.3), (H.2.5), (H.2.7), (H.2.8), (H.3.2), (H.3.4), (H.3.5), (H.4.9) and (H.4.10); particularly selected from (H.2.2), (H.2.5), (H.3.2), (H.4.9) and (H.4.10).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from group I), more preferably selected from compounds (1.2.2) and (1.2.5).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from group J), more preferably selected from compounds (J.1.2), (J.1.5),

(J.1.8), (J.1.11 ) and (J.1.12); in particular (J.1.5).

Preference is also given to mixtures comprising as component 2) at least one active sub- stance selected from group K), more preferably selected from compounds (K.1.41), (K.1.42), (K.1.44) and (K.1.47); particularly selected from (K.1.41 ), (K.1.44) and (K.1.47).

Synthesis example

With due modification of the starting compounds, the procedures shown in the synthesis exam- pies below were used to obtain further compounds I. The resulting compounds, together with physical data, are listed in Table I below.

HPLC-MS: HPLC-column Kinetex XB C18 1 ,7m (50 x 2,1 mm); eluent: acetonitrile / water + 0.1 % TFA (5 gradient from 5:95 to 100 : 0 in 1.5 min at 60°C, flow gradient from 0.8 to 1.0 ml/min in 1.5 min). MS: Quadrupol Electrospray Ionisation, 80 V (positive mode). 1. Synthesis of Intermediate ethyl 2-benzyl-4-methyl-pentanoate.

Under inert atmosphere, lithium diisopropylamide (4.457 g, 32 mmol) was dissolved in THF (250 ml.) and cooled to -78 °C. Ethyl-4-methylvalerate (5.000 g, 35 mmol) was added dropwise and stirred at -78 °C for 2 h. Benzyl bromide (7.1 16 g, 41.6 mmol) was added dropwise, stirred at - 78 °C for 1 h and subsequently for 2 h at 25 °C. Aq. sat. NH 4 CI solution was added and the or- ganic phase was extracted with MTBE, washed with water and brine, dried over MgS0 4 , and evaporated. Column chromatography (S1O2; cyclohexane/ethyl acetate 2:1 ) yielded ethyl 2-ben- zyl-4-methyl-pentanoate (8.100 g, quant.) as colorless powder.

2. Synthesis of Intermediate ethyl 2-benzyl-2,4-dimethyl-pentanoate.

Under inert atmosphere, lithium diisopropylamide (3.456 g, 42 mmol) was dissolved in THF (40 ml.) and cooled to -78 °C. Ethyl 2-benzyl-4-methyl-pentanoate (6.300 g, 26.9 mmol) was dis- solved in THF (10 ml_), added dropwise, and stirred at -78 °C for 2 h. Methyl iodide (4.579 g, 32 mmol) was added dropwise, stirred at -78 °C for 10 min and subsequently for 2 h at 25 °C. Aq. sat. NH4CI solution was added and the organic phase was extracted with MTBE, washed with water and brine, dried over MgS0 4 , and evaporated. Column chromatography (S1O2; cyclohex- ane/ethyl acetate 2:1) yielded Intermediate ethyl 2-benzyl-2,4-dimethyl-pentanoate (6.300 g, 94%) as colorless powder.

3. Synthesis of Intermediate 2-benzyl-2,4-dimethyl-pentanoic acid.

Ethyl 2-benzyl-2,4-dimethyl-pentanoate (6.300 g, 25.4 mmol) was dissolved in dioxane/EtOH 1 :1 (30 ml_). Aq. 2 M NaOH solution (25 ml.) was added and the mixture was stirred at 120 °C over night. The organic solvents were evaporated, the mixture was taken up in water and washed with cyclohexane. The aq. phase was adjusted to pH = 1 with HCI and extracted with dichloromethane. The combined organic phases were washed with water and brine, dried over MgS0 4 , and evaporated to yield 2-benzyl-2,4-dimethyl-pentanoic acid (650 mg, 12%) as color- less powder.

Synthesis of Intermediate 2-benzyl-2,4-dimethyl-pentanoyl chloride.

Under inert atmosphere, 2-benzyl-2,4-dimethyl-pentanoic acid (650 mg, 3 mmol) was dissolved in thionyl chloride (6 ml_), stirred at 95 °C for 3 h, and evaporated to yield 2-benzyl-2,4-dimethyl- pentanoyl chloride (690 mg, 98%) as a brown oil.

4. Synthesis of Ex-80.

Under inert atmosphere, 5,6-dimethyl-3-amino-pyridine (512 mg, 4.2 mmol) was dissolved in di- chloromethane (15 ml.) and treated with NEt3 (424 mg, 4.2 mmol). The mixture was cooled to 0 °C, treated with a solution of 2-benzyl-2,4-dimethyl-pentanoyl chloride (553 mg, 2.3 mmol) in di- chloromethane (3 ml_), stirred at 0 °C for 20 min and subsequently at 25 °C over night. Water was added and phases were separated. The aq. phase was extracted with dichloromethane and the combined organic phases were washed with aq. sat. NH 4 CI solution, aq. sat. NaHCC> 3 solution, and brine, dried over MgS0 4 , and evaporated. Column chromatography (S1O2; cyclo- hexane/ethyl acetate 2:1) yielded Target Molecule Ex-80 (550 mg, 73%) as colorless powder.

Table I:

Compounds Ex-1 to Ex-81 of the formula I.A-1

I.A-1

177

o

O

o\

n

H o o

C/I

o

O o\

n

H

o

o

O

o\

n

H o o

C/I

o

o\

Table 2:

5 Compounds Ex-82 to Ex-96 of the formula I.A-2

n

H o o o

* Standart 100_700

* * pos_Standard

HPLC: High Performance Liquid Chromatography; HPLC-column Kinetex XB C18 1 ,7m (50 x 2,1 mm); eluent: acetonitrile / water + 0.1 % trifluoroacetic acid (gradient from 5:95 to 100:0 in 1.5 min at 60°C, flow gradient from 0.8 to 1 .0 ml/min in 1.5 min). MS: Quadrupol Elec- trospray Ionisation, 80 V (positive mode). Rt: retention time i

II. Biological trials

Microtest

The active compounds were formulated separately as a stock solution having a concentration of 10000 ppm in dimethyl sulfoxide.

Example 1 - Activity against the grey mold Botrytis cinerea in the microtiterplate test

The stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations. A spore suspension of Botrci cinerea in an aqueous biomalt or yeast-bactopeptone-sodiumacetate or DOB solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an ab- sorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation.

In this test, the samples which had been treated with 31 ppm of the active substance from ex- amples Ex-12, Ex-14, Ex-16, Ex-33, Ex-38, Ex-42, Ex-56, Ex-63, Ex-70, Ex-74, Ex-76, Ex-77, Ex-80 and Ex-88 respectively, showed up to at most 1 1 % growth of the pathogen.

Example 2 - Activity against Fusarium cutmorum in the microtiterplate test

The stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations. A spore suspension of Fusarium cuimorum in an aqueous biomalt or yeast-bactopeptone-glycerine or DOB solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an ab- sorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation.

In this test, the samples which had been treated with 31 ppm of the active substance from ex- amples Ex-4, Ex-5, Ex-6, Ex-7, Ex-12, Ex-12, Ex-13, Ex-14, Ex-15, Ex-16, Ex-17, Ex-18, Ex-25, Ex-33, Ex-35, Ex-41 , Ex-43, Ex-44, Ex-45, Ex-46, Ex-47, Ex-49, Ex-50, Ex-53, Ex-56, Ex-57, Ex-59, Ex-63, Ex64, Ex-70, Ex-74, Ex-80 and Ex-88 respectively, showed up to at most 15 % growth of the pathogen.

Example - 3 - Activity against rice blast Pyricularia oryzae in the microtiterplate test

The stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations. A spore suspension of Pyricularia oryzae in an aqueous biomalt or yeast-bactopeptone-glycerine or DOB solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an ab- sorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation.

The measured parameters were compared to the growth of the active compound-free control variant (100%) and the fungus-free and active compound-free blank value to determine the rela- tive growth in % of the pathogens in the respective active compounds. In this test, the samples which had been treated with 31 ppm of the active substance from ex- amples Ex-30, Ex-31 , Ex-32, Ex-33, Ex-35, Ex-38, Ex-42, Ex-49, Ex-50, Ex-51 , Ex-52, Ex-56, Ex-59, Ex-63, Ex-80, Ex-81 , Ex-84, Ex-85, Ex-87, Ex-88, Ex-90, Ex-93, Ex-94, Ex-95 and Ex-96 respectively, showed up to at most 15 % growth of the pathogen.

Green House

The spray solutions were prepared in several steps:

The stock solution was prepared: a mixture of acetone and/or dimethylsulfoxide and the wetting agent/emulsifier Wettol, which is based on ethoxylated alkylphenoles, in a relation (volume) sol- vent-emulsifier of 99 to 1 was added to the initial weight of the compound to give a total of 5 ml. Water was then added to total volume of 100 ml.

This stock solution was diluted with the described solvent-emulsifier-water mixture to the given concentration.

Preventative fungicidal control of Botrytis cinerea on leaves of green pepper

Young seedlings of green pepper were grown in pots to the 4 to 5 leaf stage. These plants were sprayed to run-off with an aqueous suspension, containing the concentration of active ingredient or their mixture mentioned in the table below. The next day the plants were inoculated with an aqueous biomalt or DOB solution containing the spore suspension of Botrytis cinerea. Then the plants were immediately transferred to a humid chamber. After 5 days at 22 to 24· C and a relative humidity close to 100 % the extent of fungal attack on the leaves was visually assessed as % diseased leaf area.

In this test, the samples which had been treated with 250 ppm of the active substance from examples from Ex-33, Ex-36, Ex-38, Ex-42, Ex-80 and Ex-94 respectively, showed up to at most 15 % growth of the pathogen whereas the untreated plants were 90% infected.